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ABSTRACT
A method was developed for preparing microsomes 
from rat and guinea-pig small intestine. The microsomal 
preparations were used to compare rat and guinea-pig 
drug metabolising enzymes. Guinea-pig intestine was 
found to have a higher level of cytochrome P-450, 
cytochrome b^ and NADPH cytochrome c reductase than 
rat; ethoxycoumarin O-deethylase and naphthol 
glucuronyItransferase levels were similar in both species 
and deesterification was higher in rat than in guinea-pig 
intestine.
A method was developed for separating villous tip 
and crypt cells from rat intestine, from which microsomes 
were prepared and used to study the drug metabolising 
capacity of the two cell populations. Considerable 
xenobiotic metabolising activity was found in the 
intestinal crypt cells, but this activity was 50-70% 
of that of the villous tip cells.
y
A method for isolating viable cells from guinea- 
pig small intestine was developed, and these cells were 
used to study the metabolism of some model compounds. 
Phase I metabolism of 7-ethoxycoumarin (0-deethylation) 
was found to be forty times slower than phase II 
metabolism (glucuronidation and sulphation). Sulpho- 
transferase did not appear to be readily saturated, 
whereas glucuronidation did become saturated. 2-Hydroxy- 
biphenyl was not a good candidate for sulphation, whereas 
other phenols used were well sulphated.
The cytosol fraction of guinea-pig intestinal 
cells was used to further investigate sulphation.
Evidence for the existence of more than one intestinal, 
cytosolic sulphotransferase was found, and substrate 
inhibition of the enzymes was observed.
Isolated in situ loops of rat and guinea-pig 
small intestine were used to investigate the fate of 
7-hydroxycoumarin conjugates, formed in the intestinal 
epithelia. A considerable amount of both sulphate and 
glucuronic acid conjugates reemerged into the intestinal 
lumen, rather than pass into the blood. This confirmed 
observations made using everted sacs of guinea-pig small 
intestine.
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To my family
"But, Mousie, thou art no thjr. lane,,. .
In proving foresight may be vain:
The best-laid schemes o' Mice anT Men
Gang aft a-gley,
An* lea’e us nought but grief an* pain,
For promised joy!
Still thou art blest, compar’d w i’ me! 
The present only jtoucheth thee:
But, Och! I backward cast my e ’e
On prospects drear!
An’ forward, tho* X canna see,
X guess an1 fear!”
Robert Burns 
"To a Mouse" (1785)
ABBREVIATIONS USED IN THIS THESIS
ADP adenosine 5 ’-diphosphate
ATP adenosine 5 '-triphosphate
CoA coenzyme A
DMF N,N dimethyl formamide
DNA deoxyribonucleic acid
EDTA# ethylenediaminetetraacetic acid
Hepes N-(2-hydroxyethyl)-piperazine-N*-2-
ethansulphonic acid
NADH reduced nicotinamide-adenine dinucleotide
NADPH reduced nicotinamide-adenine dinucleotide
phosphate
PAPS 3*-phosphoadenosine 5*-phosphosulphate
Tris tris (hydroxymethyl) aminomethane (2-amino-
2-hydroxymethyl-propane-l,3-diol)
UDP uridine 5'-diphosphate
UDPGA uridine 5 1-diphosphoglucuronic acid
Enzymes Referred to in this Thesis
Enzyme number Recommended Name : Other Names
1.1.1.88 Hydroxymethylglutaryl-CoA reductase
1.4.3.4 Amine oxidase (flavin containing) :
Monoamine oxidase
1.6.2.2 Cytochrome b^ reductase (NADH)
1.6.2.4 NADPH-cytochrome reductase :
NADPH-cytochrome c reductase
1.6.6.7 Azobenzene reductase : azo-reductase
1.14.14.1 Aryl 4-monooxygenase : Aryl 4-
hydroxylase. (A cytochrome P-450 
enzyme)
1.14.14.2 Benzopyrene 3-monooxygenase : Benzopyrene
hydroxylase. (A cytochrome P-448 enzyme)
1.14.15.3 Alkane 1-monooxygenase : Fatty acid
w-hydroxylase. (A cytochrome P-450 
enzyme)
2.4.1.17 UDP glucuronosyltransferase :
glucuronyltransferase
2.5.1.13 Glutathione S-aryltransferase
2.5.1.14 Glutathione S-aralkyltransferase
2.8.2.1 Aryl sulphotransferase : phenol
sulphotransferase
3.1.1.1 Carboxylesterase : B-esterase
3.1.1.2 Arylesterase : A-esterase
3.1.3.1 Alkaline phosphatase
3.1.3.2 Acid phosphatase
3.1.6.1 Arylsulphatase : sulphatase
3.2.1.31 ft -Glucuronidase
3.5.1.4 Amidase
4.2.1.63 Epoxide hydratase
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INTRODUCTION
What is Drug Metabolism?
The human body is exposed to many potentially 
hazardous chemicals which are present in the environment.
It has been estimated that as many as 63,000 man-made 
chemicals are presently in current use (Blumberg (1978)), 
and compounds from natural sources (Gross and Newberne 
(1977)) serve to swell this number. Some of these 
chemicals will be harmless to the human body, even on 
chronic exposure, but a small dose of others could be 
fatal, whilst repeated exposure to small doses of other 
compounds could cause allergies, cancers (Ames (1979)) 
or disfigurement.
The body is exposed to these potential toxins 
in a number of different ways. The most important route 
of exposure is oral ingestion of the chemical, either as 
a component of the diet (Gross and Newberne (1977)), as
a pharmaceutical, or as an airborne environmental
\ . . .
contaminant. Most absorption of orally ingested compounds 
occurs in the small intestine. Chemicals can enter the 
body by other routes, .most commonly through the skin or 
via the lungs, and pharmaceuticals may also be administered 
anally or by injection.
Any chemical which enters the body, which is not 
normally produced by the body, and which cannot be used 
beneficially by the body, is deemed an anutrient or 
xenobiotic. Relatively few lipophilic xenobiotics which 
enter the body leave unaltered. The metabolites formed 
may be excreted either via the urine, faeces, sweat glands, 
hair follicles or expired air, and are usually more water 
soluble than the parent compound. If a lipophilic 
xenobiotic was not made more water soluble and excreted, 
it would accumulate in the body with possible toxic result 
(Hanninen et al. (1979), Joshi et al.(1977), Tayler and 
Piper (1977)).
Xenobiotic metabolism can be divided into two 
basic types of reaction. The phase I reactions, which 
include hydroxylations, oxidations, epoxidations, 
dealkylation, deamination and desulphuration, are also 
called non-synthetic or preconjugation reactions. The 
phase II reactions include conjugation with glucuronic 
acid, sulphate, amino acids and glutathione, methylation 
and acetylation, and are also called synthetic or conjugation 
reactions. Many, but not all, of the phase I reactions are 
catalysed by an enzyme system which is predominantly 
located in the endoplasmic reticulum, and is called 
cytochrome P-450. Other enzymes involved in phase I 
reactions include amine oxidase (Prough and Ziegler 
(1977)) and esterases (Inoue et al. (1979, A), Rowland 
et al.(1977)). Most xenobiotics which enter the body 
will be metabolised by more than one enzyme. Phase I 
metabolism of a xenobiotic may provide the group or 
configuration necessary for phase II metabolism to take 
place. The metabolite(s) produced by phase I metabolism 
of a foreign compound may be either more or less toxic 
than the parent compound, whereas products of phase II 
metabolism are, with a few exceptions (Bock (1977)), less 
toxic than the original compound.
Why is the Intestine Involved in Drug Metabolism?
The liver and kidney have traditionally been 
regarded as the principle sites of drug metabolism in 
the body (Hartiala (1973)), but the importance of other 
tissues is now being recognised (Aitio (1973), Connelly 
and Bridges (1980)). For example, drug metabolism by 
the skin is an important consideration when assessing 
the effects of air pollution and topically applied drugs. 
Inhaled cigarette smoke and polluted air will come in 
contact primarily with the lungs, hence xenobiotic 
metabolism there, again cannot be ignored. The other
major first line of defence against xenobiotics. is the 
intestine. Any orally ingested compound will come in 
contact with the intestine before reaching the liver 
or kidneys.
Most pharmaceuticals are administered orally; 
there are many anutrients in the food we eat (Powell 
et al.(1974)), and other xenobiotics which could be 
swallowed include pesticides, tobacco and alcohol.
The greatest absorption of most orally ingested material 
takes place in the small intestine, therefore, the 
intestinal epithelia are exposed to a wide variety of 
xenobiotics and any metabolism there will affect their 
absorption, excretion and toxicity to the rest of the 
body.
What is the Structure of the Small Intestine?
The small intestine is organised on three basic 
levels. The outermost layers comprise the longitudinal 
and circular muscle coats. Within these are the submucosal 
and mucosal layers. The mucosa of the small intestine 
consists of three layers, the absorptive layer,-the lamina 
propria, and the muscularis mucosae. The muscle coat 
separates the mucosa from the underlying submucosa 
(Figure 1) (Levitan and Wilson (1974)). The middle layer, 
the lamina propria, is heterogeneous in composition and 
contains various cell types. In addition to its structural 
function, the lamina propria produces immunoglobulins.
The absorptive layer consists of a single sheet of 
columnar epithelium attached directly to the underlying 
lamina propria. In the duodenum and jejunum of man, the 
villi range from 0.5 to 1mm in height and increase the 
absorptive surface of the gut nearly 8-fold (Levitan and 
Wilson (1974)).
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Figure 1 Schematic diagram of two sectional villi and 
a crypt to illustrate the histologic organisation of the 
sfcall intestinal mucosa. (From Levitan and Wilson (1974))
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Figure 3 Schematic illustration of the specialisation of 
the apical cytoplasm of the plasma membrane of intestinal 
absorptive cells. (From Levitan and Wilson (1974))
The surface of the villi contains absorptive, 
goblet and enterochromaffin cells (Figure 1). The crypts 
contain undifferentiated cells and are the region where 
cells multiply. ‘ As cells migrate toward the villus tip, 
they differentiate into specific cell types. The time 
required for cells to migrate from the crypt to the villus 
tip is 5-7 days in the human duodenum and jejunum and 
about 3 days in the ileum, (Levitan and Wilson (1974), 
Eastwood (1977)), and 2 to 3 days in rodents.
The well differentiated principal cells of the 
intestinal villus, generally known as the columnar 
absorbing cells, are by far the most numerous cell type 
and form a virtually unbroken surface layer (Toner (1968)) 
The most distinctive specialisation of the intestinal 
absorbing cell is the striated or brush border which 
consists of discrete microvilli. These microvilli 
(Figure 2) further increase the absorptive surface of 
the intestine about 30- to 40-fold (Levitan and Wilson 
(1974)). A distinctive surface coating is present on 
the apical surface of the absorbing cells of certain 
species, notably man, cat and bat, in both small and 
large intestine. 'This material is not ^ coating of the 
epithelium as a whole, but is related to the individual 
cells, and is not simply a layer of mucus. It has been 
suggested that this coating could be regarded as an 
integral part of the cell membrane (Toner (1968)). The 
fuzzy coat (Figure 3) contains acid mucopolysaccharide 
and may represent a special form of glycocalyx. The 
surface coating may be significant in relation to 
absorption, and may also protect the cell surface.
The crypt cells fulfil the function of cell 
renewal for the intestinal epithelium as h whole. The 
cells of the crypt are therefore undifferentiated or
proliferative cells. There is a transition from crypt 
cell to villous cell morphology at the crypt neck, and 
Certain histochemical changes take place in the epithelial 
cells as they mature. The most pronounced difference 
between crypt and villous cells lies in the length and 
packing of the microvilli, there being far fewer in the 
crypt cells. The terminal web is virtually nonexistent, 
and the orientation of the microvilli tends to be 
irregular (Toner (1968)). The fuzzy coat is less 
prominent, although still recognisable.
The goblet cell is a simple, unicellular gland 
secreting a sulphated carbohydrate-protein complex, 
which is thought to have a lubricant and protective 
function. The typical goblet cell has a narrow base, 
a basally placed nucleus, and an apex distended by* 
accumulated precursor mucus material, mucinogen. This 
cell has an apical striated border morphologically similar 
to that seen on the surface of the absorptive epithelial 
cell.
The pyramidal Paneth cells are situated at the 
base of the intestinal crypts. Their distinctive feature 
is their apical granulation apparently due to secretion.
The nature and function of the Paneth cells are not yet 
settled. They probably produce some form of exocrine 
secretion with a predominantly protein composition, and 
it is likely that this secretion is concerned with digestion 
(Toner (1968)).
The enterochromaffin cells have a characteristic 
morphology and distinctive staining reactions, some of 
which are based upon a capacity to reduce silver and 
chromium salts. The basal granulation of these cells, 
and their similarity to other cells with known endocrine
function, suggests that they are endocrine secretory in 
nature, and it is now accepted that the enterochromaffin 
cell system produces the hormone 5-hydroxytryptamine, 
otherwise known as serotonin.
Cells of apparently lymphoid origin, at least in 
terms of morphology, are commonly found in the intestinal 
epithelium in variable numbers, although their origin, 
function and fate are a matter of speculation (Toner 
(1968)). .
The principal cells of the intestinal villi are 
the main absorptive cells, with the cells of the crypts 
probably contributing to a lesser extent to the absorptive 
function of the small intestine. It is probable, therefore, 
that these cells contain the enzymes involved in drug 
metabolism.
How do Xenobiotics Reach the Small Intestine?
Compounds which enter the mouth and are swallowed 
travel down the oesophagus to the stomach. Few compounds 
are absorbed to a significant extent in the stomach. On 
leaving the stomach, the compounds will enter the 
duodenum, then the jejunum and ileum, these three portions 
together, forming the small intestine. The surface area 
available for absorption in the small intestine is much . 
greater than that in the stomach (the presence of villi 
and microvilli increases the area approximately 300 times). 
Oral ingestion of xenobiotics is the most significant route 
via which compounds will reach the small intestine.
Xenobiotics which are injected can also reach the 
intestine via biliary excretion from the liver. Some of 
these compounds will already have been metabolised, 
particularly in the liver, before reaching the intestinal
epithelia, but this will not preclude further metabolism 
taking place in the intestine. Substances absorbed by 
the skin, via the lungs or by the colon (eg. from a rectal 
enema) may also reach the liver and thence the small 
intestine, owing to biliary excretion, but in these cases, 
intestinal metabolism of the drug will probably contribute 
little to its overall disposition.
Xenobiotics also reach the small intestine via 
the mesenteric blood supply, although it is. not known 
to what extent they may be subsequently metabolised in 
the epithelia. Metabolism of compounds reaching the 
intestine by this, or any other indirect route, would not 
be very significant unless the intestine was capable of 
carrying out a reaction which did not occur elsewhere in 
the body,or a toxic metabolite was formed which caused 
damage to the intestinal cells. Rectal administration 
of a xenobiotic could result in some of the drug reaching 
the small intestine via the colon and caecum, but the 
amount would be very small.
By What Routes can Xenobiotics and their Metabolites 
Leave the Small Intestine?
Xenobiotics and their metabolites can leave the 
small intestine either by absorption into the mesenteric 
blood, which would result in them going to the liver, or 
absorption into the lymph, and thence to the general 
systemic circulation, or by excretion into the intestinal 
lumen, which would taken them to the caecum and colon.
If the first route is taken, the xenobiotic would then 
either be excreted in the bile, and thus returned to the 
intestine, or absorbed into the general systemic 
circulation. Compounds have been detected in the thoracic 
duct lymph of rats following their absorption from the 
small intestine. However, the amount found represented
only a small percentage of the total dose absorbed, 
and was probably not due to direct absorption into the 
lacteals, but rather to the ability of the compounds 
to distribute in the body water compartments, of which 
lymph is a part (Sieber et ad.(1974)). Compounds excreted 
via the bile, or directly into the lumen can be eliminated 
in the faeces, or reabsorbed by the small or large intestine 
(Levine (1978), Pang and Gillette (1978), Volp and Lage 
(1977)). Those absorbed into the general systemic 
circulation could be excreted in the urine .or recycled 
back into bile or other secretory fluids.
What Drug Metabolism Occurs in the Small Intestine?
The small intestine is capable of carrying out 
a wide variety of drug metabolising reactions (Shirkey
(1977)), and is probably nearly as versatile as the liver. 
The level of the enzymes is usually lower in the intestine 
than in the liver, but for some reactions, such as 
deesterification, the intestine may have the higher level.
A comprehensive review of intestinal drug metabolism may 
be found in the PhD thesis of Shirkey (1977), hence the 
present report only covers in detail the literature of 
the last 3 years.
Phase I Reactions
The majority of phase T reactions are catalysed 
by cytochrome P-450, which was the subject of a recent 
review by Blumberg (1978). There are few reports in which 
cytochrome P-450 content of the intestine was estimated 
directly (Le. spectrally). Rat is the most commonly used 
laboratory animal, and estimates of the amount of 
cytochrome P-450 in rat intestine have been llpmoles/mg 
protein (Stohs jet aJ. (1976)), and 18pmoles/mg protein 
(Shirkey et al.(1979, A)). Knoll et al.(1977) failed to 
detect a measurable amount of cytochrome P-450 in their
rat intestinal microsomes, but found 240pmoles/mg protein 
in guinea-pig intestinal microsomes. Tredger and Chhabra
(1977) were also unable to measure cytochrome P-450 in 
rat intestinal microsomes, but reported 470pmoles/mg 
microsomal protein in rabbit small intestine, whilst 
Ichihara et al.(1979) reported a very similar amount 
(400pmoles/mg protein) of cytochrome P-450 in their 
rabbit intestinal microsomes. The cytochrome P-450 
content of rat colon has been measured by Fang and 
Strobel (1978, B), who found 16pmoles/mg microsomal 
protein.
In many cases cytochrome P-450 level has been 
measured indirectly, by studying its enzyme activity.
The most commonly used substrate for this purpose has 
been benzo(a)pyrene. Metabolism of benzo(a)pyrene 
produces a number of different metabolites, many of 
which are conjugates. The metabolism of polycyclic ~
hydrocarbons has been described by De Pierre and Ernster
(1978). Bock et al.(1979) instilled benzo(a)pyrene 
(lOOnmol) into a rat intestinal loop in situ, and showed 
that, after 30 minutes, 43% of the substrate was 
metabolised, with 86% of the metabolites being found in 
the portal blood. Isolated intestinal cells from rat
were used by Grafstrom et al. (1979) to study benzo(a)pyrene 
metabolism. They reported that 3pmoles of metabolites 
were formed /10 cells per minute. A similar isolated 
cell system was used by Stohs et aJL. (1977), who alsog
reported 3pmoles of metabolites formed /10 cells per 
minute. The same group (Stohs et^  al. (1976)) used microsomes 
from rat intestine as the enzyme source and obtained nearly 
300pmoles of metabolites /mg protein per minute. Tredger 
and Chhabra (1977) investigated circadian rhythms of drug 
metabolism and found a maximum level of benzo(a)pyrene 
metabolism by rat intestinal microsomes of less than 
12pmoles of 3-hydroxybenzo(a)pyrene produced /mg protein
per minute. It is possible that they did not detect all 
the metabolites formed, since Stohs ct aX.(1976) found 
that 3-hydroxybenzo(a)pyrene accounted for only 13.5% 
of the total metabolites formed by rat intestinal 
microsomes. Rabbit intestine was found to be nearly 5 
times as active as rat intestine, in the metabolism of 
benzo(a)pyrene, with 58pmoles of 3-hydroxybenzo(a)pyrene 
being formed /mg protein per minute (Tredger and Chhabra 
(1977)).
Microsomes from rat colon have also been shown 
to metabolise benzo(a)pyrene, with nearly 7pmoles of the
3-hydroxy metabolite being formed /mg protein per minute 
(Fang and Strobel (1978, B)). The S9 fraction from rat 
colonic cells produced 3.9pmoles 3-hydroxybenzo(a)pyrene 
/mg protein per minute (Fang and Strobel (1978, A)).
It is difficult to compare results obtained using 
different tissue preparations, eg. microsomes, S9 fractions, 
isolated cells, and jui situ isolated loops of intestine, 
particularly since they all contain different amounts of 
protein, and cell fractionation may result in the loss of
y
some of the enzyme activity (see Chapter 1). Investigation 
of the metabolism of benzo(a)pyrene provides information on 
a fair range of metabolites produced by the small intestine, 
provided high pressure liquid chromatography is used to 
separate out the metabolites (Stohs et al. (1977)). Benzo(a)- 
pyrene is also commonly used as a substrate when investigating 
induction of cytochrome P-450. Benzo(a)pyrene is a 
carcinogen found in cigarette smoke and charcoal-broiled 
beef, both of which are commonly ingested in western society. 
The ultimate carcinogen of benzo(a)pyrene is thought to be 
the 7, 8-dihydrodiol 9, 10-epoxide, rather than the parent 
compound. The extent of metabolism of benzo(a)pyrene which 
occurs in the small intestine, on absorption, could thus 
significantly alter its toxicity.
Formation of nitrosamines, which are also carcinogens, 
has been recently reported to occur in the small intestine. 
Bartsch et al.(1977) have found a good correlation between 
the metabolic capacity of various tissues for N-nitrosamine 
activation and the number of tumours induced in these 
tissues by the N-nitrosamine metabolite(s). Hashimoto 
et al.(1976) found that dimethyInitrosamine was formed 
from dimethylamine and nitrate by the bacteria in the 
intestinal tract. They also noted that the rate of 
disappearance of the metabolite was greatest in the small 
intestine, presumably because the rate of absorption was 
greatest there. Nitrosamines may be ingested in foods, 
inhaled or formed in situ in the body from the parent 
amines and nitrate. Secondary amines, nitrite and nitrate 
are widely distributed in nature, the amines being present 
in fish meal, fish products, cereals, tea and tobacco, 
while nitrite and nitrate occur particularly in vegetables 
and other plants and in drinking water (Hashimoto et_ al.
(1976)). Although the intestinal wall may not be important 
in the formation of diraethylnitrosamine from dimethylamine 
and nitrate, it could be very important in the formation 
of dimethylnitrosamine from N-(acetoxy)methyl-N-methyl- 
nitrcsamine, by deesterification, and in forming active 
metabolites of nitrosamines which might damage the intestine 
itself or the liver. Esterase is found both in the soluble 
fraction of intestinal cells (Bartsch et al. (1977)), and in 
the microsomal fraction (Inoue et al.(1979, B)).
Hydroxylation of xenobiotics in the small intestine 
has been investigated using a variety of substrates. Bock 
et al.(1979) instilled (lOOnmol) naphthalene into an 
isolated in situ loop of rat small intestine and found 
that a variety of hydroxylated metabolites were produced.
In all, 16% of the naphthalene was metabolised in 30 
minutes, more than 80% of the metabolites being found in 
the portal blood. The metabolites of naphthalene which
were identified were 1-naphthol, o~quinone, catechol 
and dihydrodiol (Bock et al.(1979)). When perazine was 
administered in situ, in the rat, 3-hydroxyperazine, 
conjugated with glucuronic acid, was one of the major 
metabolites, though it accounted for only 3.7% of the 
administered dose (after 60 min incubation) (Breyer and 
Winne (1977)). Mahon et al.(1977) found that, in man, 
N-hydroxyethyl flurazepam was one of the metabolites of 
flurazepam produced in the small intestine, though it 
was a minor metabolite. Shirkey et alt(1979) used a 
microsomal preparation from rat intestine to investigate 
biphenyl 4-hydroxylation. They found that the maximum 
rate of formation of 4-hydroxybiphenyl was 0.2nmol/min/mg 
protein with normally prepared microsomes, and 0.24nmol/ 
min/mg protein with acid-precipitated microsomes. Hydroxy- 
lation of benzphetamine by rat colonic microsomes produced 
0.51nmol of formaldehyde per minute per mg protein (Fang 
and Strobel (1978, B)). When the same authors used the 
S9 fraction from rat colon, they found an activity of 
0.06nmol/min/mg protein for the, same reaction, the lower 
activity being due to a higher protein concentration in 
the S9 fraction. .
Another cytochrome P-450 catalysed reaction which
has been investigated in the small intestine using a
variety of substrates is demethylation. Harmine demethylase,
in isolated intestinal cells from rat, produced 21pmoles
0of both free and conjugated harmol per 10 cells per 
minute (Grafstrom et al.(1979)). Microsomes from guinea- 
pig small intestine were used as the enzyme source when 
chlorpromazine demethylation was studied (Knoll et al. 
(1977)). Between 5.5% and 6.5% of the (7.74pM) chlorprom­
azine was demethylated in 30 minutes. When perazine 
(900nmol/kg) was instilled into an isolated loop of rat 
intestine in situ, desmethylperazine was found in both 
the intestinal lumen and the portal blood, as a minor
metabolite (Breyer and Winne (1977)). Rabbit intestinal 
microsomes produced 0.55nmole formaldehyde /mg microsomal 
protein /minute by the demethylation of benzphetamine 
(Tredger and Chhabra (1977)), whilst demethylation of 
aminopyrene by rabbit microsomes yielded 0.65nmoles of 
formaldehyde /minute per mg protein (Xchihara et al.(1979)). 
Rat colon microsomes produced 0.3nmoles of formaldehyde 
per minute/mg protein from the demethylation of ethyl- 
morphine (Fang and Strobel (1978, B)), and 0.73nmoles 
of 4-nitrophenol /minute per mg protein from the 
demethylation of 4-nitroanisolec The S9 fraction of rat 
colonic cells produced 0.055nmoles of formaldehyde /minute 
per mg protein from the demethylation of ethylmorphine, 
and 0.043nmoles /minute per mg protein from the demethylation 
of 4-nitroanisole (Fang and Strobel (1975, A)).
O-Oeethylation of ethoxycoumarin by isolated cells 
from rat intestine has been studied by two groups (Shirkey 
et al»(1979, B), Grafstrom et al.(1979)). When ImM
ethoxycoumarin was used the rate of O-deethylation was
6 .6pmoles metabolised /10 cells per minute (Grafstrom
eli jal. (1979) ). 7-Ethoxycoumarin at lOOpM concentration 
resulted in 3.5nmoles being metabolised per 14 x 10^ cells 
in 45 minutes, ie. approximately 5.6pmoles product formed
r* ■
/IQ cells per minute, assuming deethylation to be linear 
with time and cell concentration, which was not the case 
(Shirkey et al.. (1979, B)). Flurazepam metabolism by 
human small intestine gave rise to mono- and didesethyl- 
flurazepam and N-desalkyflurazepam in almost equal amounts, 
which together accounted for nearly 80% of the radioactivty 
found in the portal vein, with 20% being the parent 
compound and the remainder being N-hydroxyethylflurazepam 
(Mahon et al. (1977) ). Ethoxyresorufin (6jiM) was 0-deethylated 
to produce 4pmoles resorufin /10^ cells per minute, by 
isolated cells from rat intestine (Grafstrom et al.(1979)).
Ranee and Shillingford (1977), investigating the metabolism 
of some phenolic opiates, using everted gut sacs, found 
that buprenorphine and possibly diprenorphine, were 
dealkylated, the former by 25% at lOpg/ml concentration, 
and the latter by 12% at 10pg/ml luminal concentration.
Aldrin epoxidase is a typical mixed function 
oxidase reaction, yielding dieldrin as the product 
(Riviere and Bach (1979)). It has been found in the 
intestine of rat, quail and sheep (Riviere and Bach
(1979), Turner at al.(1977, B). The quail had the 
highest level of duodenal epoxidase, of the 3 species 
studied.
Turner et al.(1977, B) studied a range of phase X 
reactions in sheep intestine, using whole tissue slices 
as the enzyme source. As well as aldrin epoxidase they 
found 0-demethylase (4-nitroanisole), N-demethylase 
(N-methylaniline), azo-reductase (1, 2-dimethyl- 4- 
(-4-carbox-phenylazo)-5-hydroxybenzene), nitro-reductase 
(4-nitrobenzoic acid), N-deacetylase (acetanilide), 
esterase (2-naphthyl acetate), and amidase (benzanilide), 
in measurable amounts in all regions of the gastrointestinal 
tract which they examined, ie the rumen, abomasum, 
duodemum, jejunum, ileum and colon.
Reducing equivalents are fed to cytochrome P-450 
via NADPH cytochrome c reductase, hence the level of 
this enzyme can influence the activity of cytochrome 
P-450. The activity of NADPH cytochrome c reductase has 
been measured in rat small intestinal microsomes by 
Stohs et al.(1976) and Shirkey et al.(1979, B). The 
first group reported finding an activity of 51.5nmoles 
of cytochrome c reduced per mg protein per minute, whilst 
Shirkey et al.(1979, B) reported a much lower value of 
27.Inmoles of cytochrome c reduced per mg of protein per
minute. The discrepancy could have been, at least partly, 
due to a strain difference in the rats. The level of 
this enzyme in rabbit small intestine has been measured 
as 90.5nmoles of cytochrome c reduced per mg protein per 
minute (Tredger and Chhabra (1977)), but has.also been 
reported as being 46.7nmoles cytochrome c reduced per mg 
protein per minute (Ichihara et al.(1979)).
Probably the most important phase I reaction in 
the small intestine, which is not catalysed by cytochrome 
P-450, is deesterification. There are a variety of 
specific and non-specific esterases in the intestine, 
some of which are found in the soluble fraction of the 
cell* and others in the microsomal fraction (Hartiala 
(1973)). The hydrolysis of some phthalate diesters has 
been studied, using intestinal preparations from rat, 
ferret and baboon (Lake et al»(1976), Lake et al.(1977)). 
The baboon and rat were found to be more active in 
hydrolysing these esters than the ferret. Sheep small 
intestine was active in metabolising 2-naphthyl acetate 
(Turner et al.(1977)). A microsomal preparation from 
rat small intestine metabolised 4-nitrophenol acetate and 
indoxyl acetace, at roughly the same rate (Shirkey et al. 
(1979, B)). The absorption and metabolism of 2 ampicillin 
esters, pivampicillin and carampicillin was investigated 
in human small intestine in vivo (Swahn (1976)). There 
was evidence that considerable hydrolysis of these drugs 
took place before and during absorption through the 
intestinal wall. This metabolism was shown not to be 
due to the intestinal contents, thus the intestinal 
epithelial esterase(s) was responsible. The localisation 
of esterase in rat small intestine was investigated 
histochemically by Van Dongen et al. (1977), who found 
that the esterase activity was lowest in the crypts of 
Lieberkuhn, and increased towards the villous tips. 
Esterase activity in human, rat, mouse, guinea-pig, rabbit 
and dog tissues was compared by Inoue et al. (1979, B).
Using everted sacs of rat intestine, these workers found
that the ester-type drug, indanylcarbencillin (1-CBPC),
was absorbed 3 times as fast as the non-ester-type drug,
carbenicillin (CBPC), and the ester was hydrolysed during
absorption, so that no 1-CBPC was found on the serosal
side of the sacs. Esterase activity was found to be
higher in the intestinal mucosa than in whole intestine,
intestinal contents, pancreas and plasma, of rats (Inoue
et al.(1979, B)). It was also higher in villous cells
than in crypt cells. The intestinal esterase had a much
lower molecular weight (approximately 30%) than hepatic
esterase, and was one of the B-esterase group (carboxyl-
esterase). There was a difference in the substrate
specificity of esterases in human intestine and those of 
*
laboratory animals, the mouse having the highest specific 
activity' and the dog the lowest (Inoue et al. (1979, B)).
The esterase from human intestine was purified, and its 
substrate specificity investigated (Inoue et al.(1979, A)). 
It was found to have a molecular weight of between 53,000 
and 55,000, and to hydrolyse short chain esters and ester- 
type drugs (aspirin, procaine, 1-CBPC), but not long chain 
esters ( p -naphthyl oleate, olive oil, amide type drugs).
Phase II Reactions
Glucuronidation
Glucuronidation of xenobiotics is the most 
thoroughly investigated, and in most cases the most 
active conjugation reaction of the small intestine 
(Hanninen et al.(1979), Caldwell (1978), Heitanen and 
Lang (1978)). The mechanism of glucuronidation involves 
transfer of the glucuronic acid moiety from uridine- 
diphosphoglucuronic acid (UDPGA), catalysed by glucuronyl 
transferase, to the xenobiotic or endogenous substrate.
Many reactive groups (-OH, -C00H, -NH2 , -SH) form 
glucuronides, and this is part of the reason why
glucuronidation is quantitatively so important (Bock
(1977)). There is evidence of a multiplicity of 
glucuronyltransferases in liver (Bock (1977)), but no 
evidence has yet been presented for multiplicity of this 
enzyme in the intestine.
Metabolism of benzo(a)pyrene by a rat intestinal 
loop in situ resulted in approximately 20% of the metabolites 
being found as glucuronides (Bock et al. (1979)), though the 
exact nature of the metabolites was not determined. Cells, 
isolated from rat intestine, were used by Stohs et al.
(1977) to metabolise benzo(a)pyrene. Almost two thirds of 
the total metabolites formed were conjugates of glucuronic 
acid, the glucuronides being mainly formed with 3-hydroxy- 
benzo(a)pyrene.
.'.When naphthalene was instilled into a rat intestinal 
loop ill situ, 40% of the metabolites formed were conjugates, 
mostly glucuronides of the dihydrodiol and 1-naphthol 
(Bock ert slI. (1979))... However, only 16% of the naphthalene 
present was metabolised during the 30 minute incubation, 
therefore only 6.4% of the naphthalene used was found as 
glucuronic acid conjugates. i-Naphthol itself was rapidly 
conjugated (30nmoles/10 cells/hour) by cells isolated from 
rat intestine (Grafstrom et al,(1979)), and the glucuronide 
of 1-naphthol was the major metabolite found (66%) by 
Shirkey ejfc al.(1979, A), using rat intestinal cells. 
2-Naphthol was metabolised less than half as fast as
1-naphthol (approx 13nmoles/10 cells/hour) by isolated 
cells (Grafstrom et al,(1979)).
Phenol itself, and substituted phenols are commonly 
used as substrates for glucuronidation reactions.
Metabolism of phenol by cells isolated from rat small 
intestine resulted in 14.8% being conjugated with 
glucuronic acid after an hour long incubation with
ft
8 x 10 cells per millilitre (Shirkey et al.(1979, A)).
Lucier et al. (1977) used 4-nitrophenol as the substrate 
when investigating the development of the glucuronidating 
capacity of guinea-pig and rabbit small intestine before 
and after birth. They also looked at sex differences in 
drug metabolism by guinea-pig small intestine, and found 
there were no sex differences, if adult animals were used.
The same substrate was used by Schiller and Lucier (1978) 
to investigate glucuronidation in crypt and tip cells 
from rat intestine. They found glucuronyltransf erase to 
be twice as active in the villous tip cells as in the 
crypt cells, using isolated cells supplemented with 
UDPGA. Turner et al.(1977, B) investigated glucuronyl- 
transferase in sheep intestine, using 2-aminophenol as 
the substrate. They found the jejunum to be the most 
active region of the intestinal tract, as far as this 
enzyme was concerned. A series of phenolic opiates was 
used by Ranee and Shillingford (1977) to study absorption 
and metabolism by everted gut sacs from rat small intestine. 
Data from their 5 drugs appeared to show that the availability 
of opiates to the portal system was significantly influenced 
by intestinal conjugation and that the efficiency of the 
conjugation, which was shown to be glucuronidation, was 
a function of the lipophilicity of the substrate.
Harmol was glucuronidated by isolated intestinal 
cells from rat, with approximately 5nmoles glucuronide 
formed /10 cells in an hour (Grafstrom et al.(1979)). 
Paracetamol glucuronide was the major metabolite of 
paracetamol, formed by isolated intestinal cells (Grafstrom 
el; jal, (1979) ) . 7-Hydroxycoumarin was glucuronidated by 
rat intestinal cells approximately 5 times as fast as it 
was sulphated (Shirkey et al, (1979, A)). Perazine was 
hydroxylated and then glucuronidated during absorption 
through rat small intestine in situ, though the absolute 
amount of perazine metabolised was less than 20% of that
administered (246nmol) (Breyer and V/inne (1977)).
Glucuronidation of two steroids by the intestine 
has also been studied. Diethylstilboestrol and testosterone 
were glucuronidated by rat small intestine (Lasker and 
Rickert (1977) and guinea-pig small intestine (Lucier 
et al.(1977) respectively.
Sulphation
Sulphate conjugation is probably the second most 
important phase II reaction in the small intestine. The 
mechanism of sulphation involves transfer of a sulphate 
group from phosphoadenosine phosphosulphate (PAPS), also 
called 1 active sulphate*, to the acceptor molecule (may 
be a xenobiotic or endogenous substrate), catalysed by 
sulphotransferase. Sulphotransferase in the small 
intestine is particularly important for disposing of 
phenolic compounds ingested in the diet (Powell and 
Curtis (1978)), swallowed accidentally or taken orally 
as a pharmaceutical.
Benzo(a)pyrene metabolism by isolated intestinal 
cells from rat gave a few sulphate conjugates, which were 
not positively indentified, but thought to be 6-hydroxy- 
methyl-benzo(a)pyrene sulphate (Stohs et al.(1977)).
Rat intestinal cells conjugated phenol with sulphate, 
and this accounted for 15% of the metabolites produced, 
when 7-hydroxycoumarin was the substrate, the sulphate 
conjugate again accounted for approximately 15% of the 
metabolites formed (Shirkey et al.(1979, A)). An in situ 
loop of rat intestine changed 12.5% of the perazine 
instilled into it (246nmol) into perazine sulphoxide, in 
an hour (Breyer and Winne (1977)). Chlorpromazine 
sulphoxide v/as the major metabolite of chlorpromazine, 
produced by guinea-pig intestinal microsomes, and it
accounted for between 7.25% and 11.5% of the chlorpromazine 
(7.7pM - 116jiM) used (Knoll ejt al. (1977)).
It has been shown that, in rat and guinea-pig 
liver, there is more than one sulphotransferase, with 
different, but sometimes overlapping, substrate specificities 
(Banerjee and Roy (1966, 1967, 1968), Sekura and Jakoby
(1978)). So far no evidence has been published for the 
existence of more than one sulphotransferase in the small 
intestine. Sulphotransferase is a cytosolic enzyme, unlike 
glucuronyltransferase, which is microsomal.
Other Phase II Reactions
Glutathione-S-transferase is another important 
cytosolic, conjugating enzyme which is involved in the 
transfer of sulphur. Conjugation with glutathione is the 
first step in mercapturic acid formation.
Pinkus et al.(1977) investigated glutathione-S- 
transferase activity in rat small intestine. They found 
that, as in liver, glutathione transfer in the intestine 
is catalysed by a family of enzymes, differing in their 
substrate specificity. The range of activities they 
found in the intestine was similar to that of rat liver.
The highest levels of glutathione-S-transferase were 
found in the villous cells of the duodenum and jejunum, 
where the greatest absorption of xenobiotics takes place. 
Glutathione-S-transferase has also been found in sheep 
intestine, where the highest level of activity was located 
in the jejunum (Turner et al. (1977, B)). A small amount 
of paracetamol-S-glutathione was formed when (ImM) 
paracetamol was incubated with cells isolated from rat 
intestine (Grafstrom et al.(1979)), and an even smaller 
amount of paracetamol-S-cysteine was formed.
Cysteine conjugates are formed by glutathione 
conjugation and subsequent cleavage of the glutamic acid 
and glycine moieties from glutathione by specific 
peptidases (Pekas _et al. (1979) ) . Cysteine conjugates 
of propachlor have been formed by everted sacs of rat 
small intestine, with the glutathione conjugate proposed 
as the intermediate (Pinkus et al.(1979)). The cysteine 
conjugate comprised 33% of the propachlor metabolites: 
formed (fe. between 15% and 24% of the substrate available).
The intestine is not very active in conjugation 
reactions involving transfer of amino acids. Benzoic 
acid (IOOjiM) was not measurably metabolised by isolated 
intestinal cells from rat, though rat hepatocytes conjugated
m
virtually all the (lOOpM) benzoic acid present with glycine 
or glucuronic acid (Shirkey et al.(1979, B)).
Rat small intestinal cells acetylated 8% of the 
aniline (IOOjiM) present in the incubation mixture in an 
hour and approximately 0.1% was found as N-acetyl-p- 
aminophenol, but no other metabolites of aniline were 
detected (Shirkey jet al. (1979, B) ).
What Factors Affect Intestinal Drug Metabolism?
Exogenous Factors
Several hundred drugs, insecticides, carcinogens 
and other chemicals are known to affect the activity of 
the xenobiotic metabolising enzymes in the liver. Some 
of these have also been shown to alter intestinal drug 
metabolising enzymes, and many more which probably would 
affect intestinal enzymes have not yet been investigated 
(Shirkey (1977)).
Induction
Enzyme induction entails derepression of a gene, 
leading to increased synthesis of the enzyme, induction 
of an enzyme is very often caused by an increased amount 
of its substrate. In the case of cytochrome P-450, which 
has a very wide substrate range, it means that a broad 
spectrum of compounds can cause induction (Blumberg
(1978), Hanninen et al.(1979), Marshall (1978), Vesell
(1977)).
The two chemicals most commonly employed when 
investigating induction of xenobiotic metabolising enzymes 
are 3-methylcholanthrene and phenobarbitone. 3-Methy- 
cholanthrene, when administered intraperitoneally did not 
have an effect on rat intestinal microsomal cytochrome 
P-450 (Bridges and Fry (1978)), but when it was given 
orally, it produced a more than 30-fold induction of 
cytochrome P-450 related benzo(a)pyrene metabolism 
(Stohs et al.(1976)), but had no effect on NADPH cytochrome 
c reductase activity. Isolated cells from rat intestine 
were used to study induction by 3-methylcholanthrene.
Sb?.rkey et ■ al ,(1979;'A) found that 3-methylcholanthrene 
administered intraperitoneally roughly doubled O-deethylation 
of 7-ethoxycoumarin. When the same compound was given 
orally, it had a much greater effect on the intestinal 
enzymes. Stohs et al.(1977) observed a 30-fold induction 
of benzo(a)pyrene metabolism, whilst Grafstrom et al (1979) 
observed a similar induction of benzo(a)pyrene metabolism, 
harmine demethylase increased by 86%, and deethylation of 
ethpxyresorufin and ethoxycoumarin were 42-fold and 43-fold 
respectively greater than the control values.
When phenobarbitone was administered to rats 
intraperitoneally, 7-ethoxycoumarin O-deethylation was 
roughly doubled (Shirkey et al,(1979, A)). Given orally,
phenobarbitone increased glucuronidation of 1-naphthol 
by isolated loops of rat small intestine (Turner et al. 
(1977, A)), and was also found to increase the cytochrome 
P-450 content of rat intestine approximately 6.5-fold, 
benzo(a)pyrene metabolism was doubled and NADPH cytochrome 
c reductase was not affected (Stohs et .al.(1976)).
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is 
a contaminant produced during the synthesis of the 
herbicide 2,4,5-trichlorophenoxyacetic acid, which causes 
a wide variety of damage in different species, eg. chloracne 
in man, oedema in chickens and mammals, suppression of 
cell-mediated immunity, hepatic necrosis in different 
laboratory animals, malformations in mice, and behaviour 
disturbances in man (Aitio and Parkki (1978)). Despite 
its many toxic effects, when administered intragastrically 
to rats, it did not significantly alter intestinal drug 
metabolising enzymes (Aitio and Parkki (1978)), though it 
had a pronounced effect on enzymes in liver, lung and 
kidney. This finding could have been due to the 7-day 
period between administration of the TCDD and measurement 
of the enzymes. It is quite possible that by then, if 
any induction had occurred in the intestine, the enzyme 
levels would have returned to normal, since cell renewal 
in the intestine takes only 2 to 3 days in rat. Schiller 
and Lucier (1978) found a doubling of intestinal UDP- 
glucuronyltransferase activity one day after an oral dose 
of TCDD, though this level of induction is much less than 
that observed in other tissues seven days after TCDD 
administration (Aitio and Parkki (1978)).
Oral administration of benzo(a)pyrene, itself 
often used as a model substrate for cytochrome P-450, 
increased glucuronidation of 1-naphthol (ImM), but when 
a higher concentration of 1-naphthol was present (2mM),
there was no increased glucuronidation after benzo(a)pyrene 
administration (Turner et al*(1977, A)). Cigarette smoke 
(which contains benzo(a)pyrene) increased epoxide 
hjj'dratase activity of rat small intestine, after both 
single and repeated exposure, up to a maximum of 175% 
of controls values. Arylhydrocarbon hydroxylase activity 
of the small intestine was also increased on single and 
repeated exposure of the animals to cigarette smoke, to 
a maximum of 800% of control values after 5 days repeated 
exposure. The UDP-glucuronyltransferase activity also 
increased several fold after repeated exposure to the 
smoke (Uotila (1977)).
Inhibition
As well as being induced, drug metabolising 
enzymes can be inhibited by various chemicals. Inhibition 
is a phenomenon normally studied iji vitro, and its 
significance to drug metabolism in vivo is not clear.
Selective inhibition is used in. vitro mainly in order to 
characterise the enzyme(s) involved in a specific reaction, 
or to determine whether inhibition of one enzyme-will 
result in increased activity of another. V
Stohs et jal..(1976) used cc-naphthoflavone as an 
inhibitor when investigating intestinal benzo(a)pyrene 
monooxygenase of uninduced and 3-methylcholanthrene 
induced rats. They found that 70pM cc-naphthoflavone 
completely inhibited benzo(a)pyrene metabolism by intestinal 
microsomes from the induced animals, but 7pM oC-naphthoflavone 
activated (4.5 times) metabolism by control microsomes, 
and 70pM decreased the activity by only 20%. The same 
group looked at the effect of various inhibitors upon 
benzo(a)pyrene metabolism by isolated rat intestinal cells. 
Metyrapone and SKF 525-A inhibited benzo(a)pyrene metabolism 
by cells from control rats and from 3-methylcholanthrene
treated rats. Rotenone and oc-naphthof lavone inhibited 
benzo(a)pyrene metabolism by cells from induced animals, 
but activated metabolism by cells from control rats 
(Stohs et al,(1977)).
The sulphation of harmol In vivo was inhibited by 
2,6-dichloro-4-nitrophenol, and by some chemically related 
compounds, though since the inhibitors were administered 
by intraperitoneal injection, and the sulphates detected 
in the urine, the liver, rather than the intestine was 
considered to be the major tissue involved in this 
instance (Koster et al.(1979)). Mulder and Meerman
(1978), have similarly studied in vivo inhibition of 
sulphation by various drugs, but the relevance of this 
work to intestinal metabolism is not clear.
Activation
The activation of drug metabolising enzymes can 
occur in vitro, and involves an increased activity of 
the enzyme, which is not due to an increased amount of 
the enzyme being present. The drug metabolising enzymes 
which are most susceptible to activation are cycochrome 
P-450 and UDP-glucuronyltransferase, which are both 
microsomal, membrane-bound, enzymes. The activation 
may, therefore, be due either to an effect on the 
membrane or on the enzyme itself. Stohs eh al.(1976,
1977) have observed activation of cytochrome P-450 by 
oc-naphthoflavone and rotenone (see above), but activation 
of the liver enzymes has been more thoroughly investigated 
(ag. Cinti (1978), Bock and Lilienblum (1979), Benford and 
Bridges (1979), Kapitulnik et al.(1977), Thomson and 
Holtzman (1977)).
Diet
The food we eat contains many, potentially harmful 
chemicals, such as plant phenolics (Gross and Newberne 
(1977)), as well as the nutrients which are essential to 
growth and well-being, and maximum absorption of these 
compounds occurs in the small intestine. It is likely, 
therefore, that the diet will have an effect on the level 
of the xenobiotic metabolising enzymes, especially since 
many of these enzymes also play an important role in 
metabolising endogenous compounds. Since most studies 
on the effects of diet have to be performed in vivo, it 
is difficult to assess to what extent the intestinal 
enzymes are affected, since enzymes in liver, kidney 
and qther tissues will also be subject to dietary 
modification.
The effect of deficiencies of various macronutrients 
(ie.carbohydrate, lipid, protein, lipotrppes) and micro- 
nutrients (vitamins, minerals) on drug metabolism in_ vivo 
has been reviewed by Campbell and Hayes (1974), and the 
effect of diet on gastrointestinal drug absorption has 
been reviewed by Welling (1977). Drug absorption will 
affect and be affected by drug metabolism. The relation­
ship of diet to cancers of the intestinal tract has been 
the subject of a number of studies (Castleden (1977),
Cruse et al.(1978), Lowenfels et al.(1977), Reddy et al. 
(1977)).
The effect of variation of specific dietary 
components on drug metabolism, and particularly drug 
metabolism by the intestinal wall, has been investigated 
by a number of groups. Altering the relative amounts of 
the three major dietary constituents, i.e. protein, lipid 
and carbohydrate, can affect intestinal drug metabolism.
A low carbohydrate and high protein diet decreased the
half-life of antipyrine and theophylline in man, from 
that when a normal diet, which was high in carbohydrate 
and low in protein was eaten (Kappas et a!L. (1976)). A 
high carbohydrate diet has been shown to delay absorption 
of indomethacin (Walluseh et al.(1978)). A diet which 
was low in protein increased (30-fold) the LDj-q dose of 
carbon tetrachloride in rats (McLean (1977)), and has 
also been shown to increase intestinal UDP-giucuronyl- 
transferase in rats (Hietanen and Lang (1978)). 
Glucuronyltransferase was also increased by feeding rats 
a diet containing 2% cholesterol, whereas 5% cholesterol 
and a cholesterol-free diet resulted in the same enzyme 
level as was present during feeding with the standard 
diet#(Hietanen and Lang (1978)). Feeding rats a high 
fat diet, rich in cholesterol led to an increase in 
cholesterol esterification, resulting from enzyme 
induction (Norum et al,(1977)). Dietary cholesterol 
(2%) enhanced aryl hydrocarbon hydroxylase activity in 
rat intestine, and doubled UDP-glucuronyltransferase 
activity (Hietanen and Laitinen (1978)).
More specific dietary effects have also been 
documented. Cabbage and brussel sprouts have been shown 
to stimulate drug metabolism in rat intestine and in man 
(Conney et al.(1977), Pantuck et al.(1976, 1979)). It 
was postulated that this induction was due to the presence 
of various indoles, in these vegetables, which, in purified 
form, were able to stimulate intestinal drug metabolism 
(Pantuck et £1.(1976)).
Charcoal, broiled beef increased intestinal 
phenacetin metabolism in rats, and had a similar effect 
in humans (Alvares et al.(1979, A and B), Pantuck et al. 
(1975), Conney et al.(1977)). This inductive effect is 
probably due to the presence of polycyclic aromatic 
hydrocarbons, such as benzo(a)pyrene metabolites, in the 
charcoal broiled beef.
Chronic ethanol ingestion caused an increase in 
cytochrome P-450 content and benzo(a)pyrene hydroxylase 
in the intestinal mucosa of rats (Seitz et al.(1978)). 
However, ethanol ingestion leads to a number of enzymic 
changes in the liver as well as the intestine, so this 
is probably not a specific induction of cytochrome P-450.
A deficiency in ascorbic acid decreased 7-ethoxy­
coumarin O-deethylase activity in guinea-pig liver and 
lung, but hot in the intestine (Kuenzig et al. (1977)). 
Neither epoxide hydrase nor benzo(a)pyrene hydroxylase 
were affected in lung, liver or intestine by a low 
ascorbate level in guinea-pig.
• *
Endogenous Factors
Various factors inherent in an animal or man 
will, to some extent, have an effect on the level of 
the drug metabolising enzymes. These factors are 
additional to the environmental factors discussed above, 
and in most cases specific effects on intestinal drug 
metabolism are not elucidated.
Interindividual differences in human drug 
metabolism have been shown to be predominantly genetic, 
rather than environmental in nature (Nebert (1978),
Vesell (1977)). This was demonstrated with experiments 
involving identical twins (monozygotic) and non-identical 
twins (dizygotic). The monozygotic twins had very similar 
plasma half-lives of bishydroxycoumarin, whereas the 
dizygotic twins had dissimilar half-lives.
The sex of rats has been shown to. affect hepatic 
drug metabolism (Kato (1974), Benford and.Bridges (1979)), 
but it is not certain whether intestinal drug metabolism 
is also sex dependent.
There are marked species and strain differences 
in the capacity of both phase I and phase II reactions 
to metabolise xenobiotics (Chhabra et al.(1974), Hanninen 
et £1.(1979), Inoue et £l. (1979, B), Lake et al. (1977), 
Litterst et £1.(1975, 1977), Riviere and Bach (1979),
Tredger and Chhabra (1977)).
Drug metabolism varies with age and circadian 
rythm (Benford and Bridges (1979), Hanninen et al.(1979), 
Tredger and Chhabra (1977), Vesell (1977), Gillette
(1979)), being lower in utero, at birth, and at noon.
Disease has been shown to affect drug metabolism 
in man as well as in laboratory animals, but in man 
interindividual differences, effects of age, diet, 
weight, body size and genetic constitution have made 
assessment of precise disease effects difficult (VesoAl
(1977)). Those diseases which are of genetic origin are 
the easiest to assess for effects on drug metabolism 
(Caldwell (1978)).
Other endogenous factors which may influence 
intestinal drug metabolism are intestinal motility, 
biliary secretions, pancreatic secretions, hormones 
and the intestinal microflora (which themselves can 
metabolise drugs).
Aims of the Present Investigation
(1) To study the individual reactions of drug metabolism 
in detail, it is necessary to use a cell fraction, so 
that there is minimal interference from competing reactions, 
and cofactor requirements may be determined. The micro­
somal fraction contains some of the most important enzymes 
involved in drug metabolism, including cytochrome P-450 
and glucuronyItransferase. In recent years, progress has
been made towards developing a reproducible method for 
preparing microsomes from intestinal epithelial cells 
(Stohs jet al.(1976), Shirkey jet £1.(1979, B)), but these 
methods have, so far, only been applied to rat intestine. 
One of the aims of the present investigation is to 
develop a method for preparing intestinal microsomes 
which is applicable to the rat and other species, and 
which results in microsomes containing high levels of 
drug metabolising enzymes.
(2) Microsomes can supply information on individual 
reactions, but to study the relationship between two 
reactions, a more complex system is required. Whole, 
viable, isolated cells have a number of advantages over 
cell fractions, such as microsomes; they do not require 
added cofactors, they allow phase I and phase II reactions 
to be studied simultaneously, they are normally quicker
to prepare than microsomes* and they provide a system 
which is closer to that in vivo than a cell fraction is.
In the present investigation, it is intended to develop 
an improved method for isolating epithelial cells, for 
use in drug metabolism studies. ✓
(3) Cells and cell fractions can be used to investigate 
metabolism by the small intestine, but cannot provide 
information on the fate of the metabolites produced.
To determine where xenobiotic metabolites, formed in 
the intestinal epithelia, end up, it is necessary to 
use sections of whole gut, either in vitro or in situ.
It is proposed to use everted gut sacs, and isolated, 
in situ loops of small intestine to investigate the fate 
of xenobiotic metabolites.
i . • •
(4) Intestinal sulphotransferase has never been studied 
in detail, and yet it may play an important role in
metabolism of both exogenous and endogenous compounds. 
Most sulphotransferase is located in the cytosol, or 
soluble fraction of the cell, along with the enzyme 
system which produces ’active sulphate1 or PAPS. It 
is proposed to investigate intestinal sulphotransferase, 
using the cytosol fraction of the cell, in order to 
gain more knowledge of its properties and substrate 
requirements.
CHAPTER 1
RAT AND GUINEA-PIG INTESTINAL MICROSOMES
INTRODUCTION
Many different tissue preparations can be used to 
study intestinal drug metabolism. These include cell . 
fractions, such as microsomal suspensions or cytosolic 
preparations, whole isolated cell suspensions, cell or 
organ cultures, everted gut sacs, tissue slices, isolated 
loops of intestine in situ or whole perfused intestine in 
situ. The simplest of these systems to study is a cell 
fraction, though it is not usually the easiest to prepare.
Use of a cell fraction enables a single reaction to be 
studied in isolation, by addition of the appropriate 
substrate and cofactor. A clearer picture of the kinetics 
of a'reaction can be obtained using a cell fraction, since 
there will be few or no competing reactions, unless the 
system studied happens to be. a multi-enzyme system, in 
which case rather complex kinetics may be observed. A 
species comparison is more easily made using a cell fraction, 
and comparing specific activities and kinetics. The 
endoplasmic reticulum of the intestinal epithelial cells 
has been shown to be the site of the principal mono-
y
oxygenase (Wattenberg et al.(1962)) and glueuronyl transferase 
system (Hartiala (1961)) of the gut. Hence for the initial 
studies on intestinal drug metabolism, a microsomal 
suspension has been used.
Rats were chosen for the present study because they 
are the most commonly used experimental animal, especially 
in the fields of drug metabolism and toxicology, and thus 
a lot is known about the drug metabolism systems of rat 
liver. A tissue comparison is thereby easily obtained.
It should also be possible to complete the findings in 
vitro with those from the many studies performed in vivo 
on rats.
Very few workers have managed to obtain a good 
microsomal preparation from rat intestine containing a 
stable cytochrome P-450 (Hoensch et al.(1975), Stohs et 
al.(1976>, Shirkey et al.(1979, B>). Failure by other workers 
to obtain a good intestinal microsomal preparation (Chhabra 
et al.(1974), Knoll et al.(1977), Lake et al. (1973),
Tredger and Chhabra (1977), Ueleke (1969), Zampaglione and 
Mannering (1973)) have resulted mainly from poor methodology 
which entailed scraping the mucosal cells off the intestine, 
followed by homogenisation and only one pre-microsomal 
centrifugation step. Intestinal cytochrome P-450 is readily 
destroyed by autolytic enzymes which are released from 
damaged cells on scraping. The method developed by Shirkey 
et al.(1979, B), involving a high frequency vibration of 
everted intestine in order to obtain epithelial cells 
devoid of non-mucosal contamination, followed by a low 
speed centrifugation to sediment nuclei and brush borders, 
has resulted in an easily reproducible method for procuring 
rat intestinal microsomes with high levels of cytochrome 
P-450 and other drug metabolising enzymes. This method is 
potentially equally applicable to other species.
Guinea-pigs were chosen for comparison with rats 
because it was easy to prepare a good isolated intestinal 
epithelial cell suspension from guinea-pigs, whereas 
isolated cells from the rat intestine are prone to mucus 
contamination which results in clumping of the cells and 
loss of viability (see Chapter 2).
Intestinal cells in the crypts of Lieberkuhn are 
immature villous cells. After a number of divisions in 
the lower half of the crypt, the epithelial cell 
differentiates during a 12 hour period, while migrating 
along the upper half of the crypt. After entering the 
functional compartment of the villus the cells migrate 
for about 36 hours toward the tip of the villus where
they are extruded into the intestinal lumen (De Both et al. 
(1974)). Many workers have compared enzyme levels in the 
crypt cells with those of the villous cells (Bickle et a L
(1977), Van Dongen _et £l. (1977), Imondi et al. (1969) ,
Kremski et al.(1977), Merchant and Heller (1977), Nordstrom 
and Dalqvist (1973), Nordstrom et £1.(1968), Sugano et al,
(1978), Sunter et £1.(1978), Webster and Harrison (1969)).
The most commonly studied enzymes in these cases were those 
concerned with digestion, which are mainly located in the 
brush border of the cells. Only two studies have compared 
the level of drug metabolising enzymes in crypt and villous 
tip cells (Hoensch et £l.(1975), Schiller and Lucier (1978)). 
Methods which have been used for separating crypt and 
villous tip cells include cryostat sectioning (Bickle et al« 
(1977), Van Dongen et al.(1977), Nordstrom and Dalqvist 
(1973), Nordstrom et £l.(1968), differential scraping 
(Hoensch et al.(1975), Sugano et £1.(1978), sequential 
washing (Kremski et al .(1977), Merchant and Heller (1977), 
and vibration and dilation (Harrison and Webster (1969), 
Schiller and Lucier (1978), Webster and Harrison (1969)).
The last method, slightly modified, is used in the present 
investigation to compare the levels of some microsomal 
enzymes involved in drug metabolism in the crypt and 
villous tip cells of rat small intestine.
MATERIALS AND METHODS
Chemicals and Equipment
The vibromixer, Model El, A.G. Chemap, Zurich, was ’ 
obtained through Shandon Southern, Camberwell, Surrey, 
England; the variable speed laboratory motor, Model S63C, 
from Camlab, Cambridge, England. Sodium sulphite 2,4,6- 
trinitrobenzene sulphonic acid, 1-naphthol were obtained 
from BDH Laboratories Ltd, Poole, Dorset, England; 
nicotinamide adenine dinucleotide phosphate reduced form 
(NADPH), bovine Serum albumin (fraction V), indoxylacetate, 
cytochrome c (type III), Triton X-100, Brij *35’, 
umbelliferone, UDP-glucuronic acid ammonium salt (UDPGA), 
4-nitrophenol were obtained from Sigma Chemicals Co, Poole, 
Dorset, England; 1-naphthyl glucuronide sodium salt was 
purchased from Koch Light Labs, Colnbrook, Bucks, England. 
7-Ethoxycoumarin was prepared according to the method of 
Ullrich and Weber (1972) as follows: Umbelliferone (5g) 
was refluxed for 12 hours with a slight excess of potassium 
carbonate and ethyl iodide in acetone (50ml) over a water 
bath at 61-63°C. After precipitation and recrystallisation 
from aqueous ethanol, the product was considered homogeneous 
as judged by melting point (88-88.5°C) and thin layer 
chromatography (2*5mm silica gel HF254, Merck, Germany, 
using benzene: ethanol: acetic acid, 96.5:3:0.5, as solvent).
Animals
Male Wistar albino rats 200-250 grams, and male Gordon 
Hartley guinea-pigs 300-400 grams were used. The animals 
were fed standard laboratory diets (Spillers No. 1 Laboratory 
Diet, Spillers Ltd, Croydon, for the rats, aiid FD1 diet, 
Christopher Hill Gp. Ltd, Poole, Dorset, for guinea-pigs), 
ad libitum and were also allowed free access to tap water.
Tissue Preparation
Animals were killed at approximately the same time 
each day (8.3.0-9.. 30am) by cervical dislocation. The 
abdomen was opened, an incision made in the small intestine 
immediately below the pyloric sphincter and a polythene 
cannula inserted. The intestine was filled with cold 
(0-4°C) 0.9% NaCl (w/v), pH 7.4, from a 20ml plastic 
syringe attached to the cannula. The cannula was withdrawn 
and the gut clamped with artery forceps to retain the saline 
solution while the mesentery were cut and stripped away.
The intestine was cut through at the aboral end, the contents 
flushed out, and the intestine was placed in ice-cold saline. 
All subsequent procedures were carried out in a cold room at
0-4°C.
Microsomal Preparation
The method used is a slight modification of that of 
Shirkey et al.(1979, B). Three 20cm lengths of intestine 
were inverted over-metal rods which were then attached to a 
vibromixer and vibrated vertically at high frequency (100Hz) 
and low amplitude (1.5mm) for one minute at 4°C in 0.9%
Nad-, pH 7.4. This solution, which contained sloughed 
cells and acellular material in strands of mucus, was 
discarded. The intestine was vibrated for a further 30 
minutes in 0.9% NaCl containing 5mM EDTA (pH 7.4). The 
cells were harvested by centrifugation (1000gn,ov for 1IllaX
min in MSE minor bench-top centrifuge).
The pellet of isolated cells was weighed in a tared 
centrifuge tube and homogenised in hypotonic sucrose (4ml 
of 75mM sucrose, pH 7.4, for lg wet weight cells), in a 
Potter Elvehjem teflon glass homogeniser (size B). Eight 
up and down strokes were used, and a variable speed 
laboratory motor (max speed 12000 rpm, low torque) was used 
to drive the pestle. The homogenate was then immediately
readjusted to isotonicity by the addition of an equal
volume of 0.5M sucrose (pH 7,4), and diluted to Ig cells
in 16ml solution by addition of 0.3M sucrose buffer
(pH 7.4). The diluted homogenate was then centrifuged at
lOOOg at 4°C (MSE Minor, swing out 4 x 50ml rotor), the, max
pellet was washed twice with 10ml 0.3M sucrose and the 
supernatants combined. The pellet contained the nuclei 
and brush borders of the cells. The combined supernatants 
were centrifuged at X4Q00g „ for 10 min. (MSE High SpeedIllaX
18 centrifuge, fixed angle 8 x 50ml rotor at 11000 rpm).
The pellet from this spin contained the mitochondria and 
lysosomes. This supernatant was centrifuged at 100000gmQ„ma.A
for 1 hour (MSE Superspeed 50 centrifuge, fixed angle 
8 x 25ml rotor at 40000 rpm) to produce a particle-free 
supernatant and a microsomal pellet. The microsomal pellet 
was resuspended (lg wet weight cells to 4ml solution) in 
0.1M Tris-HCl, pH 7.4.
Preparation of Crypt and Villous Tip Cell Microsomes
Cells from the villous tips and the crypts of 
Lieberkuhn were separated by a modification of the method 
of Harrison and Webster (1969). The intestine was washed 
and removed from the animal as described above, and three 
20cm lengths of gut were everted over dialysis tubing 
which covered hollow metal rods which had holes drilled 
out along their lengths, in order that buffer could be 
infused into the rods to dilate the dialysis tubing. The 
rods were vibrated, as above, for 1 minute in 0.9% NaCl 
to remove acellular material and sloughed cells, then for 
30 minutes in 0.9% NaCl containing 5mM EDTA (pH 7.4). The 
cells from this half-hour vibration were harvested as before 
and called the 'tip cells'. Buffer (0.9% NaCl containing 
5mM EDTA, pH 7.4) was then infused into tjie rods, causing 
the dialysis tubing, and thus the intestine, to dilate.
The rods were vibrated for a further 20 minutes in the
same saline/EDTA solution and these cells again harvested 
by centrifugation and were termed the rcrypt cells'. The 
intestine remaining after the two vibrations was of a 
smooth, shiny appearance and transparent. Microsomes 
prepared from both cell populations as above.
Estimation of Protein
Protein concentration was determined by the method 
of Goodwin and Choi (1970). The tissue suspension was 
diluted with 0.1M sodium tetraborate to contain approximately 
100-200pg protein/ml. To 0.5ml aliquots of this dilution 
was added 3ml of freshly prepared reagent (equal volumes of 
the following aqueous solutions: 2,4,6-trinitrobenzene 
sulphonic acid 0.5mg/ml; 0.1M sodium tetraborate; 0.05M 
sodium sulphite). The solutions were mixed, incubated at 
70°C in a water bath for 15 minutes, cooled to. room 
temperature and the yellow colour produced was measured at 
420nm on a Cecil CE272 U.V. spectrophotometer. Suitable 
blanks (0.1M sodium tetraborate) and protein standards 
(crystalline bovine serum albumin fraction V, 50-500pg/ml 
in 0.1M sodium tetraborate) were subjected simultaneously 
to the same procedure. '
Enzyme Assays
Alkaline phosphatase (E.C.3.1.3.1) was assayed by 
a modification (Jones and Mayer (1973)) of the method 
described by Bergmeyer (1963). The incubation system 
contained 75mM Na^COg^NaHCOg buffer, pH 9.4, 14mM MgCl^,
7mM Zn SO^ (both added separately) and 0.03-0.25mg tissue 
protein in a final volume of 3.5ml. The reaction was 
started by the addition of 4-nitrophenyl orthophosphate 
(12mM final concentration) and the samples incubated at 
30°C. After 20 minutes, the reaction was'stopped by 
addition of 2.5ml NaOH solution (IN), the reaction mixtures 
centrifuged at maximum setting in a bench centrifuge
(MSE Minor), and the formation of 4-nitrophenol estimated
in the supernatant from the increase in absorbance at 405nm.
X cm 3 1A molar extinction coefficient of E.^- 18.53 x 10 mole 
_i 405
cm was used in calculations. Acid phosphatase (E.C.3.1.3.2)
was assayed by the same procedure as alkaline phosphatase,
but 75mM citrate--citric acid buffer, pH 4.9, was used and
2+ 2+Mg and Zn were omitted from the reaction mixture. 
Incubation was carried out at 37°C for 30 minutes.
Arylesterase (E.C.3.1.1.2) was assayed by modification 
of the method described by Shephard and Hubscher (1969) 
using indoxylacetate as substrate. The reaction mixture 
consisted of 50mM potassium phosphate buffer pH 6.8, ImM 
EDTAj Triton X-100 (0.1%) and 20-lOOpg of microsomal 
protein. After a 2 minute preincubation at 25°C, the 
reaction was started by the addition of 50pl indoxylacetate 
(50mM in methanol) and followed spectrophotometrically at
386nm for up to 5 minutes. A molar extinction coefficient
lcm 3 —1 —1of E00,, 3.1 x 10 mole cm was used to calculate initial3o6 2
rates. The reaction was followed using lcm cuvettes in a
Pye Unicam SP1800 split beam recording spectrophotometer
with constant temperature cell compartments. A blank
without enzyme was run simultaneously to correct for
spontaneous substrate hydrolysis.
NADPH - Cytochrome c reductase (E.C.1.6.2.4) activity 
was measured by recording the appearance of reduced cytochrome 
c at 550nm in a Pye Unicam SP1800 U.V. split beam spectro­
photometer (Mazel (1972), Phillips and Langdon (1963)).
The incubation mixture contained NADPH 5 x 10 M, KCN 
l.OmM, cytochrome c 5 x 10""^M, EDTA ImM, 0.1M tris-HCl 
buffer, pH 8.0, in a final volume of 2.5ml. After pre­
incubation at 37°C for 2 minutes, the reaction was started 
by addition of the enzyme source and followed for 3-4 
minutes. A blank without enzyme was followed simultaneously.
The O-deethylation of 7-ethoxycoumarin was assayed 
according to the method of Ullrich and Weber (1972). The 
incubation mixture contained NADPH 2jimole, 7-ethoxycoumarin 
(lOOpM final concentration) added in 200pl of distilled 
water, 1.5-2.0mg microsomal protein in a volume of 2ml 
Tris-HCl (0.1M, pH 7.6). After preincubation (2 min at 
37°C) the reaction was started by the addition of NADPH.
The formation of 7-hydroxycoumarin was followed directly
Q
in a lcm curette at X370nm excitation and 450nm emission 
in an Hitachi-Perkin Elmer MPF-3 spectrofluorimeter, fitted 
with a 150 watt xenon lamp and constant temperature cell 
holder. The 7-hydroxycoumarin formed was identified 
according to Ullrich and Weber (1972).
Glucuronidation of 1-naphthol was determined by a 
modification of the method of Bock (1974) for the fluorimetric 
determination of 1-naphthyl glucuronide. Contained in a
0.5ml volume of TrisrHCl (0.1M, pH 7.6) was UDPGA 5mM,
-5 • -4
1-naphthol (4 x 10 to 4 x 10 M final concentrations,
added in lOOpl distilled water), MgCl2 5mM final concentration,
Brij *35' 0.1% and tissue equivalent to 0.2mg of microsomal
protein. The solutions were incubated in a water bath at
37 C. After 4 minutes, the reaction was stopped by the
addition of 1ml of ice-cold glycine-trichloroacetic acid
buffer (0.5M, pH 2.2) and the tubes were placed in ice
water. UDPGA was without effect on the fluorimetric assay
and could be omitted from control and standard incubations.
A standard of 1-naphthyl glucuronide sodium (l-20nmoles
used as a ImM aqueous solution) was added to the appropriate
tubes. The incubates were then rotary extracted for 10
minutes (30 cycles/min) with chloroform (6ml) and centrifuged
(2000 rpm for 15 minutes) to remove the unreacted naphthol
and precipitate the protein solubilised by the detergent.
An aliquot of the aqueous layer (200jil - iml) was adjusted
to 1.5ml with glycine - sodium hydroxide buffer (1.0M,
pH 10.6) and the fluorescence read at X303nm excitation
and 334nm emission.
Microsomal Cytochromes
Microsomal cytochrome concentration was determined
in the presence of sodium dithionite by the reduced minus
oxidised difference spectrum method of Omura and Sato
(1964) using a differential extinction coefficient of 
— 1 —1171mM*~ cm*” for the 423nm (peak) minus 406nm (trough) 
wavelength pair.
Cytdchrome P-450 was similarly estimated from the
sodium dithionite reduced versus carbon monoxide difference
spectrum using the differential extinction coefficient of 
- 1 - 191mM cm for the wavelength pair 450nm minus 490nm, 
using a Pye Uni cam SP 1800 recording U.V. spectrophotometer.
RESULTS
A comparison of some properties of rat and guinea- 
pig intestinal microsomes is shown in Table I. The yield 
of cells from guinea-pig intestine is 50% greater than 
from rat intestine, but the total microsomal protein from 
the two species is roughly the same. The greater weight 
of cells obtained from guinea-pig intestine is probably 
due to a larger diameter of gut giving a greater surface 
area than rat intestine. Cytochrome P-450 content of 
rat intestine was found to be 75% of the levels found in 
guinea-pig intestine. Guinea-pig liver also has a higher 
cytochrome P-450 content than rat liver. Cytochrome b^ 
content of rat intestine was very similar to the cytochrome 
P-450 content, on a molar basis. In guinea-pig intestinal 
microsomes the cytochrome bg content was almost twice that 
of cytochrome P-450 and more than double the amount of 
cytochrome b^ observed in rat intestine. Arylesterase 
activity in rat intestine was more than double that of 
guinea-pig, and was as active as the rat liver esterase.
The NADPH cytochrome c reductase of guinea-pig intestine 
(219nmoles/win/mg) was more than twice as active as that 
of rat intestine (93nmoles/min/mg) (Table I). The ethoxy- 
coumarin O-deethylase (at lOOpM substrate cone) was roughly 
the same in both species, in spite of the differences in 
cytochrome P-450 content.
The glucuronidation of 1-naphthol by rat intestinal
-4microsomes (Figure 1) gave a value of 1.25 x 10 M for the 
Kra and 15nmoles/min/mg protein for Vmax for the activated 
enzyme. The same reaction with guinea-pig microsomes 
(Figure 2) produced a maximum rate at 120jiM substrate, 
but with a higher substrate concentration the velocity 
of the reaction decreased. This meant that it was not 
possible to obtain values for Km or Vmax of the reaction.
Some of the properties of microsomes isolated from 
the villous tip and crypt cells of rat small intestine are 
shown in Table II. The yield of cells from the crypts of 
Lieberkuhn was less than 30% of the total cell weight.
The amount of microsomal protein obtained from the crypt 
cells was only 25% of the total microsomal protein (crypt 
+ tip.cell protein). The cytochrome P-450 content of the 
crypt cells was found to be 40% of that of the tip cells, 
whereas cytochrome b^ content of the crypt cell microsomes 
was 73% of that of the tip cells. The crypt cells contained 
NADPH cytochrome c reductase which had a specific activity 
70% of that present in the villous tip cells. The 
O-deethylation of 7-ethoxycoumarin, which is a cytochrome 
P-450 catalysed reaction, was achieved in the crypt cell 
microsomes at 47% of the rate of the tip cell microsomes.
If the O-deethylating activity of both cell populations 
is expressed as activity per nanomole cytochrome P-450, 
then the cytochrome P-450 of the crypt cells is found to 
be as active as that of the tip cells, whereas arylesterase 
and NADPH cytochrome c reductase are 70-75% as active in 
the crypt cells as in the tip cells.
Glucuronidation of 1-naphthol by the enzymes of 
crypt and tip microsomes was compared in Table III. It 
can be seen from Table III that at all substrate 
concentrations the rate of glucuronyl transferase was 
the same regardless of the position of the cells along 
the villi. The maximal velocity achieved was also the 
same for both cell types, when expressed as nanomoles of 
product formed per minute per mg microsomal protein.
To validate the separation of the two cell populations, 
two further enzyme activities were studied. Acid phosphatase 
is a lysosomal enzyme, but on fractionation it tends to be 
found fairly evenly spread throughout the cell fractions. 
Alkaline phosphatase is a digestive enzyme located in the
brush border of the epithelial cells. Cryostat sectioning 
(Nordstrom and Dalqvist (1973)) has shown that acid 
phosphatase is found at roughly the same concentration in 
crypt cells as in villous tip cells, whereas alkaline 
phosphatase is at a much lower level in crypt cells than 
in tip cells. Table IV demonstrates that acid phosphatase 
was as active in all cell fractions of the crypt cell 
population as in the corresponding villous tip cell fractions. 
Alkaline phosphatase was only half as active in the crypt 
cells as it was in the tip cells. Thus, although one enzyme 
can be present at the same level of activity in both cell 
populations, another enzyme can be much less active in one 
of the cell types.
Rat Guinea-Pig
Total yield of cells, (g) 1.94 2.9
Total microsomal protein (mg) 27.2 26.3
Cytochrome P-450 (nmol/mg) 0.16 0.21
Cytochrome (nmol/mg) 0.18 0.38
Arylesterase (pmol/min/mg) 3.9 1.8
NADPH Cytochrome c reductase 93.0 219.0
(nmol/min/mg)
7-Ethoxycoumarin 0-deethylase 0.113 0.124
(nmol/min/mg)
Values are the means of 6 (rat) or 8 (guinea-pig)
determinations.
TABLE I A COMPARISON OF RAT AND GUINEA-PIG
INTESTINAL MICROSOMES
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Figure 1 - GLUCURONIDATION OF 1-NAPHTHOL BY RAT
INTESTINAL MICROSOMES
Incubations were carried out at 37°C for 
4 minutes and the enzyme was activated with 
0.1% Brij '35'.
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Incubations were carried out at 37°C for 
4 minutes and the enzyme was activated with 
0.1% Brij ’35’.
Crypt Tip Crypt/Tip %
Yield of cells 0.78 1.95 40%
(g)
Total microsomal 7.6 22.4 34%
protein (mg)
Cytochrome P-450 0.053 0.135 40%
(nmol/mg)
Cytochrome b^ 0.11 0.15 73%
(nmol/mg)
Arylesterase 3.11 4.13 75%
(jimol/min/mg)
NADPH Cytochrome 70.0 101.0 69%
c reductase
(nmol/min/mg)
7-Ethoxycoumarin 0.07 0.15 47%
0-deethylase
(nmol/min/mg)
Values are the means of 7 determinations.
TABLE II A COMPARISON OF RAT INTESTINAL CRYPT AND
VILLOUS TIP CELL MICROSOMES
Concentration of Crypt Tip
1-naphthol (pM) (nmoles/min/mg protein)
40 3.1 3.4
80 5.2 5.5
100 5.6 6.9
200 8.5 9.7
300 9.4 9.2
400 9.4 10.0
Values are the means of 4 determinations.
TABLE III GLUCURONYL TRANSFERASE OF RAT INTESTINAL 
CRYPT AND VILLOUS TIP CELL MICROSOMES 
(Activated with 0.1% Brij ’35’)
(A) ACID PHOSPHATASE (nmol/min/mg)
Cell Fraction
Nuclear/Brush 
Border
Mitochondria/
Lysosomes
Cytosol
Microsomes
Crypt
11.0
7.5
8.0
4.9
Tip
11.0
7.1
7.0
5.6
Crypt/Tip % 
100%
106%
• 114%
87%
(B) ALKALINE PHOSPHATASE (nmol/min/mg)
Cell Fraction
Nuclear/Brush 
Border
Mitochondria/
Lysosomes
Cytosol
Microsomes
Crypt
359.0
73.0
5.8
77.0
Tip
693.0
117.0
13.5
142.0
Crypt/Tip %
52%
63%
43%
54%
Results are the means of 4 duplicate determinations.
TABLE IV VALIDATION OF THE SEPARATION OF RAT
INTESTINAL CRYPT AND VILLOUS TIP CELLS
DISCUSSION
The modifications, described in Materials and Methods* 
which were applied to the method of Shirkey e_t al.(1979, B) 
for preparation of rat intestinal microsomes, have resulted 
in the highest ever reported value of the cytochrome P-450 
content of rat intestinal microsomes. Previous workers 
have grossly underestimated the cytochrome P-450 content 
of fat intestine owing to bad microsomal preparations, 
usually obtained from mucosal scrapings (Chhabra et al.
(1975), Correia and Schmid (1975), Hoensch et al.(1975),
Knoll et al.(1977), Kuenzig et al.(1977), Stohs et al.
(1976), Tredger' and Chhabra (1977)). Even the enzyme 
levels obtained by Shirkey et al.(1979, B), using the 
vibration method (Harrison and Webster (1969)) for 
obtaining cells, are much lower than the values reported 
in the present investigation (Table I). The alterations 
to Shirkey*s method for preparing gut microsomes which 
resulted in such a marked increase in both yield and 
specific activities of the microsomal enzymes are the 
omission of two of the washings, one at 1000grnQV and oneDlaX.
at the 14000g „ spin, and the use of a different homcgeniserin 3.x
motor. The decreased number of washings is thought to have 
decreased the amount of non-microsomal protein sediment with 
the microsomes. The change from a Stanley drill speed 
(4000-5000 rpm, high torque) to a variable speed laboratory 
motor (max speed 12000 rpm, low torque) (Camlab, Cambridge) 
resulted in more than double the amount of cytochrome P-450 
and b5 being obtained (results using Stanley drill not 
shown). This improvement was probably due to a gentler 
homogenisation process, which did not disrupt the 
intracellular organelles unduly, and thus did not release 
the autolytic enzymes from the lysosomes.
In both rat and guinea-pig intestinal microsomes 
(Table I), there was proportionately far more NADPH 
cytochrome c reductase and cytochrome bg, compared with 
the amount of cytochrome P-450, than is found in rat and 
guinea-pig liver (Chhabra et al.(1974), Oshino (1978),
Shirkey jet aJ. (1979, B). Both NADPH cytochrome c reductase 
and cytochrome bg are involved in the transfer of reducing 
equivalents to cytochrome P-450. It is now generally 
believed that the rate-limiting step in cytochrome P-450 
catalysed reactions is the rate of transfer of either the 
first or the second electron to the secondary and ternary 
cytochrome P-450 complex respectively (Bjorkhem (1977), 
Masters et al.(1973)). If this is the case, then it would 
be expected that guinea-pig cytochrome P-450 would be much
more 'active than the rat enzyme, because the NADPH cytochrome
c reductase in guinea-pig intestine is much more active 
than that of rat (Table I). However, this was not so, which 
means that it is probable that, for this substrate at least, 
the rate-limiting step is not the transfer of electrons, but 
could be the decomposition of the ternary complex (Bjorkhem
(1977)). The relatively high molar quantities of these 
cytochromes, compared with the quantity of cytochrome 
P-450 in the intestine, may indicate that alternative 
functions of these cytochromes play a more important role 
in the intestine than in the liver. Cytochrome bg is
known to be important in the desaturation of fatty acyl
CoA’s, phospholipid, alkylacyglycerophosphoryl-ethanolamine 
and in the reduction of N-hydroxyamine (Oshino (1978)), 
therefore it is possible that these functions of cytochrome 
bg are quantitatively more important in the intestinal 
epithelial cells, which play a very vital role in the 
digestion of food, including lipids, than in the hepatocytes. 
As well as being reduced by NADII cytochrome bg reductase, 
cytochrome bg can also be reduced by NADPH cytochrome c 
reductase. In fact, NADPH cytochrome c reductase may 
serve as an electron donor for all reactions in which
cytochrome bg is involved as an electron carrier (Oshino
(1978)) and this could be the reason why both of these 
proteins are present at fairly high levels and in similar 
ratios in both rat and guinea-pig intestine (Table I).
The arylesterase (indoxylacetate as substrate) of 
guinea-pig intestine was found to be less than half as 
active as that of rat intestine (Table I). Inoue et al.
(1979) compared human, rat, mouse, guinea-pig, rabbit and 
dog intestinal esterases and they too found that rat 
intestine has a more active esterase than guinea-pig 
intestine. The levels they found in guinea-pig intestine 
were very similar to those of human intestine, whereas 
mouse had much higher levels and rabbit had lower levels, 
whilst the esterase of dog intestine was almost undetectable. 
The amount of esterase activity present in the small 
intestine is an important consideration in the design of
new drugs since penicillin esters, for example, administered 
orally could be extensively cleaved on absorption in the 
intestine.
Considering the amount of cytochrome P-450 present,
y
guinea-pig intestine was less active in O-deethylation of 
7-ethoxycoumarin than might be expected, compared with rat 
intestine. This was not due to lack of NADPH cytochrome c 
reductase activity. It is probable that there are different 
species of cytochromes P-450 in guinea-pig intestine, having 
different substrate specificities to those in rat intestine. 
The values obtained in the present study (Table I) for 
O-deethylation of 7-ethoxycoumarin by guinea-pig intestine 
is very close to that obtained by Kuenzig et al.(1977)
(0.13nmol/min/mg) who used 300pM 7-ethoxycoumarin rather 
than lOOjiM.
Although rat intestine contained cytochrome P-450 
at 25% of the levels found in rat liver, the specific 
activity of 7-ethoxycoumarin O-deethylase (a P-450 catalysed 
reaction) was only 7% of that found in rat liver. It is 
possible that the cytochrome P-450 of the intestine is 
more important for metabolism of endogenous compounds, 
such as lipids, steroids, cholesterol, than is the P-450 
of. the liver. Ichihara et al*(1979) have shown that in 
rabbit intestine p a n d  w -1 fatty acid hydroxylation is 
probably a cytochrome P-450 catalysed reaction. Cholesterol 
7- oc. hydroxylase is also catalysed by cytochrome P-450, 
although this has only been demonstrated in the liver.. 
Cytochrome P-450 can also catalyse steriod C-11, C-17 and 
C-21 hydroxylation.
From Figures 1 and 2, it can be seen that there are
significant differences between rat and guinea-pig intestinal
glucuronyl transferases. The glucuronidation of 1-naphthol
by guinea-pig intestine appears to be substrate inhibited
at concentrations of 1-naphthol above 12OpM. The results
of the present investigation were obtained using microsomes
activated by 0.1% Brij ’35*. Dingell and Sossi (1979)
have shown that glucuronidation of 6-hydroxychlorpromazine
by rat liver microsomes is substrate inhibited if the
microsomes are detergent activated (0.025% Triton X-100)
but substrate activated if control microsomes are used.
Non-activated microsomes were not investigated in the
present report. In rat intestine the Km for 1-naphthol
-4was found to be 1.25 x 10 M (Vmnv = 14.7nmol/min/mg)
alaX
but it was not possible to determine the Km for guinea-pig 
intestine from a double reciprocal plot because of the 
substrate inhibition. From Figure 2, it appears that 
guinea-pig intestine has a higher affinity for 1-naphthol 
than rat intestine does. Howland and Burkhalter (1971) 
have shown that guinea-pig liver glucuronyltransferase 
has a higher (ten times as high) affinity for o-aminophenol
than does rat liver. They also showed that guinea-pig 
liver glucuronyItransferase has a higher Vmax (3 times as 
high) than rat liver. The rat liver glucuronyltransferase 
described by Bock (1977), which was activated by 0.05%
Brij 58, metabolised 1-naphthol about 6 times as fast as 
the intestinal enzyme described in the present report.
Del Villar et al.(1974) found that in rat, glucuronidation 
of morphine was approximately 4 times as fast in the liver 
as in the intestine, but when 4-nitrophenol was the substrate, 
glucuronidation was carried out 9 times fas.ter by intestinal 
microsomes than by liver microsomes. Glucuronidation of 
c^-aminophenol by slices of rat liver and duodenum took place 
at roughly the same rate per mg dry weight tissue (Hanninen 
and Aitio (1968)). Guinea-pig liver was shown to
m
glucuronidate p-nitrophenol at a rate of 3.2nmoles/mg/min 
and o-aminophenol at a rate of 2.5nmoles/mg/min,but it is
not known if these are maximal rates. It is likely that,
as well as being species specific, substrate inhibition 
will be substrate specific. Substrate inhibition of 
glucuronyl transferase of isolated intestinal cells from 
rat (Shirkey et al.(1979A)) and guinea-pig (see Chapter 2)
has not been observed, when the substrates used were
7-ethoxy-and 7-hydroxycoumarin and 2- and 4-hydroxybiphenyl.
As well as differences in their anatomical location, 
crypt and tip cells differ in a number of biochemical 
properties, especially in the levels of digestive enzymes 
(Alpers (1977), Bickle (1977), Van Dongen et al.(1977),
Imondi ejt al. (1969), Merchant and Heller (1977), Nordstrom 
and Dalqvist (1973), Sugano et al.(1978), Takesue and Sato 
(1968), Webster and Harrison (1969)). Only two previous 
reports have reported the levels of drug metabolising 
enzymes in the villous and crypt cells (Hoensch ejt al,
(1975), Schiller and Lucier (1978)). Both groups reported 
much lower levels of microsomal drug metabolising enzymes 
in the crypt cells than in the tip cells. However, the
method used by Hoensch et al. to separate the different 
cell types entailed 'differential scraping' of lengths 
of gut, which is bound to result in more non-raucosal cell 
protein being found in the crypt cell fraction, and 
contamination of all cell populations with sub-mucosal 
tissue. Schiller and Lucier used a method similar to 
that used in the present report for separating the cell 
types, but did not prepare microsomes from the cells 
thus obtained, but used the cells in suspension. Their 
isolated cells were only 70% viable at the start of their 
assay, which meant that added cofactors were required, and 
no indication was given of the cell viability at the end 
of the assay time. In the present report, the villous 
tip and crypt cells were separated by a vibration/ 
chelation method, modified from that of Harrison and 
Webster (1969), which resulted in a negligible sub-mucosal 
contamination of the cell populations and because microsomes 
were prepared from the cells, there was good comparison 
between the cell types, cofactor concentrations being the 
same and protein concentration known. From Table II, it 
can be seen that, as might be expected, yield of cells and 
microsomal protein was much less from the crypts than from 
the villi (40%). Both the amount and activity of cytochrome 
P-450 is much lower (40%) in the crypt cells than in the 
villous cells. However, the value obtained here for amount 
of cytochrome P-450 in the villous cells is 20% higher than 
that obtained by Hoensch et al.(1975), as is the value 
obtained for crypt cells, if the value obtained by Hoensch 
et al.for 'villous intermediate1 cells is averaged with 
their value for 'crypt' cells. In the present investigation 
it was not deemed feasible to separate three cell populations 
from the intestine, though this has been claimed by other 
workers (Hoensch ejt al. (1975), Schiller and Lucier (1978)).
It is probable that the cell population termed 'crypt cells' 
in the present investigation also contains some cells from
the villi, but since the cells obtained are less than 
one third of the total cell weight, the contaminating 
villous cells are unlikely to comprise the major portion 
of these cells.
Cytochrome bg and arylesterase were both found to 
have about three-quarters of the activity in the crypt 
cells that they had in the villous tip cells. NADPH 
cytochrome c reductase was found at relatively high 
levels in the crypt cells too (Table II), about 70% of 
the tip cell activity. These findings agree with those 
of Hoensch et al.(1975), who found that although cytochrome 
P-450 was much lower in the crypt cells than in the tip 
cells, cytochrome bg levels showed only a small difference 
between the cell types. Van Dongen et al.(1977) reported 
that esterase activity was readily demonstrated in crypt 
cells, (using electron microscopic cytochemistry), and 
that the esterase activity increased 3-fold from the 
bottom to tip of the crypt and 3 to 4-fold during migration 
up the villus. The enzyme they measured was localised in 
the endoplasmic reticulum, the dense bodies and the 
perinuclear space. Webster and Harrison (1969) also 
found that esterase activity at the villous tips was 
approximately 4-fold that of the crypts. Neither of these 
two previous reports expressed enzyme activities per 
milligram of microsomal protein, which could account for 
the discrepancies with the present results.
The above observations on crypt and tip cell 
microsomes agree with those of Hoensch et al.(1975) and 
suggest that intestinal monooxygenase activity is localised 
mainly in the most mature, villous tip cells and that 
cytochrome P-450 is synthesised in maturing mucosal cells 
as they migrate from the crypts to the tops of the villi. 
However, other enzymes, also involved in drug metabolism,
namely cytochrome bg, arylesterase and NADPH cytochrome c 
reductase are found at quite significant levels in the 
immature crypt cells, between 70 and 75% of the levels 
of the tip cells.
A phase II reaction was studied in the crypt and 
tip cell microsomes (Table III). It was demonstrated 
that glucuronyl transferase was as active in the crypt 
cells as in the tip cells, when 1-naphthol was used as 
the substrate. Schiller and Lucier (1978), however, 
found that, using 4-nitrophenol as substrate, glucuronyl- 
transferase in their crypt cells was only half as active 
as in the villous tip cells. However, their activities 
were expressed per milligram of total cell protein, and 
it can be seen in Table II that there is less microsomal 
protein per gram cell weight of crypt cells than of the 
villous tip cells. It is also possible that there is 
more non-microsomal protein per gram villous cells than 
per gram crypt cells, which would also tend to lower the 
specific activity of the crypt enzymes when expressed 
per gram total cell protein. The different substrate 
used would also affect the results.
: • • s' ■ ■'
To determine whether the procedure which was developed 
produced a valid separation of the villous tip and crypt 
cells, the levels of two enzymes, acid and alkaline 
phosphatase were investigated. Alkaline phosphatase 
activity is low in the crypt cells of normal rat intestine 
and becomes more apparent after the cell has left the crypt 
region. The enzyme is localised in the microvilli, along 
the lateral cell membranes and in dense bodies (Van Dongen 
_et _al. (1977) ). The gradient of alkaline phosphatase along 
the villus from crypt to tip has been well documented 
(Bickle et jJL. (1977), Van Dongen _et jJ. (1977), Merchant 
and Heller (1977), Nordstrom and Dalqvist (1967), Ibid.
(1973), Schiller and Lucier (1978), Takesue and Sato (1968),
Webster and Harrison (1969)), therefore a high level of 
alkaline phosphatase is a good indication of a villous 
tip cell population. Acid phosphatase is a lysosomal 
enzyme and it has been shown to be as active in the crypt 
cells as it is in the villous tip cells (Nordstrom and 
Dalqvist (1973), Schiller and Lucier (1978)). Table IV 
demonstrates the distribution, and specific activities 
of acid and alkaline phosphatase in all cell fractions 
of both the crypt and villous tip cell populations. It 
can be seen that acid phosphatase is as active in the 
crypt cells as in the tip cells, as previous workers have 
shown, whilst alkaline phosphatase, determined using the 
same substrate (4-nitrophenyl orthophosphate), was only 
50% as active in the crypt cells as in the tip cells.
When'total enzyme capacity was calculated this difference 
was even more striking since the crypt cells contained 
only 21% of the total alkaline phosphatase activity. This 
illustrates that, although one enzyme can show an activity 
gradient along the villus, another does not, hence the
crypt cells are not completely non-differentiated. It
\
also shows that a valid separation of the two cell 
populations was achieved.
CHAPTER 2
DRUG METABOLISM BY ISOLATED INTESTINAL CELLS
FROM GUINEA-PIG
INTRODUCTION
Cell fractions are useful when studying individual 
reactions (see Chapter 1), but in order to investigate the 
relationship between phase I and phase II reactions, a more 
complex system is required. A suspension of isolated cells 
has many advantages over a cell fraction, such as a microsomal 
suspension. No added cofactors are required with isolated 
cells. The design of the experiments is normally such that 
lower substrate concentrations are used which are closer to 
those likely to be encountered in vivo (Wiebkin e£ al.(1976)), 
partly because high substrate concentrations can be damaging 
to isolated cells. Preparation time is shorter, and the links 
between phase I and phase II reactions can be investigated.
The process of isolating cells does not create an artefactual 
barrier to absorption of xenobiotics. It has been shown 
using hepatocytes that uptake of substrates into isolated 
cells can be very rapid (von Bahr et al. (1974)). When gut 
sacs are used, the lack of an intact blood supply appears 
to create an artefactual barrier to absorption, resulting in 
accumulation of substrate and its metabolites in the mucosa 
and sub-mucosal tissue (-Hers e-t al. (1961), Houston et al.
(1974), Pekas (1971, 1972, 1974), Strahl and Barr (1971)).
With isolated cells no anaesthetic is necessary as it is 
when isolated loops of intestine are used in situ and 
incubation conditions, such as pH, substrate concentration 
and temperature can be easily controlled.
Isolated hepatocytes have been extensively used in 
recent years in studies of drug metabolism (e.g. Anderson 
et aX (1978), Fry et al.(1976), Moldlus et al.(1974), i 
Moldeus et al.(1978), Norling et al.(1978), Orrenius et al.
(1978), Shirkey eib al. (1979, A), Vadi et al*. (1975), Weigl • 
and Seis (1977), Wiebkin et al. (1976), Ibid (1978) ) , but 
very few reports have described the use of isolated
intestinal cells for drug metabolism studies (Grafstrom 
et aJ..(1979), Schiller and Lucier (1978), Shirkey et al .
(1979, A), Stohs et al (1977)). Isolated intestinal cells 
have been prepared by a variety of methods including 
chelation with EDTA (Evans et al.(1971). Halliday and 
Powell (1973), Mitjavila et al. (1972), Shakir et a l .(1978); 
vibration and chelation (Gaginella et al. (1977) . Hiilsman 
et al.(1974). Iemhoff et al.(1970). Jones and Mayer (1973), 
Savin and Cook (1978), Schiller and Lucier (1978)); rotation 
(Hiilsman et al. (1974), Iemhoff et al. (1970). Sjostrand 
(1968)); and various enzymic methods (Grafstrom et al.
(1979), Harrer et al. (1964), O ’Doherty and Kukis (1975),
Perris (1966), Prior et al.(1974), Reiser and Christiansen 
(1971), Sayeed and Baue (1972), Shirkey et al.(1979, A), Stern 
and Reilly (1965), Stohs et al.(1977)). Of the methods 
used for obtaining intestinal cells, the mechanical ones 
(vibration or rotation) resulted in the poorest viabilities, 
virtually all being below 90% viable immediately after 
isolation. Chelation with EDTA gave better viabilities on 
average, the highest in this category being that reported 
by Raul et al.(1978) at 80-90%. However, enzymic methods 
proved to be the most effective and resulted in the highest 
viabilities of all, Grafstrom et al.(1979)f Leslie and 
Rowe (1972), Stohs et al .(1977) and Shirkey et al.(1979, A) 
all reporting viabilities of 90-95%. The method used in 
the present investigation was a modification of that of 
Shirkey et al.(1979, A), which was applied in this instance 
to guinea-pig small intestine.
Guinea-pigs were chosen for this study in preference 
to rats because they were found to give higher yields of 
cells with higher viability and minimal mucus contamination 
(see Results).
The substrates chosen for this investigation were 
7-ethoxy and 7-hydroxycoumarin and 2- and 4- hydroxybiphenyl.
7-Ethoxycoumarin was chosen because it can be used to 
investigate the relationship between phase I and phase II 
reactions, and the assay used is very sensitive. 
7-Hydroxycoumarin, the product of phase I metabolism of 
7-ethoxycoumarin was employed in order that conjugation 
alone could be studied, and compared with the rate of 
phase I metabolism. The two hydroxybiphenyls are structural 
analogues which have been shown to give quite different 
patterns of conjugates when metabolised by isolated 
hepatocytes from rats (Wiebkin et al.(1978)). They thus 
allow a more detailed investigation of conjugation 
mechanisms to be performed.
MATERIALS AND METHODS
Chemicals
Protease (type VII), arylsulphatase (type Hi), 
Saccharo-1, 4-lactone were purchased from Sigma Chemicals 
Co Ltd, (Poole, Dorset, England). Ketodase (sulphatase- 
free y3-glucuronidase) was purchased from W. R. Warner and 
Co. Ltd.(Eastleigh, Hampshire). Leibovitz L-15 medium with 
glutamine, and foetal calf serum were purchased from 
Gibco Biocult (Paisley, Renfrewshire, Scotland). Hepes 
(N-2-hydroxyethylpiperazine-N*-2-ethane sulphonic acid) 
was purchased from Boehringer Corp. (Lewes, Sussex, England). 
2-Hydroxybiphenyl and 4-hydroxybiphenyl were purchased 
from BDH Ltd, (Poole, Dorset, England) and recrystallised 
from ethanol. All other solvents and chemicals used were 
of Analar grade, where possible, or as in Chapter;!.
Animals
Male Gordon Hartley guinea-pigs, 300-400g, were used. 
All other details as for Chapter 1.
' •
Isolation of Intestinal Epithelial Cells
The animals were killed and the small intestine removed 
as in Chapter 1. The method used was a modification of that 
of Shirkey et al.(1979, A). Three 20cm lengths of intestine 
were everted over a metal rod, removed from the rod and one 
end ligated. Each length was then filled to slight 
distension with a Krebs phosphate buffer, which was calcium 
and magnesium free and contained 0.5% (w/v) bovine serum 
albumin, 5mM glucose and 20mM Hepes (Krebs CMF buffer, 
pH 7.4). The other end was ligated and the lengths of 
intestine were placed in a 250ml, open, conical flask 
containing 40ml of the Krebs CMF buffer, with addition of 
protease (10 units/ml) and EDTA (ImM). The flask was
incubated in a shaking water bath (55 cycles/min) at
37°C for 20 minutes. The lengths of intestine were then
transferred to another flask containing 40ml Krebs CMF
buffer, without enzyme or EDTA, and incubation continued
for a further 10 minutes. The cells from both flasks
were filtered through bolting cloth (150pm pore size;
Henry Simon Ltd, Cheadle Heath, Stockport), the filtrates
were made up to 100ml with ice-cold buffer and centifuged
(MSE Minor) at approximately 200 g for 5 minutes. Theav
cells were washed twice with 50ml ice-cold Krebs-CMF buffer 
and finally resuspended at a concentration of approximately 
6 x 10 cells/ml in Leibovitz L-15 medium, containing 10% 
foetal calf serum (v/v). Cells were counted in an improved 
Neubauer Chamber (Gelman Hawksley, Lancing, Sussex) and 
viability assessed by the ability of the cells to exclude 
trypan blue.
Metabolism of 7-Ethoxycoumarin and 7-Hydroxycoumarin by 
Isolated Intestinal Epithelial Cells
Intestinal epithelial cell suspensions (2ml) were 
incubated with substrate (lOOpM) in 25ml open conical 
flasks in a shaking water bath (50 cycles/min) at 37°C 
for the required length of time. The reaction was terminated 
by the addition of ice-cold ether (7ml) containing 1.5% (v/v) 
iso-amyl alcohol. Under these conditions the highly 
fluorescent unconjugated 7-hydroxycoumarin was quantitatively 
extracted into the ether. The ether extracts (5ml) were 
back extracted into 0.2M glycine-sodium hydroxide buffer, 
pH 10.4 (3.5ml). The fluorescence of the aqueous layer 
was determined at X 370nm excitation and X 450nm emission, 
using a Perkin-Elmer MPF-3 spectrofluorimeter and compared 
with appropriate standards and controls. Owing to the 
limited cell yield, the free 7-hydroxycoumarin, the glucuronic 
acid and sulphate conjugates were measured in a sequential 
manner in each incubation. Although a pure p -glucuronidase 
(ketodase) was available the sulphatase contained traces of
^-glucuronidase. Hence the level of sulphate conjugation 
was determined following the hydrolysis of the glucuronide 
and ether extraction of the umbelliferone released. For 
each hydrolysis the aqueous layer was adjusted to 
approximately pH'5.0 with sodium acetate-acetic acid buffer, 
0.1M pH 4.8 (1ml), and ketodase (5000 Fishman units) or 
sulphatase (300 units) added. The solutions were incubated 
at 37°C overnight (16-18 hours). The 7-hydroxycoumarin 
standard was added to the appropriate tubes, followed by 
ether extraction and fluorimetry as described above. When 
7-hydroxycoumarin (IOOjiM) was used as substrate to assess 
phase II metabolism alone, a triple ether extraction was 
necessary to reduce background fluorescence to an acceptable 
level prior to subsequent enzyme hydrolysis and ether 
extraction.
Measurement of Hydroxybiphenyl Conjugation
The cell suspension was divided into duplicate aliquots 
6(2ml; 6 x 10 cells/ml) in 25ml open conical flasks on ice. 
The 2-hydroxybiphenyl or 4-hydroxybiphenyl was added in 
2jil dimethyl formamide (DMF) to give a final concentration 
of lOOpM. The flasks were incubated in a shaking water 
bath (55 cycles/min) at 37 C. The reaction was stopped, 
after the appropriate time interval, by placing the flasks 
on ice. The unmetabolised substrate was removed by double 
extraction into 7ml n-heptane (containing 1.5% v/v iso­
amyl alcohol) on a rotary mixer (30 cycles/min) in 15ml 
sovirel tubes, for 10 minutes. This organic phase was 
discarded and the aqueous phase remaining was then subjected 
to deconjugation. The pH of the solution was adjusted to 
roughly pH 5 by the addition of 0.2M acetate buffer, pH 5.0 
(lml), 1ml ketodase ( p -glucuronidase, 5000 Fishman units) 
was added and the solutions incubated overnight.at 37°C.
The standard was added to the appropriate tubes and the 
hydroxybiphenyls released by the enzyme incubation were 
extracted into 7ml n-heptane as above. An aliquot (2ml)
of the organic phase was back-extracted into 5ml of 0.2M 
NaOH. The hydroxybiphenyls were measured by the technique 
of Creaven, Parke and Williams (1965). To the aqueous phase 
remaining was added arylsulphatase (300 units) and the 
deconjugation and measurement procedure was repeated. 
Appropriate blanks and controls were also measured.
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RESULTS
A summary of various modifications of the original 
cell isolation method (Shirkey et al.(1979, A ) ) is given in 
Table 1. In the final method adopted, the time of incubation 
with enzyme was halved from the original 40 minutes to 20 
minutes and 20mM HEPES was added, since this was found to 
stabilise the pH of the medium. The use of 50% foetal 
calf serum in the medium was not adopted because large 
amounts of serum can lead to substrate binding to the 
albumin and not being available for absorption into the 
cells (Bridges and Wilson (1976)). The cell isolation 
method finally adopted was, of necessity, a compromise, 
chosen for high cell viability and moderately high cell- 
yield.
A suspension of intestinal epithelial cells (approx 
6 x 10 cells/ml) was incubated at 37°C in a shaking water 
bath (55 cycles/min) and cells were removed at 15 minute 
intervals in order to assess cell viability. The results 
are shown in Figure 2 for rat and guinea-pig intestinal 
cells. The viability of the rat cells started at 85%, but 
fell linearly with time to 50% viability after an hour's 
incubation at 37°C. Guinea-pig cells, however, started 
off with a much higher viability (95-97%) and remained 
close to 90% viable for up to two hours at 37°C, after 
which time a gradual decline in viability was observed.
Guinea-pig intestinal cells were used in all 
metabolism studies. The viability of the cells never 
fell below 83% after incubation for an hour with lOOpM 
of any of the substrates used (or 300|iM 7-hydroxycoumarin). 
The metabolism of 7-ethoxycoumarin by guinea-pig isolated 
intestinal cells is shown in Figure 3. Very little free 
7-hydroxycoumarin was observed at any of the time points
measured, though a slightly higher amount was present 
after the first 5 minutes of incubation. Most of the 
7-hydroxycoumarin produced by 0-deethyla.tion of the 
substrate was present as sulphate (66%) or glucuronic 
acid (30%) conjugates. The total amount of 7-ethoxycoumarin 
metabolised in an hour was less than 2% of the substrate 
present (ie less than 4 nmoles of product formed from 
200 nmoles substrate present).
When 7-hydroxycoumarin was the substrate, used in 
order to study phase II metabolism alone, the total amount 
of substrate metabolised in an hour was over 75% of that 
present (Figure 4). Thus the rate of conjugation was 
nearly forty times the rate of 0-deethylation. The
m
metabolites in this instance comprised 76% sulphates and 
the remainder were glucuronides.
The metabolism of 2-hydroxybiphenyl by the isolated 
intestinal cells is shown in Figure 5. In this case very 
few ( <  4%) of the conjugates were sulphates, the majority 
being glucuronic acid conjugates. When 4-hydroxybiphenyl 
was the substrate (Figure 6), the total amount metabolised 
in an hour was approximately 25% of the substrate present, 
whereas with 2-hydroxybiphenyl only 9% of the substrate 
was metabolised in the same time. At the early time points 
there was more 4-hydroxybiphenyl glucuronide produced than 
sulphate (up to 30 min), but after 40 minutes incubation 
there was more sulphate produced than glucuronide.
Sulphation of 4-hydroxybiphenyl was linear with time, 
whereas glucuronidation was not (Figure 6). With all of 
the substrates used there appeared to be a saturation of 
the glucuronyl transferase taking place, whereas sulphation 
did not become saturated with time (at lOOpM substrate 
concentration).
Figures 7-9 illustrate the effect increasing substrate 
concentration has on the conjugation of 7-hydroxycoumarin,
2- and 4-hydroxybiphenyl. In each case glucuronic acid 
conjugation appeared to become saturated. With 7-hydroxy­
coumarin as substrate (Figure 7) sulphate conjugation did 
not become saturated, even at 300jiM substrate concentration.
At all substrate concentrations sulphate accounted for 
approximately 80% of the 7-hydroxycoumarin metabolites. 
However, when 2-hydroxybiphenyl was used (Figure 8), very 
little sulphate ( <  10%) was produced at all substrate 
concentrations, with a maximum amount of sulphate formed 
between 25 and 50pM 2-hydroxybiphenyl. Figure 9 presents 
quite a different picture. In this instance 4-hydroxy- 
biphenyl was the substrate, and although glucuronidation, 
at all substrate concentrations, gave the expected pattern, 
sulphation did not. Up to 15jiM 4-hydroxybiphenyl, there 
was an increase in the absolute amount of sulphate formed, 
but above 15jiM the absolute amount decreased with increasing 
substrate concentration (Figure 9). Figure 10 expresses 
these results in an alternative way, as percentage of 
sulphate divided by glucuronide produced with increasing 
substrate concentration. It shows that on increasing 
4-hydroxybiphenyl concentration, the percentage of metabolites 
conjugated with glucuronic acid increased, though it can be 
seen from Figure 9 that it is not necessary for the absolute 
amount of glucuronide formed to increase for this to be the 
case. Similarly the percentage of metabolites formed as 
sulphate conjugates decreased with increasing substrate 
concentration (Figure 10), even though the absolute amount 
of sulphate formed increased up to 15jiM substrate.
A - Alteration of incubation times (10 units protease/ml)
Incubation with Incubation without
enzyme (min) enzyme (min)
40 5
o 30 5
o 20 5
* 20 . 10
B - Alteration of enzyme concentration '
*** 5 units protease for 40 min
*** 7.5 units protease for 20 min
C - Additions to incubation medium
** 1M N-acetyl cysteine 
* 20mM HEPES
0.05M Dithiothreitol 
0.05M 2-Mercaptoethanol 
10% 07/V gelatine 
** 10% (V/V) glycerol
o 50% (V/V) Foetal calf serum
o - improvement over original conditions
* - improvement observed and modification adopted
** - decrease in viability
*** _ decrease in cell yield
Table 1 Modifications of Cell Isolation Method in 
Attempt to Optimise Conditions
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Figure 2 - VIABILITY OF ISOLATED INTESTINAL CELLS ON
INCUBATION AT 37°C
Isolated intestinal cells from rat:0, and
guinea-pig:#, were suspended at a concentration 
6of 6 x 10 cells/ml in Leibovitz L-15 medium, 
containing 10% (v/v) foetal calf serum, and 
incubated in a shaking water bath (55 cycles/ 
min) at 37°C. Aliquots (0.25ml) were withdrawn 
at the times indicated and viability of the 
cells was assessed by their ability to exclude 
trypan blue.
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Figure 3 - METABOLISM OF 7-ETHOXYCOUMARIN BY GUINEA-PIG
ISOLATED INTESTINAL CELLS
Intestinal epithelial cells from guinea-pig
7
(approx 1.2 x 10 cells in a 2ml volume) were 
incubated with IOOjiM 7-ethoxycoumarin at 37°C 
in a shaking water bath (55 cycles/min) for 
periods of up to 60 min. At the times indicated, 
the suspensions were extracted with ether, 
deconjugated and reextracted with ether, and 
the ether fractions extracted with glycine- 
NaOH buffer, pH 10.4. The various fractions 
obtained by this procedure were analysed 
fluorimetrically for 7-hydroxycoumarin. Cells 
were pooled from 2 animals and results represent 
the mean of three duplicate determinations. A  
total metabolites? o glucuronide; □ sulphate;
A free metabolites.
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Figure 4 - METABOLISM OF 7-HYDROXYCOUMARIN BY GUINEA-PIG
ISOLATED INTESTINAL CELLS
. S '
Intestinal epithelial cells from guinea-pig 
(approx 1.2 x 10 cells in a 2ml volume) were 
incubated with lOOpM 7-hydroxycoumarin at 37°C 
in a shaking water bath (55 cycles/min) for 
periods of up to 60 min. At the times indicated 
the suspensions were deconjugated and extracted 
with ether and the ether fraction extracted 
with glycine-NaOH buffer, pH 10.4. The various 
fractions obtained were analy sed fluorimetrically 
for 7-hydroxycoumarin. Cells were pooled from 
2 animals and results represent the mean of 
three duplicate determinations A  total 
metabolites; o glucuronide; □ sulphate.
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Figure 5 - METABOLISM OF 2-HYDROXYBIPHENYL BY GUINEA-PIG
ISOLATED INTESTINAL CELLS ,
Intestinal epithelial cells from guinea-pig
7
(approx 1.2 x 10 cells in a 2ml volume) were 
incubated with lOOjiM 2-hydroxybiphenyl at 
37°C in a shaking water bath (55 cycles/min) 
for periods of up to 60 min. At the times 
indicated the suspensions were deconjugated 
and extracted with n-heptane fraction extracted 
with NaOH (0.2M). The various fractions were 
analysed fluorimetrically for 2-hydroxybiphenyl. 
Cells were pooled from 2 animals and results 
represent the mean of three duplicate 
determinations. A  total metabolites; O 
glucuronide, □ sulphate.
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METABOLISM OF 4-HYDROXYBIPHENYL BY GUINEA-PIGFigure 6
ISOLATED INTESTINAL CELLS
Intestinal epithelial cells from guinea-pig
7
(approx 1.2 x 10 cells in a 2ml volume) were 
incubated with lOOpM 4-hydroxybiphenyl at 37°C 
in a shaking water bath (55 cycles/min) for 
periods of up to 60 min. At the times 
indicated the suspensions were deconjugated, 
extracted with n-heptane and the n-heptane 
fraction extracted with NaOH (0.2M). The 
various fractions were analysed fluorimetrically 
for 4-hydroxybiphenyl. Cells were pooled from 
2 animals and results represent the mean of 
three duplicate determinations. A  total 
metabolites; o glucuronide; □ sulphate.
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7-HYDROXYCOURMARIN METABOLISM BY GUINEA-PIG
INTESTINAL CELLS
Intestinal epithelial cells from guinea-pig
7
(approx 1.2 x 10 cells in a 2ml volume) were 
incubated with 7-ethoxycoumarin (5 - 300jiM) 
at 37°C in a shaking water bath (55 cycles/ 
min). After 20 min the suspensions were 
deconjugated and extracted with ether and 
the ether fractions extracted with glycine- 
NaOH buffer, pH 10.4. The various fractions 
obtained were analysed fluorimetrically for 
7-hydroxycoumarin. Cells were pooled from 
2 animals and results represent the mean of 
three duplicate determinations. A  total 
metabolites; o glucuronide; □ sulphate.
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2-HYDROXYBIPHENYL METABOLISM BY GUINEA-PIG 
INTESTINAL CELLS
Intestinal epithelial cells from guinea-pig
7(approx 1.2 x 10 cells in a 2ml volume) 
were incubated with 2-hydroxybiphenyl 
(5 - IOOjiM) at 37°C in a shaking water bath 
(55 cycles/min). After 30 min the suspensions 
were deconjugated and extracted with n-heptane 
and the n-heptane fraction extracted with 
NaOH (0.2M). The various fractions were 
analysed fluorimetrically for 2-hydroxybiphenyl 
Cells were pooled from 2 animals and results 
represent the mean of three duplicate 
determinations. O glucuronide; □ sulphate.
Substrate concentration ( pM )
4-HYDROXYBIPHENYL METABOLISM BY GUINEA-PIG 
INTESTINAL CELLS
Intestinal epithelial cells from guinea-pig
7
(approx 1.2 x 10 cells in a 2ml volume) 
were incubated with 4-hydroxybiphenyl '
(5 - lOOjiM) at 37°C in a shaking water bath 
(55 cycles/min). After 10 min the suspensions 
were deconjugated, extracted with n-heptane 
and the n-heptane fraction extracted with 
NaOH (0.2M). The various fractions were 
analysed fluorimetrically for 4-hydroxybiphenyl. 
Cells were pooled from 2 animals and results 
are the mean of three duplicate determinations. 
O glucuronide; □ sulphate. .
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Figure 10 - 4-HYDROXYBIPHENYL METABOLISM BY GUINEA-PIG
INTESTINAL CELLS
This figure presents the results from Figure 
9 in an alternative way.
DISCUSSION
The results shown in Figure 2 demonstrate that the 
viability of the rat intestinal cells, though quite high 
(85%) immediately after isolation, fell rapidly on 
incubation at 37°C. Considerable aggregation of the cells 
occurred, which appeared to be due to the large amount of 
mucus which was released from the goblet cells. The cells 
adhered to the mucus and formed large aggregates which made 
counting of the cells very difficult and resulted in many 
non-viable cells, possibly due to a decrease in the oxygen 
reaching the cells. Various mucolytic agents were employed 
(for details see Table 1) to try and dissolve the mucus, 
but none had any beneficial effect at the concentrations 
used, and may have interfered with drug metabolism had they 
been successful in destroying the mucus. When guinea-pig 
intestine was used as the source of isolated cells, viability 
was initially between 88 and 97% and remained close to 90% 
for up to two hours, on incubation at 37°C (Figure 2).
When drug metabolism studies were performed, cell viability 
was assessed before incubation and after incubation with
■ s'
the substrate under the harshest conditions used in the 
assay, ie.for the longest time period or with the highest 
substrate concentration. Viability of the cells never 
fell below 83% for any of the assays performed. Hence, 
guinea-pigs were used for studies of drug metabolism using 
isolated intestinal cells, in preference to rats.
The problems encountered with the preparation of 
intestinal cell; suspensions, especially from the rat, are 
not unique to the present study. Other workers have found 
that cells either come off the intestine in sheets rather 
than singly (Evans et aJ.. (1971), Harrer et al. (1964),
Hiilsman et al. (1974), Iemhoff et al. (1970), Kimmich (1970), 
Savin and Cook (1978), Shakir et al.(1978), Sjostrand (1968),
Towler et al.(1978)), have relatively poor initial viability 
(less than 85%) (Gaginella et al,(1977), Halliday and Powell 
(1973), Harrer et al. (1964) , Prior ert al. (1974) , Reiser and 
Christiansen (1971), Schiller and Lucier (1978), Shakir et 
aJL. (1978), Stern and Reilly (1965)), or have problems 
associated with mucus (Hiilsman et al. (1974), Jones and 
Mayer (1973), Sayeed and Baue (1972), Shakir et al.(1978)) .
The isolated intestinal cells prepared from guinea-pig 
small intestine, which were used in the present investigation, 
contained very few clumps of cells and those which were 
present seldom contained more than eight cells, and were 
therefore not difficult to count. Initial cell viability 
was usually 95-97% (Figure 2) and no problems due to mucus 
contamination arose, since the goblet cells and mucus appeared 
to adhere to the bolting cloth on filtration.
The O-deethylation of 7-ethoxycoumarin is a cytochrome 
P-450 catalysed reaction and the product (7-hydroxycoumarin) 
can subsequently be conjugated with either sulphate or 
glucuronic acid. Metabolism of 7-ethoxycoumarin by isolated 
intestinal cells from guinea-pigs is shown in Figure 3.
The total metabolites produced is an indication of the
y
amount of O-deethylation of the substrate. The value 
reported here for the O-deethylation of 7-ethoxycoumarin 
by guinea-pig intestinal cells is very close to that found 
by Shirkey et al. (1979, A) (less than 4 nmoles product formed/ 
1 hour/1.2 x 10 cells) for the same reaction by control 
rat intestinal cells, both of these values being greater 
than that reported by Grafstrom et al". (1979) for control 
rat intestinal cells, though the strain of rat used 
(Sprague-Dawley) in this instance may account for the 
difference, and the substrate concentration used by 
Grafstrom et al. was ten times as high as that of the other 
reports. The similarity in the rate of 7-ethoxycoumarin 
O-deethylation in rats and guinea-pigs confirmed the results
obtained using microsomes from the two species (see Chapter 
1). Conjugation of 7-hydroxycoumarin/ however, differs 
considerably between rat and guinea-pig. The guinea-pig 
produced far more sulphate than glucuronide (Figures 3 
and 4), whilst rat cells gave very few sulphates 
(Grafstrom et al. (1979), Shirkey £t al.(1979, A)), the 
majority of the metabolites being glucuronides. When 
7-hydroxycoumarin was the substrate (Figure 4), the guinea- 
pig cells conjugated over 75% of the substrate in 45 
minutes, whereas rat cells conjugated only 12% (Shirkey 
et al.(1979, A)) in the same time. The amount of glucuronides 
formed by the rat cells was, however, about two-thirds of 
the amount formed by the guinea-pig cells. The fact that 
rat intestine is poor at sulphation has also been shown by 
Stohs et al. (1977), using benzo (a) pyrene as substrate, 
and by Grafstrom et al. (1979), using 1- and 2-naphthol, 
harmine and paracetamol as substrates.
2-Hydroxybiphenyl was very poorly sulphated by 
guinea-pig intestinal cells (Figure 5), less than 6% of 
the total metabolites being found as sulphate). Its 
structural analogue, 4-hydroxybiphenyl, was sulphated and 
giueuronidated to roughly equal extents (Figure 6), 
sulphation being linear with time whilst glucuronidation 
was not. This lack of 2-hydroxybiphenyl sulphation has 
also been observed using isolated rat hepatocytes 
(Wiebkin et al. (1978)). Poor sulphation of 2-hydroxy- 
biphenyl was not compensated for by an increased 
glucuronidation (Figure 5), since both the hydroxybiphenyls 
were glucuronidated to similar extents (Figures 5 and 6).
A similar difference in the conjugation pattern of two 
substrates having very similar structures is seen when 
harmol and harmalol are metabolised by rats In vivo, or 
in vitro by rat liver (Mulder and Hagedoorn (1974)).
Harmol has one more double bond than harmalol, this being 
the only difference in their structures. At incubation
times of up to 30 minutes, glucuronides of 4-hydroxy­
biphenyl were more numerous than sulphates (Figure 6), 
but after 45 minutes incubation sulphates became more 
numerous than glucuronides. This was due to sulphate 
conjugation of 4-hydroxybiphenyl being linear with time, 
whilst glucuronidation was not. In an hour over 25% of 
the (IOOjiM) 4-hydroxybiphenyl was metabolised, but less 
than 10% of the 2-hydroxybiphenyl was conjugated in this 
time. This was due mainly to the lack of sulphation of 
the 2-hydroxybiphenyl. The difference in sulphation of 
these two substrates is further described in Chapter 3.
Conjugation by isolated intestinal cells was further 
investigated over a range of substrate concentrations.
When 7-hydroxycoumarin was the substrate (Figure 7), 
sulphate was the major conjugate formed, accounting for 
at least 75% of the metabolites over the entire substrate 
range studied (5 - 300jiM). The percentage of metabolites 
found as sulphate increased gradually (to 82%) as substrate 
concentration increased. This was due to glucuronidation 
becoming saturated at about 150pM 7-hydroxycoumarin, whereas 
sulphation did not appear to be saturated, even at 300pM 
substrate. Conjugation of 2-hydroxybiphenyl produced very 
little sulphate conjugate at all substrate concentrations 
(5 - IOOjiM) (Figure 8). The percentage of metabolites 
present as sulphate increased from 3% to 10% between 5jiM 
and 15jiM 2-hydroxybiphenyl, but decreased gradually at 
higher substrate concentrations back to 3% at 75pM and 
IOOjiM 2-hydroxybiphenyl. Thus, when 2-hydroxybiphenyl 
was substrate, sulphation became saturated, even though 
it was very low at all substrate concentrations. 
Glucuronidation also became saturated, though at a higher 
substrate concentration than sulphation (75pM for 
glucuronidation and between 25 and 50pM for sulphation). 
Glucuronidation of 4-hydroxybiphenyl also became saturated, 
this time at 50jiM substrate. Sulphation of 4-hydroxybiphenyl
increased with substrate concentration to a maximum at 
15|iM 4-hydroxybiphenyl and decreased with further increase 
in substrate concentration (Figure 9). These results are 
also illustrated in Figure 10, where they are expressed 
as the percentage ratio of glucuronide over sulphate with 
increasing substrate concentration. This (Figure 10) 
demonstrates in vitro a phenomenon which has been observed 
in vivo in rats, ie, that on increasing the concentration 
of a phenolic xenobiotic, a decreasing proportion is 
conjugated with sulphate, with a concomitant increase in 
the percentage conjugated with glucuronic acid (Levy (1978), 
Mulder and Meerman (1978), Weltering et al. (1979))«
This decrease in sulphation has in the past been attributed 
to depletion of the body’s pool of inorganic sulphate 
(Levy (1978), Slotkin et al. (1970), Houston and Levy (1976)). 
.vHowever, it has recently been shown that serum levels of 
inorganic sulphate, which reflect PAPS levels, do not 
decrease after intravenous administration of phenol to rats 
(Mulder and Meerman (1978), Weitering et al.(1979)), and the 
postulated reason for the decrease in sulphation was that it 
was due to the Km's of the sulphotransferase and glucuronyl 
transferase being different. The administration,, of sodium 
sulphate or cysteine has been shown to decrease the ascorbic 
acid inhibition of sulphation of acetaminophen (Houston and 
Levy (1976), Levy (1978), Levy and Yamada (1971)). This was 
postulated to show that sulphation of acetaminophen was 
limited by availability of inorganic sulphate (PAPS).
However, it has been reported that in the liver, the Km 
for inorganic sulphate, for sulphation, is roughly 0.3mM 
(Mulder and Meerman (1978)). Therefore under normal 
conditions, the sulphate level in blood is not optimal 
for sulphation, thus an increase in inorganic sulphate will 
increase the amount of sulphate conjugates formed. The 
present data (Figures 9 and 10) suggest that substrate 
inhibition of either the sulphotransferase itself or an 
enzyme involved in the formation of PAPS (active sulphate)
could play a very important role in the decrease in 
sulphation with increasing substrate. Another theory 
which has been proposed to explain the altering pattern 
of conjugation with increasing dose of phenolic substrate 
is that 'active sulphate' (PAPS), which is generated from 
cysteine, is more likely to be depleted in vivo than the 
formation of UDP-glucuronic acid, generated from carbo­
hydrates (Bock (1977)). However, though this theory may 
hold when applied to the liver, where glycogen provides a 
ready source of carbohydrates, in the intestine carbohydrate 
is not stored to any great extent, but PAPS is formed in 
the goblet cells for the manufacture of mucoproteins, so 
'active sulphate' is less likely to be a limiting factor 
in intestinal sulphation.
The use of cells, isolated from guinea-pig small 
intestine has shown that: (i) conjugation can occur at 
up to forty times the rate of cytochrome P-450 catalysed 
reactions; (ii) it is possible for two structurally related 
compounds, differing only in the position of one hydroxyl 
group, to give different patterns of conjugation; (iii) 
sulphation by the intestinal cells is not as easily 
capacity limited as is glucuroniaation; (iv) sulphation 
can be the subject of substrate inhibition, in the 
intestine.

CHAPTER 3
GUINEA-PIG INTESTINAL SULPHOTRANSEERASE
INTRODUCTION
In general, sulphation of a xenobiotic will render 
it less toxic, more water soluble and thus more readily 
excreted. However, sulphation can also produce reactive 
intermediates (eg. N-hydroxy-N-acetylaminofluorene-N-O- 
sulphate, N-hydroxy-phenacetin sulphate) which are more 
reactive than the parent compound and can bind covalently 
to cell constituents (Bock (1977)). Sulphate esters are 
more reactive and thereby more toxic than the corresponding 
glucuronides. The small intestine, being the main site of 
absorption of xenobiotics ingested orally, has considerable 
capacity for sulphate conjugation (George et al. (1974),
Powell et al.(1974), Powell and Curtis (1978), Shirkey et 
al.(1979, A)). The use of guinea-pig isolated intestinal 
cells showed that considerable sulphate conjugation could 
occur (Chapter 2). In this case two structural analogues 
(2- and 4-hydroxybiphenyl) gave quite different patterns 
of sulphation. A similar lack of sulphation of 2-hydroxy- 
biphenyl has been observed using rat hepatocytes (Wiebkin 
et al. (1978)). Sulphotransferase(s) is located in the 
soluble fraction of the cell (cytosol), as are the enzymes 
involved in generating 'active sulphate' (PAPS). To 
determine whether the low level of 2-hydroxybiphenyl 
sulphate formed by guinea-pig intestinal cells (Chapter 2) 
was due to poor absorption of this substrate into the cell, 
the cytosol fraction was used in a further investigation 
of guinea-pig intestinal sulphotransferase(s).
There is evidence that in the liver of both rats 
(Barford and Jones (1971), Mattock and Jones (1970), Sekura 
and Jakoby (1979)), and guinea-pigs (Banerjee and Roy (1966, 
1967, 1968)), there is more than one sulphotransferase.
There has been no previous report of multiple sulpho­
transf erases in the small intestine. The present investigation
involved the use of the cytosol fraction of guinea-pig 
intestinal cells to investigate sulphate conjugation of 
7-hydroxycoumarin, 2-hydroxybiphenyl and 4-hydroxybiphenyl. 
No attempt was made to purify the enzyme(s) involved. At 
least three sulphotransf erases have been found in guinea- 
pig liver by Banerjee and Roy (1966, 1967, 1968). One 
was specifically a phenol sulphotransferase, and the 
others were an androstenolone sulphotransf erase (also 
catalysing cholesterol sulphation), and an oesterone 
sulphotransferase, both of which had some phenol sulpho­
transf erase activity as well, either due to incomplete 
purification or overlapping substrate specificity of the 
individual enzymes.
MATERIALS AND METHODS
Chemicals
Adenosine triphosphate (sodium salt) was purchased 
from Sigma Chemicals Co, Poole, Dorset, England. All other 
chemicals and reagents were of laboratory or Analar grade 
or as previous chapters.
Animals
Male Gordon Hartley guinea-pigs were used (30Q-400g), 
housing and tissue preparation as in Chapter 1.
Preparation of Cytosol Fraction
Intestinal cells were removed from the submucosal
tissue by vibration of three lengths of everted intestine,
as described in Chapter 1. The cells were homogenised in
hypotonic KC1 (37.5mM) adjusted to pH 7.4 with 20mM tris,
in a Potter Elvejhem homogeniser, using 8 up and down strokes,
as before. The homogenate was immediately readjusted to
isotonicity (by addition of 0.25M tris-KCl, pH 7,4) and
centrifuged at 100,000 g for an hour (MSE Superspeed 50,max
8 x 25ml fixed angle rotor), to sediment all particles. The 
resultant supernatant was called the 'cytosol fraction1 and 
was diluted (with tris-HCl, pH 7.4) and used as the enzyme 
source in subsequent assays.
Assay of Sulphotransferase
The reaction mixture contained 20mM NagSO^ (0.2ml),
50mM MgClg (0.2ml), 50mM ATP (0.2ml), 0.2ml of diluted 
cytosol fraction (0.45-0.55mg protein), substrate was added 
in 2jil dimethylformamide (DMF) and the volume made up to 
2ml by addition of 0.25M tris-HCl (1.2ml), pH 7.4. The 
reaction was started by addition of the ATP. The incubations
were carried out in open 25ml conical flasks in a shaking 
water bath (55 cycles/min) at 37°C. The reaction was 
stopped, at the times specified by removal of the flasks 
from the water bath and addition of 7ml of the appropriate 
solvent (ether for 7-hydroxycoumarin, or n-heptane for 
2- and 4-hydroxybiphenyl), containing 1.5% iso-amyl alcohol. 
The unreacted substrate was extracted into the solvent, the 
aqueous solutions deconjugated overnight with sulphatase, 
and the substrate released determined fluorimetrically, as 
described in Chapter 2.
When the assay was carried out at varying pH, 
dimethyl glutaric acid - NaOH buffer (G.25M) was used at 
pH 5 - 7.5 and the tris-HCl buffer (0.25M) was used at 
pH 7.0 - 9.5. The overlapping pH readings showed no 
significant difference between the two buffers. Samples 
were incubated for 10 minutes before stopping the reaction.
RESULTS
The sulphation of 7-hydroxycoumarin (lOOjiM) by the 
cytosol fraction of guinea-pig intestinal cells is shown 
in Figure 1. Sulphation was linear with time after 5 
minutes, there was an apparently quicker phase over the 
first 3-5 minutes. Almost 200 nmoles of substrate was 
sulphated per milligram of cytosolic protein in an hour 
(Figure 1).
2-Hydroxybiphenyl (IOOjiM) was very poorly sulphated 
by the cytosolic fraction, with less than 10 nmoles being 
sulphated per milligram of protein in an hour. Sulphation 
of 2-hydroxybiphenyl was also linear with time (Figure 2).
The sulphation of 4-hydroxybiphenyl (IOOjiM) occurred 
in two linear phases, the first up until 10 minutes, had 
a faster rate of sulphation than the second (Figure 3).
The amount of sulphate formed in this instance was 
intermediate between that formed with the other two substrates, 
being approximately 48 nmoles sulphate formed per milligram 
of cytosolic protein in an hour (Figure 3).
Formation of 2-hydroxybiphenyl sulphate was linear 
with protein concentration, at up to lmg of protein per 
2ml incubation (Figure 4), as well as having been linear 
with time (Figure 2). Formation of 4-hydroxybiphenyl 
sulphate was also linear with protein concentration over 
the range studied (up to 0.8mg. protein per 2ml incubation) 
(Figure 5). The substrate concentration used in both 
Figures 4 and 5 was lOOpM.
In contrast, when substrate concentrations were varied, 
quite unexpected patterns of sulphation emerged. When 
7-hydroxycoumarin concentration was altered, a maximum amount
of sulphate was formed at 150jiM substrate (Figure 6).
The amount of sulphate formed initially increased with 
substrate concentration, to a value of 25.5 nmoles formed 
per milligram of protein in 10 minutes at 150pM 7-hydroxy~ 
coumarin. At higher substrate concentrations the amount 
of sulphate formed decreased, gradually to 17.6 nmoles per 
milligram protein in 10 minutes, formed at 400]iM substrate 
(Figure 6). The amount formed at 500jiM 7-hydroxycoumarin 
was slightly higher than at 400jiM, but was probably not 
significant.
Sulphation of 2-hydroxybiphenyl reached a maximum 
at 75jiM substrate, then gradually decreased with further 
increase in substrate concentration (Figure 7). The 
maximum value was 26 nmoles sulphate formed per milligram 
cytosolic protein in an hour, which decreased to under 
13 nmoles formed, per milligram protein in an hour, at 
500|iM 2-hydroxybiphenyl.
The situation which arose by varying 4-hydroxybiphenyl 
concentration was more complex than with the other substrates. 
Four peak values of sulphate formation were evident within 
the hundred-fold range of substrate concentration investigated 
(5-500jiM) (Figure 8). The first peak was at 5pM 4-hydroxy- 
biphenyl, and as substrate concentration was increased, 
there was a gradual decline in the amount of sulphate formed 
to a minimum, of approximately 11 nmoles sulphate formed per 
milligram of protein in io minutes, at 150jiM 4-hydroxybiphenyl. 
The second peak occurred at 200jiM substrate, falling to 
approximately 12 nmoles sulphate per milligram protein, 
formed in 10 minutes at 250pM 4-hydroxybiphenyl. Another 
peak was present at 300jiM substrate, and at 400pM 4-hydroxy­
biphenyl a smaller amount of sulphate was formed. At 500|iM 
4-hydroxybiphenyl the maximum value, of 65 nmoles product 
formed per milligram of protein in 10 minutes was found 
(Figure 8).
Sulphation of 4-hydroxybiphenyl was linear with time 
at a low substrate concentration (5|iM) as well as being " 
linear with time at IOOjiM 4-hydroxybiphenyl (Figures 9 and 
3). Virtually all the (5pM) 4-hydroxybiphenyl present was 
sulphated during the 10 minute incubation (Figure 9).
The ’kinetics’ of 4-hydroxybiphenyl sulphation by 
the guinea-pig intestinal cytosol fraction raised the 
possibility that there was more than one sulphotransferase 
present. This possibility was further investigated by 
using the two extremes of substrate concentration (5 and 
500pM), used in Figure 8, to investigate the pH optimum 
(optima) of the enzyme(s) involved (Figure 10, A and B).
When 5jiM 4-hydroxybiphenyl was used, and a 10 minute 
incubation, the pH optimum appeared at pH 7.5, with negligible 
sulphate produced below pH 6 (Figure 10, A). In contrast, 
when 500pM 4-hydroxybiphenyl was used, two pH optima 
appeared, at pH 7.0 and pH 8.5 (Figure 10, B). Quite 
significant amounts of sulphate were produced at all pH 
values studied (pH 5 - pH 9.5).
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Figure 1 - SULPHATION OF 7-HYDROXYCOUMARIN BY CYTOSOL
FRACTION OF GUINEA-PIG INTESTINAL CELLS
7-Hydroxycoumarin (lOOpM) was incubated with 
a PAPS generating system and 0.35-0.45mg 
cytosolic protein in tris-HCl buffer (0.25M, 
pH 7.4) at 37°C. At the times indicated, 
the reaction was stopped and the unreacted 
7-hydroxycoumarin removed by extraction with 
ether. The aqueous fraction remaining was 
deconjugated and the 7-hydroxycoumarin released 
determined fluorimetrically. Results represent 
the mean of three duplicate determinations.
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Figure 2 - SULPHATION OF 2-HYDROXYBIPHENYL BY CYTOSOL
FRACTION OF GUINEA-PIG INTESTINAL CELLS
2-Hyrdroxybiphenyl (lOOpM) was incubated with 
a PAPS generating system and 0.35-0*45mg 
cytosolic protein in tris-HCl buffer (0.25M* 
pH 7.4) at 37°C. At the times indicated the 
reaction was stopped and the unreacted 
2-hydroxybiphenyl removed by extraction with 
n-heptane. The aqueous fraction remaining 
was deconjugated and the 2-hydroxybiphenyl 
released determined fluorimetrically. Results 
represent the mean of three duplicate 
determinations.
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Figure 3 - SULPHATION OF 4-HYDROXYBIPHENYL BY CYTOSOL
FRACTION OF GUINEA-PIG INTESTINAL CELLS
4-Hydroxybiphenyl (lOOjiM) was incubated 
with a PAPS generating system and 0.35-0.45mg 
cytosolic protein in tris-HCl buffer (0.25M, 
pH 7.4) at 37°C. At the times indicated, the 
reaction was stopped and the unreacted 
4-hydroxybiphenyl removed by extraction with 
n-heptane. The aqueous fraction remaining 
was deconjugated and the 4-hydroxybiphenyl 
released determined fluorimetrically. Results 
represent the mean of three duplicate 
determinations.
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Figure 4 - SULPHATION OF 2-HYDROXYBIPHENYL BY CYTOSOL 
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH PROTEIN CONCENTRATION
2-Hydroxybiphenyl (IOOjiM) was incubated with 
a PAPS generating system and 0.2-1.0mg cytosolic 
protein in tris-HCl buffer (0.25M, pH 7.4) at 
37°C. After one hour the reaction was stopped 
and the unreacted 2-hydroxybiphenyl removed 
by extraction with n-heptane. The aqueous 
fraction remaining was deconjugated and the 
2-hydroxybiphenyl released determined 
fluorimetrically.
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- SULPHATION OF 4-HYDROXYBIPHENYL BY CYTOSOL 
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH PROTEIN CONCENTRATION
4-Hydroxybiphenyl (lOOpM) was incubated with 
a PAPS generating system and 0.2-0.8mg cytosolic 
protein in tris-HCl buffer (0.25M, pH 7.4) at 
37°C. After 10 minutes the reaction was 
stopped and the unreacted 4-hydroxybiphenyl 
removed by extraction with n-heptane. The 
aqueous fraction remaining was deconjugated, 
and the 4-hydroxybiphenyl released determined 
fluorimetrically.
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Figure 6 - SULPHATION OF 7-HYDROXYCOUMARIN BY CYTOSOL
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH SUBSTRATE CONCENTRATION
7-Hydroxycoumarin (5-500pM) was incubated 
with a PAPS generating system and Q.35-0.45mg 
cytosolic protein in tris-HCl buffer (0.25M, 
pH 7.4) at 37°C. After 10 minutes the reaction 
was stopped and the unreacted 7-hydroxycoumarin 
removed by extraction with ether. The aqueous 
fraction remaining was deconjugated and the 
7-hydroxycoumarin released determined 
fluorimetrically. Results represent the mean 
of four duplicate determinations.
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Figure 7 SULPHATION OF 2-HYDROXYBIPHENYL BY CYTOSOL 
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH SUBSTRATE CONCENTRATION
2-Hydroxybiphenyl (5-500]iM) was incubated 
with a PAPS generating system and 0.35-0.45mg 
cytosolic protein in tris-HCl buffer (0.25M, 
pH 7.4) at 37°C. After an hour the reaction 
was stopped and the unreacted 2-hydroxybiphenyl 
removed by extraction with n-heptane. The 
aqueous fraction remaining was deconjugated, 
and the 2-hydroxybiphenyl released determined 
fluorimetrically. Results represent the mean 
of three duplicate determinations.
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Figure 8 - SULPHATION OF 4-HYDROXYBIPHENYL BY CYTOSOL 
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH SUBSTRATE CONCENTRATION
4-Hydroxybiphenyl (5-500pM) was incubated 
with a PAPS generating system and 0.35-0.45mg 
cytosolic protein in tris-HCl buffer (0.25M, 
pH 7.4) at 37°C. After 10 minutes the reaction 
was stopped and the unreacted 4-hydroxybiphenyl 
removed by extraction with n-heptane. The 
aqueous fraction remaining was deconjugatedt 
and the 4-hydroxybiphenyl released determined 
fluorimetrically. Results represent the mean 
of three duplicate determinations.
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Figure 9 - SULPHATION OF 4-HYDROXYBIPHENYL BY CYTOSOL
FRACTION OF GUINEA-PIG INTESTINAL CELLS
4-Hydroxybiphenyl (5|iM) was incubated with a 
PAPS generating system and 0.35-0.45mg cytosolic 
protein in tris-HCl buffer (0.25M, pH 7.4) at 
37 C. At the times indicated the reaction was 
stopped and the unreacted 4-hydroxybiphenyl 
removed by extraction with n-heptane. The 
aqueous^fraction remaining was deconjugated and 
the 4-hydroxybiphenyl released determined 
fluorimetrically. Results represent the mean 
of three duplicate determinations.
*Figure 10 - SULPHATION OF 4-HYDROXYBIPHENYL BY CYTOSOL 
FRACTION OF GUINEA-PIG INTESTINAL CELLS - 
VARIATION WITH pH AT TWO SUBSTRATE 
CONCENTRATIONS
4-Hydroxybiphenyl (A, 5jiM and B, 500pM) was 
incubated with a PAPS generating system and 
0.35-0.45mg cytosolic protein in dimethylglutaric 
acid - NaOH buffer (0.25M, pH 5-7.5) or tris- 
HCl buffer (0.25M, pH 7.0-9.5) at 37°C. After 
10 minutes the reaction was stopped and the 
unreacted 4-hydroxybiphenyl removed by 
extraction with n-heptane. The aqueous fraction 
remaining was deconjugated, and the 4-hydroxy- 
biphenyl released determined fluorimetrically. 
Results represent the mean of three duplicate 
determinations.
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DISCUSSION
Conjugation of xenobiotics, especially with sulphate, 
has generally not been studied in as much detail as the 
phase I reactions of drug metabolism (Caldwell (1978)).
Sulphate conjugation of a xenobiotic can produce either 
an active, and possibly toxic, or non-active, and easily 
excreted metabolite (Bock (1977), Powell and Curtis (1978)).
Most of the sulphotransferase activity is found in the 
soluble fraction of cells (the cytosol), where the enzyme 
system responsible for the biosynthesis of PAPS (3*- 
phosphoadenosine 5 f-phosphosulphate) has been found 
(De Meio (1975)). The sulphotransferases which have been 
most extensively studied are those of liver (eg. Banerjee 
 ^ and Roy (1966, 1967, 1968), Barford and Jones (1971),
Koster et al. (1979), Mattock and Jones (1970), McEvoy and 
Carroll (1971), Mulder and Hagedoorn (1974), Sekura and 
Jakoby (1979), Wong (1975), Wu and Straub (1976)) and to 
a lesser extent brain (eg Foldes and Meek (1973), Meek and 
Neff (1973), Pennings et al.(1976, 1977), Wong (1975)), 
whilst intestinal sulphotransferase has received only scant 
attention (Bostrom et al.(1968), Powell and Curtis (1978)).
The present study of guinea-pig intestinal sulphotransferase(s), 
demonstrated that considerable sulphating activity is present 
in the intestinal epithelia. Sulphation of (lOOpM) 7-hydroxy- 
coumarin by the cytosolic enzyme(s) produced roughly 200 
nmoles of sulphate per milligram of protein in an hour 
(Figure 1). However, (100|iM) 4-hydroxybiphenyl was not as 
well sulphated, with less than 50 nmoles of sulphate produced 
per milligram of cytosolic protein in an hour, in this instance 
(Figure 3) 2-hydroxybiphenyl (lOOpM) was even less well 
sulphated, one milligram of protein produced roughly 16 nmoles 
sulphate in an hour (Figure 2 ). The amounts of 7-hydroxy- 
coumarin and 4-hydroxybiphenyl sulphate produced agree well 
with the amounts produced when whole cells were used as the
enzyme source (Chapter 2). However, the amount of 
2-hydroxybiphenyl sulphate formed was considerably higher 
(approx 16 fold) than would have been anticipated from 
results obtained using whole cells (Chapter 2). This 
indicates that the poor sulphation of 2-hydroxybiphenyl 
by isolated cells, both of guinea-pig intestine (Chapter 2) 
and rat liver (Wiebkin et al,(1978)) is probably at least 
partly due to factors other than the inherent activity of 
the appropriate sulphotransferase for 2-hydroxybiphenyl. 
However, since 2-hydroxybiphenyl is still only sulphated at a 
third of the rate of its structural analogue, 4-hydroxybiphenyl 
then part of the answer must also lie with the positioning 
of the hydroxyl group on the biphenyl molecule. It has 
been postulated that the specificity of in vivo sulpho- 
conjugation, in rabbit, is governed to some extent by the 
different substituent groups on the benzene ring of phenols 
(Williams (1938)). It has been demonstrated that the 
electrophilic ortho substituent groups tended to depress 
sulphation, whereas nucleophilic ortho substituent groups 
had the opposite effect. Meta substituent groups had a 
similar, but lower effect while para substituents had 
relatively little effect. In the present case, 2-hydroxy- 
biphenyl can be regarded as being a phenol ring. With an 
ortho substituted phenyl group. The phenyl group will 
have a tendency to be electrophilic (additional electrons 
would stabilise the ring by saturating the double bonds), 
therefore the results of the present investigation confirm 
in vitro that which was observed by Williams (1938) In vivo.
HO' .
2-hydroxybiphenyl 4-hydroxybiphenyl 7-hydroxycoumarin
Figure 11
Sulphation of all three substrates was linear with 
time, though with 7-hydroxycoumarin and 4-hydroxybiphenyl 
(Figures 1 and 3), there were two phases, a faster initial 
rate, followed by a second, slower, linear rate of 
sulphation.
The hydroxyl group of 2-hydroxybiphenyl, being angled 
towards the centre of the molecule, is in a fairly lipophilic 
environment, compared with the hydroxyl groups of the other 
two substrates (Figure 11). This could result in the 
hydroxyl of 2-hydroxybiphenyl being less accessible to the 
sulphotransferase, and be part of the reason why very little 
2-hydroxybiphenyl sulphate is formed.
The use of a crude preparation of PAPS could be 
criticized on the grounds that PAP and ADP (strong inhibitors
of sulphotransferases), may be present as contaminants
•\
(De Meio (1975)). An additional potential problem with
2—  2+the use of a PAPS generating system (ATP, SO^ , Mg , plus 
cytosol fraction as enzyme source) in kinetic studies is 
that with more than one reaction taking place, the rate- 
limiting step may not be the sulphotransferase. However,
y
the present results indicate that formation of PAPS was 
not rate-limiting in our studies, since the rate of the 
reaction was substrate-dependent even with a rapidly 
sulphated substrate such as 7-hydroxycoumarih (Figures 
1 - 3).
Sulphation of 2-hydroxybiphenyl (lOOpM) was linear 
with protein concentration at up to lmg.protein per 2ml 
incubation, and (lOOpM) 4-hydroxybiphenyl sulphation was 
also linear with protein concentration over the range 
investigated (Figures 4 and 5). The amount of protein 
used in all other assays was always less than lmg. When 
substrate concentration was varied, none of the substrates 
used gave a linear relationship between sulphate formed
and substrate concentration (Figures 6-8 ), nor were 
Michaelis-Menten kinetics applicable to the results. 
Sulphation of 7-hydroxycoumarin increased with substrate 
concentration to a maximum value of 26 nmoles sulphate 
formed (per milligram of protein in 10 minutes) at 125]iM 
7-hydroxycoumarin (Figure 6 ). At higher substrate 
concentrations the absolute amount of product formed (per 
milligram of protein in 10 minutes) decreased with increase 
in substrate concentration, up to 400]iM 7-hydroxycoumarin. 
There was a further slight increase in the amount of 
sulphate formed on going from 400pM to 500pM 7-hydroxy- 
coumarin, but this may not have been significant (Figure 6 ). 
When the concentration of 2-hydroxybiphenyl was varied 
(Figure 7), the amount of sulphate formed increased with 
substrate concentration to a maximum of 26 nmoles formed 
(per milligram protein in an hour) at 75jiM substrate. At 
higher 2-hydroxybiphenyl concentrations, the absolute amount 
of sulphate formed decreased with increasing substrate 
concentration (Figure 7). Both 7-hydroxycoumarin and 
2-hydroxybiphenyl appeared to exhibit substrate inhibition.
4-Hydroxybiphenyl gave rise to a much more,complex 
picture (Figure 8 ). There appeared, in this instance, to 
be at least four maxima, followed in three of the cases, 
by a decrease in the amount of sulphate formed with increase 
in substrate concentration. These maxima occurred at 5jiM, 
200jiM, '300pM and 500pM 4-hydroxybiphenyl. Such complex 
kinetics could only occur if a multienzyme system was 
present.
4-Hydroxybiphenyl sulphation was linear with time 
both when at a substrate concentration of 5pM (Figure 9), 
and lOOpM (Figure 3). At 5pM virtually all the substrate 
present was sulphated during the 10 minute incubation. 
Further evidence for the existence of more than one 
sulphotransferase is presented in Figure 10. Here, the
two extremes of 4-hydroxybiphenyl concentration which were 
used in Figure 8., 5pM and 500pM, were used to determine 
the pH optima of- the enzyme(s) involved. The lower 
substrate concentration (Figure 10, A) gave only one peak 
of activity, at pH 7.5, whilst 500pM 4-hydroxybiphenyl 
(Figure 10, B) gave two peaks of activity, at pH 6.5 and 
pH 8.5. This indicates that the enzyme involved in 
sulphating 5pM 4-hydroxybiphenyl was probably different 
from that which sulphated 500pM 4-hydroxybiphenyl.
McEvoy and Carroll (1971) observed that sulphurylation 
of phenols by unfractionated rat liver supernatant showed 
non-linear kinetics for the acceptor substrate, but as 
purification progressed the deviation from linear kinetics 
disappeared. Substrate inhibition was also reported by 
Pennings et al. (1978), who studied rat brain phenol 
sulphotransferase. They found that substrate inhibition 
by the sulphate acceptor (4-hydroxy-3-methoxyphenylethylene 
glycoll) was apparent at concentrations exceeding 0.05mM. 
Substrate inhibition in their studies was linear with the 
concentration of sulphate acceptor, up to 2mM. Sekura and 
Jpkoby (1979) studied a wide range of substrates for their 
rat liver sulphotransferase and found that marked substrate 
inhibition was evident with those compounds for which a 
low Km was observed. From the limited data available it 
appears that substrate inhibition occurs mainly where the 
sulphotransferases have not been completely separated, and 
with substrates having a low Km. Banerjee and Roy (1968) 
purified a phenol sulphotransferase from guinea-pig liver 
and reported no unusual kinetics (p -nitrophenol as 
substrate). Thus, substrate inhibition becomes less 
apparent as the sulphotransferases are separated and purified. 
These enzymes are very unstable during and after purification 
(Banerjee and Roy (1966), Barford and Jones (1971), Mattock 
and Jones (1970), McEvoy and Carroll (1971), Pennings et al.
(1978), Sekura and Jakoby (1979), Wu and Straub (1976)). In
order to stabilise the enzymes it appears to be necessary 
to keep them at pH 7.5, preferably in the presence of EDTA. 
Other compounds which have been added to stabilise or 
activate the sulphotransferases after separation include 
dithiothreitol (3 or ImM), sodium azide (0.05%) and 
merCaptoethanol (10|iM). There is a serious danger that 
the partial purification of these enzymes may lead to the 
modification of their properties from those of the situation 
in vivo.
There is evidence that substrate inhibition occurs
in vivo. The work of Weitering et al. (1979) has shown that,
on increasing an oral dose of phenol given to rats, a
decreasing percentage was excreted as the sulphate. This,
they showed, was not due to lack of inorganic sulphate in
the blood. Previously, workers of the same group showed
that labelled inorganic sulphate in the blood rapidly
equilibrated with the PAPS in the liver and hence the pool
size of active sulphate can be readily determined by
2—measuring blood SO^ (Mulder and Scholtens (1978)).
Weibkin and Bridges (1980) have shown that varying the 
concentration of inorganic sulphate in the incubation 
medium over a 400 fold range, had no influence on the 
sulphation of 4-hydroxybiphenyl by isolated rat hepatocytes, 
despite the fact that 4-hydroxybiphenyl sulphation appears 
to be saturable as the concentration of 4—hydroxybiphenyl 
is increased. It has been postulated that sulphate 
conjugation is capacity limited by the body's pool of 
inorganic sulphate (Houston and Levy (1976), Levy (1978), 
and Levy and Yamada(1971)), however, in these instances 
the theory sprang from the fact that administration of 
sodium sulphate or cysteine prevented inhibition of 
acetaminophen sulphation by ascorbic acid, in which case 
the sulphate could have been acting on the sulphotransferase 
to prevent competitive inhibition by the ascorbic acid, 
possibly via an allosteric modification of the enzyme, and
not necessarily by merely increasing the PAPS available. 
Slotkin et al.(1970) also claim to have shown a capacity 
limited sulphation, this time of harmol. However, as 
Weitering et al. (1975) have pointed out, the data from 
Slotkin*s paper does not support this claim, but indicates 
inhibition of glucuronidation by the sodium sulphite which 
they used to try and increase PAPS levels. Weitering et al.
(1979) suggested that the phenomenon of a decreasing 
percentage of sulphate produced on increasing the amount 
of phenol administered, could be due to the. generally lower 
Kin's of the phenolsulphotransferases than of the glucuronyl- 
transferases. It could also be due to the relative amounts 
of these enzymes present in the cells.
Figure 8 of the present investigation not only 
indicates that substrate inhibition occurred, but also 
that there was more than one sulphotransferase present 
(probably at least four) and that each of the sulpho­
transferases had a different apparent Km for 4-hydroxy­
biphenyl. Such a system of sulphotransferases in the 
intestine would enable the body to quickly and effectively 
sulphate a wide range of concentrations of phenolic 
compounds. Since each enzyme would have a different 
spectrum of substrate affinities, kinetics would be very 
complex. It has been reported (Powell et al.(1974)) that 
humans can ingest up to 600mg of phenolic material per day, 
probably mainly of plant origin (Powell and Curtis (1978)), 
and the intestinal enzymes are the body's first line of 
defence in the case of orally ingested xenobiotics.
Intestinal sulphotransferases exist not only to 
sulphate exogenous compounds which have been orally ingested, 
but also to sulphate various endogenous compounds, such as 
steroids, cholesterol and possibly bile acids. It is 
probable that in vivo endogenous and exogenous compounds 
will compete with each other for sulphation. Compounds
which approach the intestinal epithelia from the luminal 
side of the wall are well sulphated, but it is also possible 
that compounds present in the blood, which approach the 
epithelia from the mesenteric side, may also be metabolised 
in these cells. Elucidation of the full potential of the 
intestine for sulphation of xenobiotics requires further 
investigation.
CHAPTER 4
CONJUGATION AND EXCRETION OF 7-HYDROXYCOUMARIN 
IN SITU AND BY GUT SACS
INTRODUCTION
The intestinal wall is known to be very active in 
the conjugation of xenobiotics and steroids. The conjugation, 
and more especially the glucuronidation, of sterofds has 
been suggested to enhance their absorption through the 
intestinal wall (Kreek et al.(1963), Smith et al.(1963),
Herz et al.(1961)). Compounds absorbed into the intestinal 
epithelial cells can be excreted in two directions, either 
before or after metabolism has taken place (Barr and 
Riege\man (1970, B)). Excretion can occur into the mesenteric 
blood, on the serosal side of the intestine, or into the 
intestinal lumen, on the mucosal side (Barr and Riegel man 
(1970, B)). To investigate the bidirectional excretion of 
xenobiotics from the intestinal mucosa, it was necessary 
to employ a more complex system than those reported so far 
in this study (Chapters 1, 2 and 3). The simplest system 
which can be used for this purpose is an everted gut sac 
preparation. Many workers have used everted gut sacs in 
their investigations of intestinal metabolism and absorption 
(eg Barr and Riegel man (1970, B), Capel et al (1979), Chowhan
and Amaro (1977), Curry et al.’(1971), Fischer and Millburn 
(1970), Gingell and Bridges (1973), Herz et al.(1961),
Kreek et al. (1963), Pantuck et al.(1974), Pekas (1971,
1972, 1974), Smith et al.(1963), Stahl and Tapley (1963), 
Strahl and Barr (1971)). Many have used incubation times 
exceeding one hour. It is likely that with such long 
incubations the intestinal wall will have lost some of its 
integrity. In the present study, everted sacs of guinea- 
pig small intestine were used, with incubation times of up 
to 30 minutes, to investigate excretion of conjugates of 
7-hydroxycoumarin by the intestinal epithelia.
No anaesthetic is required when working with gut sacs, 
but they lack an intact blood supply, and this could create 
an artefactual barrier to absorption, leading to accumulation, 
in the tissue, of the compound being absorbed (Houston et_ al. 
(1974)). Therefore, it is expedient to confirm any findings 
obtained using gut sacs, with results obtained in situ, eg 
using an isolated intestinal loop (Barr and Riegejman (1970, B), 
Gingell and Bridges (1973), Ranee and Shillingford (1977), 
Powell ejt al.(1974)). Isolated loops of intestine in situ, 
have been used in many studies of absorption and metabolism 
of xenobiotics and steroids (Bock et al.(1979), Bock and 
Winne (1975), Breyer and Winne (1977), George et al.(1974), 
Landsberg et al. (1975), Lasker and Rickert (1978),
Nienstedt et al.(1972), Nienstedt and Hartiala (1969),
Turner et al.(1977)). When data is obtained from an 
anaethetised animal there is always the possibility that 
the anaesthetic will in some way alter the metabolism and/ 
or absorption of the xenobiotic, so just as it is deemed 
expedient to confirm findings obtained using gut sacs with 
results obtained in situ, so the reverse also holds. In 
the present study the metabolism and excretion of 7-hydroxy- 
coumarin was investigated using an in situ isolated loop of 
intestine in both rats and guinea-pigs.
Enzyme levels are not uniform throughout the intestine.
The specific activity of 3-hydroxy-3-methylglutaryl coenzyme 
A reductase has been shown to increase, as distance from the 
stomach increases (Merchant and Heller (1977), Sugano et al. 
(1978)), whereas myristate co-hydroxylase remains fairly 
constant (Ichihara ejt al. (1979)), and other enzymes studied, 
such as aminopyrine N-demethylase, cytochrome P-450 (Ichihara
et al. (1979)), alkaline phosphatase (Moog and Yeh (1973)), 
7-ethoxycoumarin 0-deethylase (Scharf and Ullrich (1974)) 
and glucuronyl transferase (Aitio et al.(l968), Hanninen 
(1968)), decrease. It is not known, however, how sulpho- 
transferase activity changes with distance along the small
intestine, and none of the aforementioned studies were 
performed on guinea-pig intestine. The present study 
investigated the conjugation of 7-hydroxycoumarin along 
guinea-pig small.intestine, using everted gut sacs. This 
investigation was necessary to relate the studies performed 
with guinea-pig intestine In situ with those results reported 
in previous chapters (Chapters 2 and 3) which were obtained 
from a different segment of guinea-pig intestine.
MATERIALS AND METHODS
Chemicals
All chemicals used were as previous chapters, or of 
Analar grade from British Drug Houses (Poole, Dorset, 
England).
Animals
Male Gordon Hartley guinea-pigs, 300-400g, and male 
Wistar albino rats, 250g, allowed free access to food and 
tap water were used.
Everted sacs of guinea-pig small intestine.
Animals were killed by cervical dislocation between 
8.30 and 9.30am.. A length of small intestine was removed 
from the animal and flushed out with ice-cold saline. The 
intestine was then cut into 10cm lengths. Each length was 
everted over a metal rod and filled to slight distension 
with ice-cold cell culture medium (Leibovitz L-15 medium 
with glutamine). The other end was ligated, and the sac 
was placed in a 50ml, open, conical flask which contained 
5ml cell culture medium. 7-Hydroxycoumarin was added in 
5]il dimethylformamide (DMF), to give a final concentration 
of IOOjiM in the luminal fluid surrounding the sac. To 
minimise the effect of variation in enzyme activity with 
distance from the stomach (for time-point assays), a 
portion of intestine from the aboral end of the section 
removed from the animal was paired with a portion from the 
oral end. The flasks were incubated in a shaking water 
bath (55 cycles/min) at 37°C for up to 30 min. The reaction 
was stopped by plunging the flasks into ice-water. An 
aliquot (0.5ml) of the luminal fluid was removed, made up 
to 2ml with fresh cell culture medium, and used for 
determination of amount of conjugates. The remainder of
the luminal fluid was discarded and the flask rinsed once 
with medium, which was also discarded. The sac was then 
cut open and an aliquot (0.5ml) of the contents taken, made 
up to 2ml with fresh cell culture medium and used for 
determination of the conjugates (see below).
Determination of variation in conjugation ability with 
distance from the pylorus.
A length of small intestine, from immediately below 
the pyloric sphincter, was removed from each guinea-pig 
and cut into eight 15cm lengths. Each length was everted 
and filled with medium, as previously described. Each 
sac was then placed in a 50ml, open, conical flask, 
containing 5ml cell culture medium with lOOpM 7-hydroxy­
coumarin. The flasks were incubated at 37°C in a shaking 
water bath (55 cycles/min) for 20 min. The reaction was 
stopped by plunging the flasks into ice-water, and an 
aliquot (0 .2ml) was taken from each flask, made up to 2ml 
with fresh cell culture medium, and used for determination 
of hydroxycoumarin conjugates (see below).
In situ isolated loop incubations. -
Animals were anaethetised with pentobarbitone or 
urethane, and a longitudinal abdominal incision was made.
The method used was a modification of that of Doluisio 
et al.(1969). In this instance a 10^15cm portion of the 
small intestine was used, rather than the entire small 
and large intestine. The section used in guinea-pigs was 
between 90 and 110cm away from the pylorus, this being the 
most accessible portion. In rats the section of intestine 
used was between 3 and 20cm below the entry of the bile 
duct. The intestinal loop was flushed out with approximately 
20ml of cell culture medium (Leibovitz L-1*5 medium with 
glutamine), to remove the intestinal contents, and this 
medium was in turn flushed out with a similar volume of
air, introduced by means of a syringe. Substrate solution 
(4-5ml cell culture medium containing lOOpM 7-ethoxycoumarin) 
at 37°C, was introduced into the loop from a plastic syringe 
via a polythene catheter, and the loop was made into a closed 
system by closing stopcocks at both ends of the loop. After 
the requisite incubation time, the entire contents of the 
loop were flushed out with air, introduced via a plastic 
syringe, into a collection syringe, and an aliquot of this 
solution (0 .2ml) was taken, made up to 2ml with fresh cell 
culture medium, and used for determination of the conjugates 
produced. Each incubation with substrate was followed by a 
5 min post-incubation 'wash*, in order to obtain an 
indication of the amount of conjugates left in the mucosa 
after such an incubation. Fresh cell culture medium (at 
37°C), which was substrate free, was introduced into the 
intestinal loop, removed after 5 min and an aliquot taken 
(0 .2ml) and made up to 2ml with fresh medium, and used for 
determination of 7-hydroxycoumarin conjugates.
Determination of 7-hydroxycoumarin conjugates.
The diluted samples (2ml) were placed in screw- 
capped tubes and 7ml ether, containing 1.5% (v/v) iso-amyl 
alcohol added. The unmetabolised 7-hydroxycoumarin was 
extracted into the ether (efficiency of extraction was 
greater than 98%) and discarded, and the extraction process 
repeated twice to reduce background fluorescence. The 
aqueous portion remaining was adjusted to pH 5 by addition 
of (1ml) sodium acetate - acetic acid buffer, 0.1M pH 4.8, 
and ketodase (5000 Fishman units) was added. The samples 
were incubated overnight (16-18 hours) at 37°C. The 
7-hydroxycoumarin standard (in 2jil DMF) was added to the 
appropriate tubes, and 7ml ether (containing 1.5% (v/v) 
iso-amyl alcohol) was added to all tubes. ’ The tubes were 
rotary extracted (30 cycles/min) for 10 min and centrifuged 
for 10 min (2000 rpm MSE Mistral 6L) at 4°C, to separate
the layers. An aliquot (5ml) of the ether layer was back 
extracted into glycine - sodium hydroxide buffer (3.5ml), 
0.2M pH 10.4, The fluorescence of the aqueous layer was 
determined at A.370nm excitation, 450nm emission in a 
Perkin Elmer MPF-3 spectro fluorimeter. To the aqueous 
layer remaining after the ether extraction was added 
sulphatase (300 units) in (1ml) 0.1M sodium acetate - 
acetic acid buffer, pH 4,8, and the samples were incubated 
overnight (16-18 hours) at 37°C. The extraction and 
measurement procedure was repeated to determine the • 
7-hydroxycoumarin sulphate formed.
RESULTS
Everted gut sacs from guinea-pig small intestine 
conjugated over 30% of the (lOOpM) 7-hydroxycoumarin present, 
in 30 minutes, most of the conjugates being released into the 
luminal fluid (Figure 1, A and B). The conjugates released 
on the serosal side of the sacs comprised roughly equal 
quantities of glucuronide and sulphate, whereas those 
released on the luminal side consisted of a- greater 
proportion of sulphate (53-65%) than glucuronide. Less 
than 17% of the total conjugates released from the mucosa 
in 30 minutes were found on the serosal side of the intestinal 
sac. .
The metabolism of 7-hydroxycoumarin in guinea-pig 
small intestine in situ (Figure 2) produced a similar 
quantity of conjugates released into the lumen as was 
found using gut sacs (Figure 1). However, in situ excretion 
of conjugates gave rise to more glucuronide than sulphate 
excreted into the lumen, which is the opposite of what 
happened using gut sacs. After a 5 minute incubation with 
substrate, 9% of the dose accumulated in the tissue and was 
excreted into the lumen during the following 5 minute 
incubation with substrate-free medium (Figure 2 B). After 
longer incubations with substrate, 4% of the substrate 
present was excreted, conjugated, into the luminal fluid 
during the 5 minute ’wash1. When the same experiment was 
performed using rats, the quantity of conjugates excreted 
into the lumen was just over half the amount which had been 
excreted from guinea-pig intestine (Figure 3, A and B).
The amount of 7-hydroxycoumarin sulphate excreted by rat 
intestine was much lower than that excreted by guinea-pig, 
whereas the quantity of 7-hydroxycoumarin glucuronide 
excreted was similar in both rat and guinea-pig (Figures 
2 and 3). The excretion of sulphate by rat intestine was
linear with time (Figure 3, A and B), whereas glucuronide 
was not excreted linearly with time. The amount of 
conjugates which was excreted into the lumen during the 5 
minute 'wash' was never more than 3|% of the substrate 
added, with rat intestine. In guinea-pig small intestine 
a greater amount of conjugates was excreted after the 5 
minute incubation (Figure 2, B) than after the longer 
incubations, but this did not occur in rat intestine 
(Figure 3, B).
Everted gut sacs of guinea-pig small intestine were 
used to investigate the level of conjugating enzymes along 
the small intestine. The results of this study are presented 
in Figure 4, A and B. The glucuronidating capacity of the 
small intestine increased over the first 45cm, before 
gradually falling over the next 75cm to approximately one 
third of the maximum value, or half the value of the first 
15cm, (Figure 4, A). The sulphating capacity remained 
fairly constant over the first 60cm, then fell to less than 
half that value over the next 60cm (Figure 4, B). Sulphating 
capacity was greater (roughly twice) than glucuronidating 
capacity at all points along the small intestine^of guinea- 
pigs.
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Figure 1 - METABOLISM OF 7-HYDROXYCOUMARIN BY EVERTED
GUT SACS FROM GUINEA-PIG. A - CONJUGATES 
RELEASED INTO THE LUMINAL FLUID, B - 
CONJUGATES RELEASED INTO THE SEROSAL FLUID
Everted gut sacs were incubated with lOOpM 
7-hydroxycoumarin at 37°C for periods of up 
to 30 min. At the times indicated, samples 
of the luminal and serosal fluid were taken. 
These samples were deconjugated, extracted 
with ether and the ether fraction extracted 
with glycine - NaOH buffer, pH 10.4. The 
various fractions obtained by this procedure 
were analysed fluorimetrically for 7-hydroxy­
coumarin. Results represent the mean of 
three duplicate determinations. A  total 
metabolites; o glucuronide; □ sulphate.
nm
ol
 
pr
od
uc
t/m
l
5 10 15 20
Incubation time (min)
6
2
201 0
Incubation time (min)
Figure 1
Figure 2 - METABOLISM AND EXCRETION OF 7-HYDROXYCOUMARIN 
BY AN ISOLATED IN SITU LOOP OF GUINEA-PIG 
INTESTINE. A - CONJUGATES RELEASED INTO 
LUMINAL FLUID DURING SUBSTRATE INCUBATION.
B - CONJUGATES RELEASED INTO LUMINAL FLUID 
DURING 5 MIN POST-INCUBATION * WASH*
7-Hydroxycoumarin (lOOpM) was incubated in 
an isolated loop of guinea-pig small intestine 
in situ for periods of up to 30 min. At the 
times indicated, the luminal fluid was with­
drawn and an aliquot taken for deconjugation, 
extraction and measurement of the 7-hydroxy­
coumarin released. After each period of 
incubation, the conjugates remaining in the 
mucosa were determined by r, 5 min incubation 
with substrate-free medium, and the conjugates 
released were measured as before. Results 
represent the mean of three determinations.
A  total metabolites; 6; glucuronide; □
4
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METABOLISM AND EXCRETION OF 7-HYDROXYCOUMARIN 
BY AN ISOLATED IN SITU LOOP OF RAT SMALL 
INTESTINE. A - CONJUGATES RELEASED INTO 
LUMINAL FLUID DURING SUBSTRATE INCUBATION.
B - CONJUGATES RELEASED INTO LUMINAL FLUID 
DURING 5 MIN POST-INCUBATION 'WASH1
7-Hydroxycoumarin (IOOjiM) was incubated in 
an isolated loop of rat small intestine in 
situ for periods of up to 30 min. At the 
times indicated, the luminal fluid was 
withdrawn and an aliquot taken for deconjugation 
extraction and measurement of the 7-hydroxy- 
coumarin released. After each period of 
incubation the conjugates remaining in the 
mucosa were determined by a 5 min incubation 
with substrate-free medium and the conjugates 
released were measured as before. Results 
represent the mean of four determinations.
A  total metabolites; o glucuronide; □ 
sulphate.
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Figure 4 - METABOLISM OF 7-HYDROXYCOUMARIN ALONG THE
SMALL INTESTINE OF GUINEA-PIGS
Glucuronide (A) and sulphate (B) produced at 
various distances away from the pylorus. 
Everted gut sacs of guinea-pig small intestine 
were incubated for 20 min at 37°C with IOOjiM 
7-hydroxycoumarin. At 20 min an aliquot of 
the luminal fluid was taken for deconjugation, 
extraction and measurement of the 7-hydroxy­
coumarin released. Results represent the 
mean of three determinations.
nm
ol
 
pr
od
uc
t 
fo
rm
ed
 
/m
l 
I 2
0
mi
n 
nm
ol
 
pr
od
uc
t 
/m
l/
20
m
in
ITU
12
10
8
6
4
2
- A
20
16
12
8
B
15 30 45 60 75 90 105 120
Distance from pylorus (cm)
15 30 45 60 75 90 105
Distance from pylorus (cm)
120
Figure 4
DISCUSSION
Xenobiotics which are metabolised in the liver can 
be excreted either via the bile or via the urine. Various 
factors determine the route of excretion of a compound, 
the most important of which are molecular weight (especially 
for glucuronides), polarity, metabolism (usually resulting 
in a more polar metabolite), other xenobiotics (in liver, 
especially those inducing cholestasis), sex, species and 
route of administration (Levine (1978)). A minimum molecular 
weight of approximately 325 + 50 is required for significant 
biliary excretion in the rat, in guinea-pig and rabbit the 
approximate figures are 400 and 475 respectively, whilst in 
man the molecular weight threshold is probably 500-600 
(Levine (1978)). A similar choice of excretory routes is 
available to compounds absorbed into the intestinal 
epithelia. From the intestinal mucosa compounds can either 
reemerge into the lumen, or be absorbed into the mesenteric 
blood (Barr and Riegelman (1970, A), Bock and Winne (197,5)). 
The factors which control route of excretion from the 
intestine have not been so far delineated. Glucuronidation 
of steroids in the intestine has been shown to enhance their 
absorption (Kreek et al.(1963), Smith et al.(1963), Herz et 
al.(1961)). However, Bock arid Winne (1975) have shown that
1-naphthol glucuronide can be absorbed from the intestinal 
lumen, unaltered into the blood stream, which belies the 
supposition that the luminal membrane of the mucosa is 
impermeable to glucuronides. When 1-naphthol was instilled 
into an intestinal loop in situ, 1-naphthol glucuronide was 
excreted into the lumen as well as into the blood (Bock and 
Winne (1975)). Little is known of the fate of sulphates 
formed in the intestinal wall, though it has been assumed 
that they would all be absorbed into the blood and transported 
to the liver (Powell and Curtis (1978)). The present report 
investigated the fate of 7-hydroxycoumarin conjugates which
were formed in the intestinal mucosa, using everted gut 
sacs and an isolated intestinal loop jln situ.
Metabolism and excretion of 7-hydroxycoumarin by 
everted sacs of guinea-pig small intestine is shown in 
Figure 1. Over the 30 minute period studied, 32% of the 
substrate present was conjugated and excreted by the 
intestinal mucosa. More than three quarters of the 
conjugates formed by the intestinal wall reemerged on 
the luminal side, whilst 5% of the total substrate present 
(IOOjiM) emerged on the serosal side, conjugated (Figure 1). 
Other workers who have used everted gut sacs have also 
found a large amount of conjugates (glucuronides) reemerging 
on the mucosal side of the wall. Barr and Riegelman (1970, B) 
found the concentration of salicylamide glucuronide in the 
mucosal fluid from 2 to 5 times greater than that of the 
serosal fluid, whilst Fischer and Millburn (1970) reported 
that the amount of stilboestrol glucuronide excreted on the 
mucosal side was 11.3 times the amount excreted on the 
serosal side. Strahl and Barr (1971), who used gut sacs 
to investigate benzoic acid conjugation, reported roughly 
equal quantities of hippuric acid in serosal and mucosal 
fluids. Others reports failed to detect significant levels 
of conjugates in the lumen (Ginge 11 and Bridges (1973),
Pekas (1972), Pantuck et al.(1974)). Relatively more 
sulphate than glucuronide was excreted on the luminal side 
from the everted intestine, whereas on the serosal side 
roughly equal quantities of sulphate and glucuronide were 
found (Figure 1). Whether this situation accurately reflects 
that in vivo is not known, but if it does, then it could 
indicate a selectivity in routes of excretion in the 
intestine, analogous to that of the liver.:
The use of everted gut sacs has been criticised by 
Levine ert al. (1970), who studied, histologically, the 
integrity of everted sacs of rat intestine before and after
incubation at 37°C. They found oedematous spaces evident 
in the villi after 5 minutes incubation, and after 30 
minutes incubation, between 50 and 75% of the normal 
epithelia had disappeared. However, incubation conditions 
used in this instance were rather harsh, with the flasks 
containing the sacs being shaken at 100 oscillations per 
minute on a Dubnoff shaker. Fischer and Millburn (1970) 
also reported histological examination of everted rat gut 
after incubation at 37°C (with no reported agitation), 
and observed only a distension of lymphatic vessels and 
occasionally a small separation of the lamina propria 
and mucosal epithelium. Thus it seems likely that the 
poor condition of the gut sacs of Levine et a l , (1970), 
was due to the harsh mechanical agitation. In the present 
study the gut sacs were shaken gently, at a speed of 55 
cycles/min and, although no histological examination was 
undertaken, the results obtained correlated well with 
those obtained in vivo (Figure 2).
To determine if an intact blood supply would 
significantly alter the disposition of metabolites in the 
small intestine, an isolated loop of guinea-pig small 
intestine was incubated with (IOOjiM) 7-hydroxycoumarin 
(Figure 2). The concentration of conjugates excreted into 
the lumen after a 30 minute incubation was approximately 
the same as that found on the luminal side of the gut sacs 
after the same incubation time (Figures 1, A  and 2, A).
The length of intestine used in situ was the same approximate 
length as the gut sacs. The excretion of compounds into 
the lumen after metabolism by an isolated intestinal loop 
in situ has been reported for steroids (Lasker and Rickert
(1978), Nienstedt et al. (1972)), and xenobiotics (Barr and 
Riegelman (1970), Bock and Winne (1975), Bock et al.(1979), 
Breyer and Winne (1977), Strahl and Barr (1971), Turner et 
al. (1977)). When diethylstilboestrol was incubated In situ, 
between 8 and 19% of the total recoverable radio-activity
was found, as the glucuronide, in the lumen (Lasker and 
Rickert (1978)). Nienstedt et al.(1972) who used 
androstenedione, found up to 24.7% of the total recoverable 
radio-activity present as glucuronide in the lumen, and 
between 0.5 and 2.3% present as the sulphate. Barr and 
Riegelman (1970) found significant quantities of salicylamide 
glucuronide in the lumen after in situ incubation of 
salicylamide, but the amount found in the blood was 3 to 
5 times as great. Bock and Winne (1975), reported that 
20% of the 1-naphthol incubated in situ was. found as the 
glucuronide in the intestinal lumen, after 30 minutes, 
whereas only 3% of naphthalene metabolites were found in 
the lumen (Bock et al. (1979)) and 6% of benzo(a)pyrene 
metabolites. Breyer and Winne (1977) reported that 6% 
of the perazine used was detected as perazine sulphoxide 
in the intestinal lumen, after in situ metabolism. Turner 
et al, (1977) used 1-naphthol in their study and found 45-80%, 
of the glucuronide formed, in the lumen. In the present 
study (Figure 2) over 30% of the substrate administered was 
detected as sulphate and glucuronic acid conjugates excreted 
into guinea-pig intestinal lumen. Between 5 and 9% of the 
conjugates found were excreted into the lumen during the 
5 minute incubation with substrate-free medium. Accumulation 
of substrate and metabolites in the intestinal tissue has 
been reported to occur when gut sacs were used (Herz et al. 
(1961), Houston et al.(1974), Pekas (1971, 1972 and 1974)). 
This is probably due to the lack of an intact blood supply, 
which results in the absorbed substrate and its metabolite(s) 
not being removed by the blood. In this instance (Figure 2) 
the conjugates which were excreted after the substrate had 
been removed, can readily be explained on the basis of the 
cell compartment model of Barr and Riegelman (1970, A), 
which was proposed to explain the mechanism of glucuronide 
synthesis and transport by the intestine. In this model, 
free drug is absorbed into the mucosal cell, where it can 
either be excreted, unchanged, into the lumen or plasma, or
metabolised and then excreted into the lumen or plasma, 
thus requiring a certain amount of xenobiotic to be present 
in the tissue when substrate solution is withdrawn from the 
lumen.
More glucuronide than sulphate was excreted into the 
lumen (Figure 2) in situ, whereas when gut sacs were used 
the reverse was the case (Figure 1). With gut sacs, roughly 
equal quantities of sulphate and glucuronide were excreted 
on the serosal side of the gut. However, when 7-hydroxy­
coumarin was metabolised by a suspension of intestinal 
cells (Chapter 2), more sulphate was formed than glucuronide. 
If it is assumed that metabolism by isolated cells accurately 
mimics metabolism in vivo, then these results appear to 
indicate a selectivity in the excretion of conjugates from 
the intestinal mucosa, le. excretion of glucuronides, which 
are formed in the endoplasmic reticulum, is favoured towards 
the luminal side, whereas sulphates, which are formed in 
the cytosol, may be preferentially excreted on the serosal 
side.
Excretion of conjugates into the lumen was,also shown 
to occur with rat small intestine in situ (Figure 3). The 
amount of conjugates excreted by rat intestine was roughly 
half that excreted by guinea-pig intestine. However, rat 
intestine is not as active in metabolising 7-hydroxycoumarin 
(Shirkey et al.(1979, A)) as'guinea-pig intestine (Chapter 2). 
The amount of sulphate formed by rat intestine has been 
reported as being much less than that formed by guinea-pig 
intestine (Shirkey et al. (1979, A), Chapter 2). This is 
reflected in the amount of sulphate excreted by rat intestine 
into the lumen (3.5 nmol/30 min) compared with that excreted 
by guinea-pig (9.5 nmol/30 min). There is not such a large 
difference between the amounts of glucuronide excreted, 
approximately 11 nmoles per 30 minutes by rat and 16 nmoles 
per 30 minutes by guinea-pig (Figures 2 and 3), which again
tallies with the known amount of metabolism occurring in 
isolated cells from the two species. Sulphation and 
excretion of 7-hydroxycoumarin by rat intestine was linear 
with time, which again is reflected by in vitro metabolism 
(Shirkey et aJ.. (1979) ). Up to 3.5 nmoles of 7-hydroxy- 
coumarin conjugates were excreted during the 5 minute 
incubation with substrate-free medium, which, as with 
guinea-pig intestine, can be explained by reference to 
the cell compartment model of Barr and Riegelman (1970, A).
The excretion of large amounts of xenobiotics into 
the intestinal lumen after metabolism by the mucosa has 
important implications, especially in the case of low 
molecular weight compounds (below 500-600 for humans) 
which would not be excreted in the bile had they been 
formed in the hepatocytes. Conjugates which are excreted 
in this way will pass down the small intestine into the 
caecum and colon, where they may be cleaved by bacterial 
P -glucuronidase and sulphatase. The bacterial flora in 
the large intestine do contain * p -glucuronidase activity
(Levine (1978), Scheline (1968, 1973), Williams (1972)), 
which has been shown to play a significant role in the 
cleavage of digitoxigenin monodigitoxoside glucuronide, 
which is the major water-soluble biliary metabolite of 
digitoxin (Volp and Lage (1978)). However, bacterial 
sulphatases, though they do occur, are not considered to 
play a significant role in hydrolysis of xenobiotic 
sulphates (Scheline (1968, 1973). If bacterial 0 -glucur­
onidase is present in significant quantities, then cleavage 
of glucuronides in the caecum or colon will lead to either 
reabsorption of the aglycone, excretion of the aglycone, or 
possibly to cell damage, since xenobiotic metabolising 
enzymes are much lower in the large than in the small 
intestine (Fang and Strobel (1978, A and B)), leading 
to possible chronic toxic sequalae, such as colonic cancer.
Enzyme levels are not constant throughout the 
intestine (see Introduction). Of the drug metabolising 
enzymes studied, cytochrome P-450 content and aminopyrine 
N-demethylase (Ichihara ejfc al.(1979)), glucuronyl transferase 
(Aitio et^  al. (1966), Hanninen et al.(1968), and 7-ethoxy- 
coumarin O-deethylase (Scharf and Ullrich (1974)) have all 
been reported to decrease as distance from the pyloric 
sphincter increases, whereas glucuronidation of diethyl- 
stilboestrol was the same in oral and aboral segments of 
rat small intestine (Lasker and Rickert (1978)). The 
present investigation showed that glucuronyl transferase 
increased over the first 45cm and decreased gradually over 
the following 75cm of guinea-pig small intestine (Figure 
4, A). A similar pattern of increase over the first segments, 
followed by a decrease in activity over subsequent segments 
was reported by Scharf and Ullrich (1974) for 7-ethoxycoumarin 
O-deethylase in mouse small intestine. Sulphotransferase, 
however, remained constant over the first 60cm, then fell 
to less than half that value over the next 60cm (Figure 
4, B). This indicates.that glucuronidation and sulphation 
are not tightly coupled reactions, since their levels do
not change concomitantly. This experiment (Figure 4) was
.fr
performed in order to relate the work done with guinea-pig 
intestine in situ, which was carried out on a segment 90- 
110cm away from the pylorus, with previous work involving 
isolated intestinal cells from guinea-pig, which was 
carried out on the first 60cm of intestine (Chapter 2).
The quantity of metabolites formed by the isolated, in situ 
loop of intestine (28 nmoles/ml/30 min) considering it came 
from a section with less than half the conjugating ability 
of that used for isolating cells, correlates well with the 
quantity of 7-hydroxycoumarin metabolites formed by isolated 
cells (60 nmoles/ml/30 min) in vitro.
The excretion of xenobiotic conjugates into the 
lumen of the intestine after metabolism in the epithelia,
raises the question of whether products of phase I metabolism 
will also be excreted into the lumen. This seems highly 
probable, since, in the intestine especially, virtually all 
phase I metabolites will be subsequently conjugated prior 
to excretion. Drugs which have an ester side chain will 
be especially prone to this since aryl esterase is very 
active in the intestine (Chapter 1). Anti-inflammatory 
agents (eg. aspirin), some of which are intestinal irritants, 
may be even more toxic if their structure makes them 
candidates for intestinal metabolism, (ie. if there is an 
hydroxyl or ester side chain), since, re-excretion into 
the lumen will prolong their intestinal residence time. 
Esterase in human intestine is not as active as that of 
rat intestine, but is roughly as active as that of guinea- 
pig (Inoue et al.. (1979, B)). Thus, the phenomenon of 
metabolites formed in the epithelia reemerging into the 
intestinal lumen could have widespread implication in 
human pharmacology.
The direction in which conjugates formed in 
hepatocytes are excreted is dependent on the molecular 
weight of the compound, with the higher molecular weight 
compounds being biliarly excreted, and low molecular 
weight compounds passing into the blood. It is possible 
that a similar selectivity operates in the intestine, but 
as yet there is no evidence to support this.
CHAPTER 5 
FINAL DISCUSSION
FINAL DISCUSSION
A number of intestinal diseases appear to be on 
the increase. The metabolism of xenobiotics by the 
intestine could lead to the production of active or 
reactive metabolites, which are capable of binding to 
DNA, and this may have a bearing on the incidence of 
intestinal cancers. A high level of intestinal 
xenobiotic metabolism may result in a significant 
amount of an administered drug being inactivated before 
it reaches the hepatic portal vein, with the result that 
the administered dose will need to be greater in order 
to obtain the required effect. A high drug dose increases 
the risk of toxic side effects and drug-drug interactions.
The induction of intestinal drug metabolising 
enzymes has important pharmacological implications. Some 
drugs may stimulate their own metabolism, and this may 
result in them becoming less effective on prolonged 
administration, if their metabolites are less active than 
the parent compounds. The opposite would be the case if 
the metabolites were more active than the parent drug 
(Conney (1967), Marshall (1978)). The level of the 
intestinal xenobiotic metabolising enzymes can be increased 
not only by drugs, but also by a number of exogenous 
compounds (see Introduction) in the diet and environmental 
contaminants. A greater awareness of intestinal drug 
metabolism may result in more rational drug design and 
formulation which will aid the treatment of intestinal 
diseases.
The present report has described the use of a 
number of different tissue preparations to investigate 
intestinal xenobiotic metabolism. When carrying out 
a quantitative comparison, whether it be of different
species, tissues or cells, it is necessary to have the 
results expressed in comparable terms. In Chapter 1, 
intestinal xenobiotic metabolising enzymes of rat and 
guinea-pig were compared, as were the enzymes of rat 
intestinal tip and crypt cells, and results were expressed 
as product formed in unit time (one minute) per milligram 
of microsomal protein. When the comparison required is 
largely qualitative in nature, then units used for 
expression of enzyme activities are not as critical. In 
Chapter 4, rat and guinea-pig intestine were compared to 
determine whether they were both able to excrete conjugates, 
formed in the intestinal epithelia, back into the lumen of 
the intestine. In this case the necessary information was 
obtained without expressing the results in units of enzyme 
activity.
It is not valid to make fine quantitative 
comparisons between data derived from the different 
tissue preparations used in this thesis, since for each 
preparation results are expressed differently, and 
conversion to comparable results would entail lengthy 
calculations, and may net always be valid. However, 
semi-quantitative trends are apparent when comparing 
different preparations. When the effect of increasing 
substrate concentration on the sulphation of 4-hydroxy- ' 
biphenyl was investigated, substrate inhibition was 
apparent both when isolated cells were the enzyme source 
(Chapter 2) and when the cytosol fraction was the enzyme 
source (Chapter 3). Similarly, the poor sulphation of
2-hydroxybiphenyl was apparent both when isolated cells 
and the cytosol fraction were used as the enzyme source.
Apparent discrepancies can arise when comparing 
results from different tissue preparations. Isolated 
intestinal cells from guinea-pig produced four times as 
much 7-hydroxycoumarin sulphate as 7-hydrOxycoumarin
glucuronide (Chapter 2), but everted sacs of guinea-pig 
intestine (Chapter 4) formed only twice as much of the 
sulphate as glucuronide, whilst isolated intestinal 
loops in situ produced twice as much glucuronide as 
sulphate (Chapter 4), when the substrate concentration 
in each case was IOOjiM. These differences arose from 
the design of the experiments. With the isolated cells, 
conjugates which had been excreted into the medium, and 
those still remaining in the cells were all measured.
With everted gut sacs, only those conjugates which had 
been excreted into the medium were determined, those 
remaining in the tissue were not. When the loop of 
intestine in situ was used, only those conjugates which 
had been excreted on the luminal side of the epithelia 
were determined, and the intact blood supply could have 
affected which conjugates were absorbed or retained in 
the tissue, in preference to being excreted.
The development of an improved method for 
preparing microsomes from rat intestine (Chapter 1) has 
shown that, previously, the amount of cytochrome P-450 
present in intestinal cells has been underestimated, 
due to loss of the enzyme during the preparation of the 
microsomes. It was evident, however, that the greater 
amount of cytochrome P-450 (160pmoles/mg protein) did 
not manifest itself as increased enzymic activity, since 
7-ethoxycoumarin O-deethylase was the same in the present 
report (Chapter 1) as in one where only llpmoles cytochrome 
P-450 /mg protein was reported (Shirkey et al .(1979, B)). 
What, therefore, is the function of this 'extra1 intestinal 
cytochrome P-450?
It has been shown that in liver, cytochrome P-450 
exists in multiple forms (eg Thomas et al.(1979)), and 
the same has been postulated to occur in the intestine 
(Shirkey (1977)). The different forms of cytochrome P-450
have differing substrate specificities, which may overlap, 
therefore, an increased amount of the enzyme need not lead 
to increased metabolism of one specific substrate.
There are a number of endogenous compounds which 
can act as substrates for cytochrome P-450, most of which 
have been demonstrated using liver cytochrome P-450 
(Triilzsch (1977)). The w  and u-1 hydroxylation of fatty 
acids has been demonstrated to be cytochrome P-450 
catalysed in liver, kidney cortex and intestinal microsomes 
(Triilzsch (1977), Ellin et al. (1973), Ichihara et al.
(1979)), and 1 oe-hydroxylation of 25-hydroxyvitamin 
Dg has been shown to occur in kidney (Ghazarian et al. 
(1978)) and liver (Triilzsch (1977)). Other likely 
endogenous substrates for intestinal cytochrome P-450 
include cholesterol (7 oC -hydroxylase), bile acids 
(taurolithocholate, taurochenodeoxycholate, taurodeoxycholic 
acid), steroids (testosterone, androstenedione, oestrogens), 
sulphoconjugated steroids and cortisol (Triilzsch (1977)), 
all of which are substrates for liver cytochrome P-450.
Other xenobiotic metabolising type enzymes also 
play a role in metabolism of endogenous compounds.
Steroids, for example, are known to be glucuronidated 
in the small intestine. The primary function of such 
enzymes is not certain. It is possible that they exist 
mainly to metabolise endogenous compounds, and that 
xenobiotic metabolism is a secondary function, arising 
as an adaptive response to repeated exposure to foreign 
compounds. If this is the case, then in the absence of 
any exogenous substrates, there would still be significant 
amounts of these enzymes present in the body. However, 
if the primary function of these enzymes is to dispose 
of foreign compounds, then it is probable that a much 
lower amount of the enzymes would be present in the 
absence of xenobiotics. This dilemma has yet to be 
resolved.
The method of preparation of microsomes from 
intestinal cells reported in this thesis should be 
appropriate to extend the species comparison of intestinal 
xenobiotic metabolism. The method of preparing microsomes 
could, with some modifications, be applied to the intestine 
of larger animals, such as dog, pig or man. Microsomal 
preparations are useful when making tissue comparisons, 
because the results for all tissues can be expressed in 
the same units (product formed in unit time per mg 
microsomal protein), so quantitative comparisons can 
be made. A microsomal preparation is a much simpler 
system than a whole cell, and so it can be used to 
study individual enzymes. Cofactor requirements of 
enzymes are more easily determined when there is no 
competing reaction, and little or no endogenous cofactor 
is present. The simplest system is the best one to use 
when investigating enzyme kinetics, since concurrent 
reactions can otherwise give spurious results.
Microsomes can be solubilised to release the 
membrane-bound enzymes, which can then be at least 
partially purified. Cytochrome P-450 and NADPH-
■ S ' -
cytochrome P-450 reductase are two of the liver enzymes 
which have been purified in this way (eg Ingelman-Sundberg 
and Gustafsson (1977), Dean and Coon (1977), Bell and 
Hodgson (1977), Dignam and Strobel (1977)). The purified 
enzymes can be used in more detailed studies, aimed at 
characterising the enzymes, such as in the preparation 
of monoclonal antibodies (etg. Guengerich and Mason (1979), 
Pinkus et al.(1977)). Very few detailed studies have 
been made on the intestinal xenobiotic metabolising 
enzymes, and it is not known for example if any of the 
enzymes found in the intestine are the same as, or 
different from, those of the liver.
The cytosol fraction of intestinal cells could 
be used in a number of further studies of intestinal 
xenobiotic metabolising enzymes. Investigation of the 
cytosolic sulphotransferase (Chapters 2 and 3) indicated 
that sulphation of xenobiotics in the intestine is 
probably catalysed by more than one sulphotransferase, 
in guinea-pig. Substrate inhibition of the sulpho­
transf erases was observed both in isolated cells and 
the cytosol (Chapters 2 and 3). Similar studies performed 
on rat intestinal cells would be useful since more is 
known about sulphation in vivo in rat than in guinea-pig. 
Purification, or separation, of the different sulpho- 
transferases would provide unequivocal confirmation of 
the existence of multiple forms of this enzyme in the 
intestine. The purified enzymes could also be used in 
more detailed kinetic studies, particularly of substrate 
inhibition and identification of natural substrates.
Glutathione-S-transferases are another group of 
cytosolic enzymes which play an important role in drug 
metabolism. At least seven distinct glutathione-S- 
transferases have been isolated from rat liver, and the 
indications are that several forms also exist in rat 
intestinal cells (Pinkus et al.(1977)). Transfer of 
glutathione is the first step in mercapturic acid 
formation, among other reactions (eg. glutathione conjugates 
can be subsequently cleaved to give cysteine conjugates 
(Pekas et al.(1979)), but little is known of the extent 
to which glutathione conjugation occurs in the small 
intestine. An investigation using the cytosol fraction, 
or separation of the different glutathione-S-transferases 
could provide much information on the ability of the 
intestine to conjugate xenobiotics with peptides.
156
Viable, isolated cells in suspension ha.ve proved 
to be a useful tool for drug metabolism studies in the 
liver, but so far have been used in very few investigations 
of intestinal drug metabolism (Grafstrom et al. (1979), 
Shirkey et al. (1979,- A), Stohs et al. (1977)). Isolated 
cells are in many ways more versatile than cell fractions. 
They do not require added cofactors, and can be used to 
investigate the relationship between different reactions, 
such as between the phase I and phase II reactions of 
drug metabolism. As well as being used in metabolism 
studies, isolated cells can be used to study the uptake 
of a xenobiotic from solution into the cell, and its 
subsequent release, either before or after metabolism 
has taken place. Isolated cells, possessing an intact 
cell membrane, may present a barrier to the absorption 
and metabolism of some compounds, which would not be 
apparent where a cell fraction is used. Substrate 
specificity could thus be elicited at the membrane 
barrier as well as by the enzyme itself.
With some modifications, the method used to 
isolate cells from guinea-pig small intestine, could be 
applied to the small and large intestines of other 
animal species, including man. Culturing of such cell 
systems could prove useful, especially when dealing with 
human tissue. Culturing cells refers to the maintenance 
of viable cells in vitro for more than twenty-four hours. 
Such systems can be used to study induction in vitro, and 
are thus useful in determination of structure-activity 
relationships of enzyme inducers. The effects of 
xenobiotics on cellular metabolism, particularly related 
to cell division, can be assessed using cultured cells.
The cytotoxicity and cell transforming ability of . 
xenobiotics and their metabolites can also be investigated 
using cultures (San and Williams (1977)). When studying 
human intestinal drug metabolism in vitro, culturing of
tissue explants or isolated cells would allow a larger 
number of studies to be performed on one tissue sample, 
and if storage of the cells is successful (e.g. in liquid 
nitrogen), then this would extend the range of useful 
studies.
Cell cultures do suffer from a number of drawbacks, 
the most significant of which is the dedifferentiation of 
cells which occurs with culture time. Loss of cell 
morphology, and various enzymic activities can occur on 
prolonged culturing. If the original cell suspension 
was a heterogeneous mixture of cell types, on culturing, 
one cell type could outgrow the others and become the 
dominant form. In cultured liver cells, fibroblast 
overgrowth occurs, starting at day four of the culture 
(Fry et al.(1979)). With primary maintenance cultures 
(i.e, from freshly isolated cells rather than established 
cell lines), different laboratories are likely to obtain 
different results since each culture is unique, and the 
same applies to one laboratory performing the same 
experiment at different times. Similar problems exist, 
albeit to a lesser extent, when using established cell 
lines, because mutations occur, which result in the 
characteristics of the cell line being altered. Regular 
checks against standards are necessary in order to 
determine the constancy of the cell line. However, 
provided there is an awareness of the possible pitfalls, 
and proper controls are run concurrently, cell cultures 
could be gainfully employed in studies of intestinal 
drug metabolism.
To determine the relevance of in vitro studies 
to the situation which exists in vivo, it is necessary 
to be able to correlate work done in vitro with jln situ 
or in vivo studies. Much work has already been done 
in vivo using rats, and also in situ. Most studies
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have, however, been concerned principally with the 
absorption of xenobiotics from the intestine, and the 
metabolism occurring during absorption. The present 
investigation (Chapter 4) has shown that 7-hydroxycoumarin, 
instilled into an isolated, in situ loop of rat or guinea- 
pig small intestine, was conjugated in the intestinal 
epithelia and a substantial amount of the conjugates 
was excreted into the intestinal lumen. Conjugates 
excreted in this manner may travel down the intestine 
to the caecum and colon, where the wealth of bacterial 
enzymes could cleave them and release the parent compound, 
or they could be cleaved in the small intestine by lytic 
enzymes in the epithelia or secreted pancreatic enzymes.
The level of xenobiotic metabolising enzymes is lower 
in the colon than in the small intestine, so reconjugation 
is less likely to occur there than if cleavage took place 
in the small intestine. Reabsorption of the parent phenol 
could occur in the large intestine, and damage to the 
colonic cells may result. The excretion of metabolites 
into the lumen may be selective: investigations using
a wide range of substrates may indicate some of the 
factors governing the selectivity. Excretion of 
metabolites from hepatocytes is selective, with higher 
molecular weight compounds being secreted into the bile, 
and low molecular weight compounds going to the kidney, 
a similar situation may pertain to intestinal epithelia.
Work performed on animal tissues should ultimately 
be related to man. To relate in vitro animal studies to 
human drug metabolism, it is necessary to develop methods 
whereby human intestinal xenobiotic metabolising enzymes 
can be determined in vitro. Culturing of cells or tissue 
explants has already been discussed. Rather than simply 
measuring metabolites which are excreted from cells, 
microdensitometry and microfluorimetry might be used to 
measure the enzyme activity of individual cells. Labelled
antibodies could similarly be used to measure enzyme 
levels. Biopsy samples are the most readily available 
source of human tissue, so the development of methods 
for measuring enzyme activity in biopsy samples would 
be a very valuable tool in the investigation of intestinal 
xenobiotic metabolism (Bock et al<(1978), Scott et al. 
(1977)).
The metabolism of xenobiotics by the small 
intestine can be examined using a number of different 
systems. The simplest is a purified enzyme system, 
but this is also technically the most difficult to 
obtain. The most complex system is a whole, living 
animal, but in this instance it is difficult to isolate 
the effect of intestinal drug metabolising enzymes from 
those elicited by other tissues. In between these two 
extremes lie a number of in vitro and iri situ systems, 
a few of which have been used in the present investigation 
to study intestinal xenobiotic metabolism. Gne can never 
hope to answer all the questions concerned with intestinal 
xenobiotic metabolism, since the product of all research 
is more questions, but a greater understanding of the 
role of the intestinal drug metabolising enzymes might 
lead to the prevention or cure of some human intestinal 
diseases.
REFERENCES
References
Aitio, A. Dissertation for. M. D» Thesis, University of 
Turku, Finland (1973).
Aitio, A., Hanninen, 0., Hartiala, K. Acta. Physiol. 
Scand. 73, 33A-34A (1968).
Aitio, A., Parkki, M. G. Toxicol. Appl. Pharmacol. 
44, 107-114 (1978).
Alvares, A. P., Pantuck, E. J., Anderson, K. E., Kappas 
A., Conney, A. H. Drug Me tab.. Rev. j),185-206 (1979)
Ames, B. N. Science 204, 587-593 (1979).
Andersson, B., Berggren, M., Moldeus, P. Drug Metab. 
Disposition (3, 611-616 (1978).
Banerjee, R. K., Roy, A. B. Molec. Pharmacol. 2,
56-66 (1966).
Banerjee, R. K., Roy, A. B. Biochim. Biophys. Acta.
137, 211-213 (1967).
Banerjee, R. K. , Roy, A. B. Biochim. Biophys. Acta.
151, 573-586 (1968).
Barford, D. J., Jones, J. G. Biochem. J. 123,
427-434 (1971).
Barr, W. H. ,< Riegelman, S, J. Pbarm. Sci. 59,
154-163 (1970, A).
Barr, W. H., Riegelman, S. J. Pharm. Sci. 59,
164-168 (1970, B).
Bartsch, H., Margison, G. P., Malaveille, C.,
Camus, A. M., Brun, G., Margison, J. M., Kolar, G. F., 
Wiessler, M. Arch. Toxicol. 39., 51-64 (1977).
Bell, D. Y., Hodgson, E. Gen. Pharmacol. JS, 113-119
(1977).
Benford, D. J., Bridges, J. W. Biochem. Soc. Trans.
7, 1107-1108 (1979).
Bergmeyer, H. V. In: "Methods of Enzymatic Analysis" 
pp. 783-784 Acad. Press N. Y. and Lond. (1963).
Bikle, D. D., Empson, R. N. Jr., Herman, R. H., 
Morrissey, R. L., Zolock, D. R. Biochem. Biophys. 
Acta. 499, 61-66 (1977).
Bjorkhem, I. Pharmacol. & Ther. 1, 327-348 (1977).
Blumberg, W. E. .Quar. Rev* Biophys. 11, 481-542 (1978).
Bock, K. W. Nauhyn Schmeideberg’s Arch. Pharmacol 283,
319-330 (1974). -
Bock, K. W. Arch. Toxicol. 39, 77-86 (1977).
Bock, K. W., Brunner, G., Hoensch, H., Huber, E.,
Jostling, D. Eur. J. Clin. Pharmacol. 14, 367-373
(1978).
Bock, K. W., Clausbruch, U. C. V., Winne, D. Med.
Biol. 57, 262-264 (1979). |
Bock, K. W., Lilienblum, W. Biochem. Pharmacol. 28, 
695-700 (1979).
Bostrom, H. Scand. J. Clin. Lab. Invest. 8(3, 33-54 
(1965).
Bostrom, H., Brbmster, D., Nordenstam, H., Wengle, B. 
Scand. J. Gastroenterol. 3, 369-375 (1968).
Breyer, U., Winne, D. Biochem. Pharmacol. 26, 
1275-1280 (1977).
Bridges, J. W., Fry, J. R. In: "Membranous Elements 
and Movement of Molecules", Vol. 6 of "Methodological 
Surveys in Biochemistry" Reid, E. (Ed.) pp. 375-383 
Ellis Horwood, Chichester (1977).
y ■
Bridges, J. W., Fry, J. R. In: "The Induction of Drug 
Metabolism" Estabrook, R. W., Lindenlaub, E. (Eds.) 
pp. 453-469 Schattauer Verlag, Stuttgart (1978).
Bridges, J. W., Wilson, A. G. E. In: "Progress in Drug 
Metabolism" Vol. 1 Bridges, J. W. and Chasseaud, L. F. 
(Eds.) pp. 193-247 Wiley, Chichester (1976).
Caldwell, J. In: "Conjugation Reactions in Drug 
Biotransformation" Aitio, A. (Ed.) pp. 477-485 Elsevier/ 
North Holland Biomedical Press, Amsterdam (1978).
Campbell, T. C., Hayes, J. R. Pharmacol. Rev. 26, 
171-197 (1974).
Capel, I. D., Pinnock, M. H., Williams, D. C. Eur. J. 
Cancer 15, 127-132 (1979)
Castleden, W. M. Brit. J. Cancer 35, 491-495 (1977).
Chhabra, R. S., Pohl, R. J., Fouts, J. R. Drug Metab. 
Disposition 2, 443-447 (1974).
Chowhan, Z. T., Amaro, A. A. J. Pharm. Sci. 66, 
1249-1253 (1977).
Cinti, D, L. Pharmacol. Ther. 2, 727-750 (1978).
Connely, J., Bridges, J. W. In: "Progress in Drug 
Metabolism" Vol. 4 in press (1980).
Conney, A. H. Pharmacol. Rev. 1J3, 317-366 (1967).
Conney, A. H., Pantuck, E. J., Hsiao, K.-C., Kuntzman, R 
Alvares, A. P., Kappas, A. Fed. Proc. 36, 1647-1652 
(1977).
Correia, M. A. Schmid, R. Biochem. Biophys. Res. 
Commun. 65, 1378-1384 (1975).
Creaven, P. J., Parke, D. V., Williams, R. T. Biochem. 
J. 96, 879-885 (1965).
Cruse, J. P., Lewin, M. R., Ferulano, G. P., Clark, C« G 
Nature 276, 822-824 (1978).
Curry, S. H., D ’Mello, A., Mould, G. P. Brit. J. 
Pharmac. 42, 403-411 (1971).
Dean, W. L., Coon, M. J. J. Biol. Chem. 252, 3255-3261
(1977).
Del Villar, E., Sanchez, E,, Tephly, T. R . . Drug Metab. 
Disposition 2, 370-374 (1974).
De Meio, R. H. In: "Metabolic Pathways" Vol. 7. 
"Metabolism of Sulfur Compounds" Greenberg, D. M. (Ed. ) 
pp. 287-358 Acad. Press (1975).
De Pierre, J. W., Ernster, L. Biochim. Biophys. Acta. 
473, 149-186 (1978).
Dignam, J. D., Strobel, H. W. Biochemistry 16, 
1116-1122 (1977).
Dingell, J. V., Sossi, N. Drug Metab. Disposition 7^, 
61-64 (1979).
Doluisio, J. T., Billups, N. F., Dittert, L. W. ,
Sugita, E. T., Swintosky, J. V. J. Pharm. Sci. 58, 
1196-1202 (1969).
Eastwood, G. L. Gastroenterol. 72_, 962-991 (1977).
Ellin, A., Orrenius, S., Pilotti, A., Swahn, C.-G.
Arch. Biochem. Biophys. 158, 597-604 (1973).
Evans, E. M., Burdett, K. Gut 14, 98-103 (1973).
Evans, E. M., Wrigglesworth, J. M., Burdett, K. J. Cell 
Biol. 51, 452-464 (1971).
Fang, W.-F., Strobel, H. W. Cancer Res.-38, 2939-2944 
(1978, A).
Fang, W.-F., Strobel, H. W. Arch. Biochem. Biophys.
186, 128-138 (1978, B).
Fischer, L. J., Millburn, P. J. Pharmacol. Exper.
Ther. 173, 267-275 (1970).
Foldes, A., Meeke, J. L. Biochim. Biophys. Acta 327, 
365-373 (1973).
Fry, J. R., Jones, C. A., Wiebkin, P., Belleman, P., 
Bridges, J. W. Anal. Biochem. 71, 341-350 (1976).
Fry, J. R., Wiebkin, P., Bridges, J. W. Biochem.
Soc. Trans. 7, 119-121 (1979).
Gaginella, T. S., Haddad, A. C., Go, V. L. W . ,
Phillips, S. F. J. Pharmacol. Exper. Ther. 201,
259-266 (1977).
Geelen, J., Goert, A., Meijer, R., Vander Yies,'J<.
Acta. Endocrinol. 86, 216-224 (1977).
George, C. F., Blackwell, E. W., Davies, D. S.
J. Pharm. Pharmac. R6, 265-267 (1974).
Ghazarian, J. G., Weber, J. L., Sealy, R. C. Febs 
Lett. 86, 213-218 (1978).
Gillette, J. R. Fed. Proc. 38, 1900-1909 (1979).
Gingell, R. , Bridges, J. W. Xenobiotica 3^, 599-604
(1973).
Goodwin, J. F., Choi, S. Y. Clin. Chem. 16^ , 24-31 
(1970).
Grafstrom, R., Moldeus, P., Andersson, B., Orrenius, S. 
Med. Biol. 57, 287-293 (1979).
Grisafe, J. A., Hayton, W. L. J. Pharm. Sci. 67, 
1211-1215 (1978).
Gross, R. L., Newberne, P. M. Clin. Pharmacol. Ther. 
22, 680-698 (1977).
Guengerich, F. P., Mason, P. S. Molec. Pharmacol. 15, 
154-164 (1979).
Halliday, J. W. , Powell, L. W. Clin. Chim. Acta. 43, 
267-276 (1973).
Hanninen, D., Aitio, A. Biochem. Pharmacol. 17, 
2307-2311 (1968).
Hanninen, O., Aitio, A., Hartiala, K. Scand. J. 
Gastroenterol. J3, 461-464 (1968).
Hanninen, O., Aitio, A., Hietanen, E. Med. Biol. 57, 
251-255 (1979).
Harrer, D. S., Stern, B. K., Reilly, R. W. Nature 203, 
319-320 (1964).
Harrison, D. D., Webster, H. L. Exper. Cell Res. 55, 
257-260 (1969).
Hartiala, K. Biochem. Pharmacol. (5, 82-90 (1961).
Hartiala, K. Physiol. Rev. 5^, 496-534 (1973).
Hashimoto, S., Yokokura, T., Kawai, Y., Mutai, M.
Food Cosmet. Toxicol, 14,. 553-556 (1976). /
Herz, R. Jr., Tapley, D. F., Ross, J. E. Biochim. 
Biophys. Acta. 53, 273-284 (1961).
Hietanen, E., Laitinen, M. Biochem. Pharmacol. 27, 
1095-1097 (1978).
Hietanen, E., Lang, M. In: "Conjugation Reactions in 
Drug Biotransformation" Aitio, A. (Ed.) pp. 399-408 
Elsevier/North Holland Biomedical Press, Amsterdam
(1978).
Hietanen, E. Vainio, H. Acta. Pharmacol. Toxicol. 
33, 57-64 (1973).
Hoensch, H., Woo, C.H., Schmid, R. Biochem. Biophys. 
Res. Commun. 65, 399-406 (1975).
Houston, J. B. , Levy, G. J. Pharm. Sci. 6|>, 1218-1221
(1976).
Houston, J. B., Upshall, D. G., Bridges, J. W. J. Pharmacol. 
Exp. Ther. 189, 244-254 (1974).
Howland, R. H., Burkhalter, A. Biochem. Pharmacol. 20, 
1463-1470 (1971).
Huang, K. C. Life Sci. 4, 1201-1206 (1965).
Hulsmann, W. C., Van Den Berg, J. \Y. D., de Jonge, H. R.
In: "Methods in Enzymology" Vol. XXXII "Biomembranes",
Part B, Fleisher, J., Packer, L. (Eds.) pp. 665-673 
Acad. Press (Lond.), (1974).
Ichihara, K., Yamakawa, I., Kusunose, E., Kusunose, M*
J. Biochem. 86, 139-146 (1979). .
Iemhoff, W. G. J., Van Den Berg, J. W. O., De Pijper A. M., 
Hulsman, W. C. Biochim. Biophys. Acta. 215, 229-241
(1970).
Imondi, A. R., Balis, M. E., Lipkin, M. Exper. Cell.
Res. 58, 323-330 (1969).
Ingelman-Sundberg, M., Gufstafsson, J.-A. Febs Lett.
74, 103-106 (1977).
Inoue, A., Morikawa, M., Yamada, T., Sugiura, M.,
Tsudoi, M. Jap. J. Pharmacol. 29, 17-26 (1979, A).
Inoue, M., Morikawa, M., Tsuboi, M., Sugiura, M. Jap.
J. Pharmacol. 29, 9-16 (1979, B).
Jones, G. M., Mayer, R. J. Biochim. Biophys. Acta 
304, 334-641 (1973).
Joshi, S. R., Rice, J. M., Wenk, M. L., Roller, P. R.,
Keefer, L. K. J. Nat. Cancer Inst. 58, 1531-1536 (1977).
Kapitulnik, J., Poppers, P. J., Buening, M . K .,
Fortner, J. G., Conney, A. H. Clin. Pharmacol. Ther.
22, 475-484 (1977).
Kappas, A., Anderson, K. E., Conney, A. H., Alvares, A. P. 
Clin. Pharmacol. Ther. 20, 643-653 (1976).
Kato, R. Drug Metab. Rev. 3^, 1-32 (1974).
Kimmich, G. A. Biochemistry, 9^, 3659-3668 (1970).
Knoll, R. , Christ, W. , Miiller-Oerlinghausen, B. ,
Coper, H. Naunyn-Schmiedebergrs Archiv. Pharmacol.
297, 195-200 (1977).
167
Koster, H., Scholtens, E., Mulder* G. J. Med, Biol. 
57, 340-344 (1979).
Krantz, J. C. Amer. J. Pharm. 449, 90-91 (1977).
Kreek, M. J., Gugenheim, F. G., Ross, J. E., Tapley, D, F« 
Biochim. Biophys. Acta. 74, 418-427 (1963).
Kremski, V. C., Varani, L., DeSaive, C., Miller, P., 
Nicolini, C. J. Histochem. Cytochem. 25, 554-559
(1977).
Kuenzig, W., Tkaczevski, V., Kamm, J. J., Conney, A. H., 
Burns, J. J. J. Pharmacol. Exper. Ther. -201, 527-533
(1977).
Lake, B. G., Hopkins, R., Chakraborty, J. , Bridges, J. W., 
Parke, D. V. Drug Metab.. Disposition 1, 342-349 (1973).
Lake, B. G., Phillips, J. C., Hodgson, R. A., Severn, B. J. 
Gangolli, S. D., Lloyd, A. G. Biochem. Soc. Trans. A, 
654-655 (1976).
Lake, B. G., Phillips, J. C., Linnell, J. C., Gangolli, S. 
Toxicol. Appl. Pharmacol. 3*9, 239-248 (1977).
Landsberg, L., Berardino, M. B., Silva, P. Biochem. 
Pharmacol. 24, 1167-1174 (1975).
Lasker, J. , Rickert, D. E. Xenobiotica j*, 665-672
(1978).
Lehrmann, C., Dllrich, V., Rummel, W. Naunyn- 
Schmiedeberg*s Arch. Pharmacol. 276, 89-98 (1973).
Leibovitz, A., Amer. J. Hygiene 7J3, 173-180 (1963).
Leslie, G. I., Rowe, P. B. Biochemistry 11, 1696-1703 
(1972).
Levine, R. R., McNary, W. F., Kornguth, P. J., LeBlanc, R. 
Eur. J. Pharmacol. 9, 211-219 (1970).
Levine, W. G. Annu. Rev. Pharmacol. Toxicol. 18, 81-96 
(1978).
Levitan, R., Wilson, D. E. In: MTP International
Review of Science, Physiology Series One, Vol. 4.
Jacobson, E. D., Shanbour, L. L. (Eds.) pp. 293-341 
Butterworths, London (1974).
Levy, G. In: "Conjugation Reactions in Drug 
Biotransformation" Aitio, A. (Ed.) pp. 469-476 
Elsevier/North Holland Biomedical Press, Amsterdam 
(1978).
Levy, G., Yamada, H. J. Pharm. Sci. 60, .215-221 (1971).
Litterst, C. L. , Mimnaugh, E. G., Gram, T. E. J. Nat. 
Cancer Inst. 59, 1737-1740 (1977).
Litterst, C. L., Mimnaugh, E. G., Regan, R. L.,
Gram, T. E., Drug Metab. Disposition. 3, 259-265
(1975).
Lowenfels, A. B., Anderson, M. E. Cancer 39^ 1809-1814
(1977).
Lucier, G. W., Sonawane, B. R., McDaniel, 0. S. Drug 
Metab. Disposition 279-287 (1977).
Mahon, W. A., Inaba, T., Stone, R. M. Clin. Pharmacol. 
Ther. 22, 228-233 (1977).
Marshall,W. J. Ann. Clin. Biochem. JL5, 55-64 (1978).
Masters, B. S. S., Nelson, E. B., Schacter, B. A.,
Baron, J., Isaacson, E. L. Drug Metab., Disposition 
1, 121-127 (1973).
Mattock, P., Jones, J. G. Biochem, J. 116, 797-803
(1970).
Mazel, P. In: "Fundamentals of Drug Metabolism'nrd 
Drug Disposition" La Du, B. N., Mandel, H. G., Way, E. 
(Eds.) p. 543 Williams and Wilkins, Baltimore (1972),
McEvoy, F. A., Carroll, J. Biochem. J. 123, 901-906
(1971).
McLean, A. E. M. Fed. Proc. 36, 1688-1691 (1977).
Meek, J. L., Neff, N. H. J. Neurochem. .21, 1-9 (1973).
Merchant, J. L., Heller, R. A. J. Lipid Res. 18,
722-733 (1977).
Mitjavila, M. T., Mitjavila, S., Derache, R. Biol. 
Gastro-Enterol. £5, 273-280 (1972).
Moldeus, P., Grundin, R., Vadi, H., Orrenius, S.
Eur. J. Biochem. 46, 351-360 (1974).
Moog, F. , Yey, K.-Y. Comp. Biochem. Physiol. 44,
657-666 (1973).
Mulder, G. J. , Hagedoorn, A. H. Biochem. Pharmacol.
23, 2101-2109 (1974).
Mulder, G. J., Meerman, J. H. N. In: "Conjugation 
Reactions in Drug Biotransformation" Aitio, A. (Ed.) 
pp. 389-397 Elsevier/North Holland Biomedical Press, 
Amsterdam (1978).
Mulder, G. J., Scholtens, E., Biochem. J. 172, 247-251 
(1978).
Nebert, D. W. Biochimie 60, 1019-1030 (1978).
Nienstedt, W., Harri, M.-P., Hartiala, K. Steroids 
Lipids Res. 3, 193-200 (1972).
Nienstedt, W., Hartiala, K., Scand. J. Gastroenterol.
4, 483-488 (1969).
Nordstrom, C., Dahlqvist, A. Scand. J. Gastroenterol.
8, 407-416 (1973).
Nordstrom, C., Dahlqvist, A., Josefsson, L. J. Histochem. 
Cytochem. 15, 713-721 (1968).
Norling, A., Andersson, B., Berggren, M ., Moldeus f P.
Acta. Pharmacol. Toxicol. £3, 311-317 (1978).
Norum, K. R., Liljeqvist, A.-C., Drevon* C. A. Scand. J. 
Gastroenterol 12, 281-288 (1977).
O'Doherty, P. J. A., Kuksis, A. Can. J. Biochem. 53, 
1010-1019 (1975).
Omaye, S. T., Turnbull, J. D. Biochem. Pharmacol. 28, 
1415-1420 (1979).
Omura, T., Sato, R. J. Biol. Chem. 239, 2370-2378 
(1964).
Orrenius, S., Andersson, B., Jernstrom, B., Moldeus, P.
In: "Conjugation Reactions in Drug Biotransformation" 
Aitio, A. (Ed.).pp. 273-282 Elsevier/North Holland 
Biomedical Press, Amsterdam (1978).
Oshino, N. Pharmac. Ther. 2, 477-515 (1978).
Pang, K. S., Gillette, J. R. J. Pharmacokinet. 
Biopharmaceut, 6_, 355-368 (1978).
Pantuck, E. J., Hsiao, K.-C., Kaplan, S. A., Kuntzman, R c., 
Conney, A. H. J. Pharmacol. Exper. Ther. 191, 45-52 
(1974).
Pantuck, E. J., Hsiao, K.C., Kuntzman, R., Conney, A. H t 
Science 187, 744-746 (1975).
Pantuck, E. J., Hsiao, K.-C., Loub, W. D., Wattenberg, L. W. 
Kuntzman, R., Conney, A. H. J. Pharmacol. Exper. Ther.
198, 278-283 (1976).
Pantuck, E. J., Pantuck, C. B., Garland, W. A., Min, B. H., 
Wattenberg, L. W., Anderson, K. E., Kappas, A., Conney, A. H 
Clin. Pharmacol. Ther. 25, 88-95 (1979).
Pekas, J. C. Am. J. Physiol. 220, 2008-2012 (1971).
Pekas, J. C. Toxicol. Appl. Pharmacol. 23, 62-70
(1972).
Pekas, J. C. Toxicol. Appl. Pharmacol. 29, 404-419
(1974)
Pekas, J. C., Larsen, G. L., Feil, V. J. J. Toxicol. 
Environ. Health j>, 653-662 (1979).
Pennings, E. J. M., Vrielink, R., Van Kempen, G. M. J. 
Biochem. J. 173, 299-307 (1978).
Pennings, E. J. M., Vrielink, R., Wolters, W. L.,
Van Kempen, G. M. J. J. Neurochem. £7, 915-920 (1976).
Perris, A. D. Can. J. Biochem. 44, 687-693 (1965).
Phillips, A. M., Langdon, R. G. J. Biol. Chem. 237, 
2652-2660 (1963).
Pinkus, L. M., Ketley, J. N., Jakoby, W. B. Biochem. 
Pharmacol. 26, 2359-2364 (1977).
Powell, G. M., Curtis, C. G. In: "Conjugation Reactions 
in Drug Biotransformation" Aitio, A. (Ed.) pp. 409-416 
Elsevier/North Holland Biomedical Press, Amsterdam
(1978).
Powell, G. M., Miller, J. J., Olavesen, A. H . , Curtis, C. G. 
Nature, 252, 234-235 (1974).
Prior, R. L., Topping, P. C., Visek, W. J. Biochemistry 
JL3, 178-183 (1974).
Prough, R. A., Ziegler, D. M. Arch. Biochem. Biophys.
180, 363- 373 (1977).
Ranee, M. J., Shillingford, J. S .  Xenobiotica 7^,
529-536 (1977).
Raul, F. , Kedinger, M., Simon, P., Grenier, J. ,
Haffen, K. Biol'ogie Cellulaire 33, 163-168 (1978).
Reddy, B. S., Mastromarino, A., Wynder, E. Cancer 39, 
1815-1819 (1977).
Reiser, S., Christiansen, P. A. Biochim. Biophys.
Acta. 225, 123-139 (1971).
Riviere, J. L., Bach, J. Bull. Environ. Contam.
Toxicol. 21, 498-501 (1979).
Rowland, I. R., Cottrell, R. C., Phillips, J. C.
Food Cosmet. Toxicol. JL5, 17-22 (1977).
San, R. H. C., Williams, G. M. Proc.Soc. Exper.
Biol. Med. 156, 534-538 (1977).
Savin, M. A., Cook, J. D. Gastroentrol. 75, 688-694
(1978).
Sayeed, M. M., Baue, A. E. Proc. Soc. Exper. Biol.
Med. 142, 580-585 (1972).
Scharf, R., Ullrich, V. Biochem. Pharmacol. 23, 
2127-2137 (1974).
Scheline, R. R. J. Pharm. Sci. 57, 2021-2037 (1968).
Scheline, R. R. Pharmacol. Rev. 25, 450-523 (1973).
Schiller, C. M., Lucier, G. W. Chem.-biol. Interac.
22, 199-209 (1978).
Scott, B. B., Fairman, M. J., Toothill, C., Losowsky, M.
Digestion 15, 182-187 (1977).
Seitz, II. K., Garro, A. J. , Lieber, C. S. Biochem. 
Biophys. Res. Commun. 85, 1061-1066 (1978).
Sekura, R. D., Jakoby, W. B. J. Biol. Chem. 254, 
5658-5664 (1979).
Shakir, K. M. M., Sundaram, S. G., Margolis, S.
J. Lipid Res. 19, 433-442 (1978).
Shephard, E. H., Hubscher, G. Biochem. JH. 113, 429-440 
(1969).
Shirkey, R. J. PhD Thesis, University of Surrey (1977).
Shirkey, R. J., Kao, J., Fry, J. R. , Bridges, J. W.
Biochem. Pharmacol. 28, 1461-1466 (1979, A).
Shirkey, R. J., Chakraborty, J., Bridges, J. W. Anal. 
Biochem. 93, 73-81 (1979, B).
Sieber, S. M., Cohn, V. H., Wynn. W. T. Xenobiotica 
4, 265-284 (1974).
Sjostrand, F. S. J. Ultrastructure Res. 22, 424-442 
(1968).
Slotkin, T. A., Di Stef ano, V., Au, W. Y. W. J.
Pharmacol. Exper. Ther. 173, 26-30 (1970).
Smith, F. R., Tapley, D. F., Ross, J. E. Biochim. 
Biophys. Acta. .69, 68-73 (1963).
Stahl, T. J., Tapley, D. T. Endocrinology 73y 271-272 
(1963).
Stern, B.K., Reilly, R. W. Nature 205, 563-565 (1965).
Stohs, S. J., Grafstrom, R. C., Burke, M. D., Moldeus, P 
Orrenius, S. G. Arch. Biochem. Biophys. 177, 105-116
(1976).
Stohs, S. J., Grafstrom, R. C. , Burke, M. D., Orrenius, 
Arch. Biochem. Biophys. 179, 71-80 (1977).
Strahl, N. R., Barr, W. H. J. Pharm. Sci. 60, 278-281
(1971).
Sugano, M., Okamatsu, H., Ide, T. Agric. Biol. Chem.
42, 2009-2014 (1978).
Sunter, J. P., Appleton. D. R., Wright, N. A., Watson, A 
Brit. J. Cancer 37, 662-672 (1978).
Swahn, A. Eur. J. Clin. Pharmacol. 9, 299-306 (1976).
Takesue, Y., Sato, R. J. Biochem. (Tokyo) 64, 873-883
(1968).
Tayer, R., Piper, D. W. Cancer 39, 2520-2523 (1977).
Thomas, P. E., Korzeniowski, D., Ryan, D., Levin, W. 
Arch. Biochem. Biophys. 192, 524-532 (1979).
Thompson, J. A., Holtzman, J. L. Biochem. Pharmacol. 
26, 1803-1808 (1977).
Toner, P. G. Internat. Rev. Cytology 2£, 233-343 (1968).
Towler, C. M., Pugh-Humphreys, G. P., Porteus, J. W.
J. Cell Sci. 29, 53-76 (1978).
Tredger, J. M. , Chhabra, R. S. Xenobiotica J7, 481-489 
(1977).
Triilzsch, D. Acta. Hepato-Gastroenterol. 24, 302-306 
(1977).
Turner, J. C., Shanks, U., Kelly, W. J. , Green, R. S.
Gen. Pharmacol. 8, 51-54 (1977, A).
Turner, J. C., Green, R. S., Kelly, W. J. Gen.
Pharmacol. 8, 239-242 (1977, B).
Uehleke, H. Proc. Eur. Soc. Drug Toxicity 1£, 94-100
(1969).
Ullrich, V., Weber, P. Hoppe-Seyler’s Z. Physiol.
Chem. 353, 1171-1177 (1972).
Uotila, P. Res* Commun. Chem. Pathol. Pharmacol. 17, 
101-114 (1977).
Vadi, H., Moldeus, P., Capdevila, J., Orrenius, S.
Cancer Res. 35, 2083-2091 (1975).
Van Dongen, J. M., Kooyman, J., Visser, W. J . , Holt, S. J, 
Galjaard, H. Histochem. J. 9, 61-75 (1977).
Vesdl , E. S. Clin. Pharmacol. Ther. 22, 659-679
(1977).
Volp, R. F., Lage, G. L. Drug Metab. Disposition (3, 
418-424 (1978).
Von Bahr, C., Vadi, H., Grundin, R., Moldeus, P.,
Orrenius, S. Biochem. Biophys. Res. Commun. 59,
334-339 (1974).
Wallusch, W. W., Nowak, H., Leopold, G., Netter, J. 
Internat. J. Clin. Pharmacol. Biopharm. 1(3, 40-44
(1978).
Wattenberg, L. W., Leong, J. L., Strand, P. J. Cancer 
Res. 22, 1120-1125 (1962).
Webster, H. L., Harrison, D. D. Exper. Cell. Res. 56, 
245-253 (1969).
Weigl, K., Sies, H. Eur. J. Biochem. 77, 401-408
(1977).
Weitering, JV G., Krugsheld, K. R., Mulder, G. J. Biochem. 
Pharmacol. 28, 757-762 (1979).
Welling, P. G. J. Pharmacokinet. Biopharmaceut. J),
291-334 (1977). -
Weibkin, P., Fry, J. R., Jones, C. A., Lowing, R.,
Bridges, J. W. Xenobiotica (5, 725-743 (1976).
Weibkin, P., Fry, J. R., Jones, C. A., Lowing, R.,
Bridges, J. W. Biochem. Pharmacol. 27, 1899-1907 (1978).
Williams, R.T. Biochem. J. 32, 878-887 (1938).
Williams, R. T. Toxicol. Appl. Pharmacol. 23, 769-781
(1972).
Wong, K. P. J. Neurochem. 24, 1059-1063 (1975).
Wu, S.-C. G., Straub, K. D. J. Biol. Chem. 251, 6529- 
6536 (1976).
Zampaglione, N. G., Mannering, G. J. J. Pharmacol 
Exper. Ther. 185, 676-685 (1973).
1106 BIOCHEM ICAL SOCIETY T R A N SA C T IO N S
Elcombe, C. R., Bridges, J. W., Gray, T. J. B., Nimmo-Smith, R. H. & Nctter, K. J. (1975) 
Biochem. Pharmacol. 24,1427-1433 
Fennell, T. R. Dickins, M. & Bridges, J. W. (1979) Biochem. Pharmacol. 28, 1427-1429 
Franklin, M. R. (1971) Xenobiotica 1, 581 
Parke, D . V. & Rahman, H. (1971) Biochem. J. 123, 9p 
Philpot, R. M. & Hodgson, E. (1971) Life Sci. 10, 503-512
Intact Guinea-Pig Intestinal Cells as a Model for Studying 
Drug Metabolism
JA N E T  R . D A W SO N  and JAM ES W . BRIDG ES
D epartm ent o f  Biochem istry and Institute o f  Industrial and 
Environmental H ealth and Safety , University o f  Surrey, Guildford,
Surrey, G U I 5X H , U .K.
A  suspension o f  isolated, intact cells is a  very useful system for investigation o f  cellular 
functions. In the field o f  drug metabolism, the use o f  isolated cells enables phase I and  
phase II reactions to be studied simultaneously, w ithout the addition o f  cofactors. 
This means that the isolated cell system is for many purposes a much better reflection  
o f  the situation in vivo than a  cell fraction such as m icrosomai preparation, whilst a t  
the sam e tim e retaining the advantage o f  good control o f  experimental conditions. 
Isolated hepatocyte preparations have been widely used in biochem ical studies and the  
m ethods for their preparation are now  fairly standard (Fry & Bridges, 1976). Isolation  
o f intestinal epithelial cells gives a greater technical difficulty than a hepatocyte prepara­
tion because many other cell types are also present in large am ounts and the presence 
o f  mucus, which is produced by the goblet cells even in  an isolated cell suspension, 
tends to produce large aggregates o f  cells, which very quickly lose their viability, are  
difficult to work with and m ay be a  barrier to the diffusion o f  substrates into cells and  
the measurement o f  product formation.
W e have recently developed an enzymic method (J. R . D aw son & J. W . Bridges, 
unpublished work) w hich results in suspensions o f  individual isolated cells from guinea- 
pig intestine. W ith this preparation the goblet cells appear to adhere to the mucus and  
remain on  the bolting cloth during filtration. The viability o f  this cell suspension, w ith  
. exclusion o f  the dye Trypan Blue used as a measure o f  an intact cell membrane, w as  
never less than 88 % even after 2 h  incubation at 37°C. The high viability o f  the prepara­
tion  w as confirmed by determining the conjugafion o f  4-hydroxybmhenyI (IOO um), 
which was found to be linear for over 1 h. This cell preparation was thus considered  
suitable for the study o f  drug metabolism for periods o f  up to 1 h.
After their isolation, intestinal cells were resuspended at a concentration o f  6 x  105 ce lls / 
m l and used in 2m l portions. The substrates were all dissolved in AW -dimethylformamide 
and used at a final concentration o f  IOO^ um. 7-Ethoxycoumarin was used to dem onstrate 
the relationship between phase I and phase II reactions. Phase I reactions were found to  
be m uch lower in the intestine cells than in liver cell preparations.
Table 1. M etabolism  o f  some foreign compounds by  guinea-pig intestinal cells
Enzyme activity (m ol o f  product form ed/20 min per 
1.2 x lO 7 cells)
Substrate O-De-ethylation Glucuronidation Sulphation
7-Ethoxycoum arin ' 2.26 0.67 1.49
7-H ydroxycoum arin —  21.1 66.5
4-Hydroxybiphenyl —  11.9 9.1
2-H ydroxybiphenyl —  13.0 0.47
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O-De-ethylation o f  7-ethoxycoumarin occurred at the rate o f  only 2.26 nm ol o f  
product form ed/20m in per 1.2 x  107 cells (Table 1). Virtually all o f  the7-hydroxycoumarin  
produced was conjugated with either sulphate (66 %) or glucuronic acid (30 %). W hen 
7-hydroxycoumarin was the substrate 75 % o f  the conjugates were sulphates. The m uch  
greater conjugation rate for 7-hydroxycoumarin than for 7-ethoxycoumarin dem on­
strated that O-de-ethylation was the rate-limiting reaction in the metabolism o f  7- 
ethoxycoum arin. A ddition o f  4-hydroxybiphenyl to isolated cells resulted in equal 
am ounts o f  sulphate and glucuronic acid conjugates at 20m in (Table 1), but the pro­
portion o f  sulphate conjugates increased w ith incubation time. In contrast, 2-hydroxy- 
biphenyl formed virtually no sulphate conjugates, whereas glucuronic acid conjugates 
were produced to  the same extent as w ith 4-hydroxybiphenyl (Table 1). This indicates 
that steric features m ay influence sulphation to a much greater extent than they influence 
glucuronidation. W hether this effect occurs with other pairs o f  phenols is currently 
under investigation. The above experiments show  that the isolated intestinal cell pre­
paration used in the present study is a good m odel for the study o f  the drug-metabolizing 
capability o f  the intestine.
Effect of Age and Sex on Enhancement of Biphenyl 2-Hydroxylation
D IA N E  J. B E N F O R D  and JAM ES W . BR ID G ES
Institute o f  Industrial and Environmental H ealth and Safety  and  
D epartm ent o f  Biochemistry, University o f  Surrey,
Guildford, Surrey, G U 2 5X H , U.K.
Biplienyl is metabolized predominantly to  4-hydroxybiphenyl by m ost mammalian  
species. M any m inor metabolites have also been identified, including 2-hydroxy- and
3-hydroxy-biphenyl. Pretreatment o f  rats w ith many aromatic hydrocarbons has been  
show n to  selectively induce 2-hydroxylation o f  biphenyl whereas pretreatment w ith  
phenobarbitonecauses induction o f  4-hydroxylation. Tredger e ta l. (1976) demonstrated  
that hepatic microsomal biphenyl 2-hydroxylation is preferentially activated by certain 
corticosteroids in vitro. Betamethasone was particularly effective and thus has been used 
to  investigate the age and sex dependence o f  biphenyl-2 hydroxylation in rats.
W ashed liver microsomal fractions (2m g/m l) from male or female rats (10-49 days 
old) were added to  an N AD PH -generating system containing isocitric acid (3 .5mM), 
N A D P  (0.5mM), isocitrate dehydrogenase (0.4unit/m l) and M g S 0 4 (5mM) in sod ium - 
potassium  phosphate buffer (O.O.'mM), p H 7.6, Betamethasone (10~4m in 10/d o f  
dimethylformamide (D M F )) was added and the preparation preincubated in a shaking 
water bath at 37°C for lm in . Biphenyl (13mM in 1.5% Tween 80) was added (final 
concentration 3.25 mM in 2 ml total volum e) and the incubation continued for 5m in. 
The reaction was stopped by addition o f  4 m-HC1 (0.5m l) and the phenolic m etabolites 
were extracted into trimethylpentane containing 1.5% amyl alcohol (7 ml). These 
extracts were filtered through a 0 .5/un M illipore Teflon filter to rem ove large particles 
o f  protein, evaporated to dryness, redissolved in trimethylpentane (100/d) and the 
hydroxybiphenyls analysed by high-pressure liquid chromatography (Burke e t al., 
1977). Control incubations omitted betamethasone but included its solvent (10/d o f  
D M F ). Biphenyl w as added after the reaction was stopped for blank samples.
In com m on w ith many other cytochrom e P-450-dependent reactions, the ability 
o f  hepatic m icrosomal fraction to hydroxylate biphenyl positions 2, 3 and 4  increased 
from birth to a  peak at 21 days (45g) in both male and female rats. In the 21-day-old  
m ale rat the activities for 2-, 3- and 4-hydroxylation were about 620 ,160  and lOOOpmol/ 
min per mg o f  microsomal protein respectively. Female values were slightly less (460, 
140 and 800pm ol/m in per mg o f  m icrosomal protein). Betamethasone caused an increase 
o f  about 100% in biphenyl 2-hydroxylation by hepatic m icrosomal fractions o f  both  
male and fem ale 21-day-old rats (see Fig. 1).
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XENOBIOTIC METABOLISM BY ISOLATED INTESTINAL 
EPITHELIAL CELLS FROM GUINEA-PIGS
J. R . D a w so n  * and J. W . B r id g e s
Department of Biochemistry and Institute of industrial and Environmental Health and Safety, University of 
Surrey, Guildford, Surrey GU2 5XH, U.K.
{Received 9 April 1979; accepted 31 May 1979)
Abstract— A method is described for the preparation of viable isolated intestinal epithelial cells from guinea- 
pigs. The preparation has been demonstrated to metabolise a number of model drug metabolism substrates. 
For ethoxycoumarin the rate of de-ethylation has been demonstrated to be the rate limiting step in Its 
conversion to 7-hydroxycoumarin sulphate and 7-hydroxycoumarin glucuronide. On increasing the sub­
strate concentration glucuronidation was saturatable whereas sulphation was not. In the case erf' 4- 
hydroxybiphenyl sulphation and glucuronidation rates were comparable, whereas for 2-hydroxybiphenyl 
glucuronidation was the predominant and sulphation the minor pathway. Stereo selectivity in the sulpba- 
transferases is postulated as the explanation of this observation.
The contribution o f  the wall o f the small intestine to the 
metabolism o f  xenobiotics is an important considera­
tion for orally ingested compounds. Metabolism o f  
xenobiotics by the intestine has beep studied using 
microsomal system s, gut sac preparations and in situ  
isolated loops o f intestine [ 1—4]. Microsomal systems 
require the addition o f  cofactors, substrate concentra­
tions used are usually much higher than would be 
encountered in vivo, and the media used are non- 
physiological. When gut sac preparations are used, the 
lack o f an intact blood supply may present an artificial 
barrier to diffusion, and substrate tends to accumulate 
in the tissue [1, 5]. In isolated in situ  loops o f small 
intestine it is difficult to control the pH o f the perfusate, 
the ‘dead space’ (i.e. the regions where the perfusate is 
not exposed to the intestinal wall) will give artificially 
low levels o f  metabolites, and since these experiments 
are carried out under anaesthetic, the anaesthetic may 
influence the results obtained.
Only very limited use has been made o f isolated 
intestinal cell preparations for studying drug metabo­
lism [6 , 7]. Such preparations have a number o f poten­
tial advantages, for example no added cofactors are 
required, there is no artefactual barrier to the diffusion 
o f  substrate and metabolites into and out o f the cells, 
and incubations can be carried out under carefully 
controlled conditions, yet the system remains a rela­
tively simple one. Various means have been used to 
isolate intestinal cells, including mechanical vibration, 
chelation, scraping and enzymic methods [8 -1 5 ] .
In this paper we report a method for the isolation of 
viable cells from guinea-pig small intestine and their use 
to study O-de-ethylation o f 7-ethoxycoumarin and con­
jugation o f 7-hydroxycoumarin, 4-hydroxybiphenyl 
and 2-hydroxybiphenyl. Guinea-pigs were chosen for 
this, study because it was possible to obtain a high yield 
of single, viable cells from guinea-pig intestine, with 
minimal interference from mucus, which is prevalent in 
the rat.
* J. R. D. was a recipient of a Beecham Research 
Studentship.
MATERIALS AND METHODS
Chemicals '■
Protease (type VII), arylsulphatase (type H I), um- 
belliferone and bovine serum albumin (fraction V ) were 
purchased from Sigma Chemicals Co. Ltd. (P oole, Dor­
set, England). Ketodase (sulphatase-free, o x  liver /?- 
glucuronidase) was purchased from W . R . Warner & 
Co. Ltd. (Eastleigh, Hampshire). Leibovitz L-I5 me­
dium with glutamine, and foetal calf serum w ere pur­
chased from G ibco Biocult (Paisley, Renfrewshire, 
Scotland). HEPES (V-hydroxyethylpiperazine-V'-2- 
ethane sulphonic acid) was purchased from Boehringer 
Corp. (Lewes, Sussex). 7-Ethoxycoumarin w as synthe­
sized according to the method o f Ullrich and  Weber 
[16]. All other solvents and chemicals u sed  were o f  
Analar grade from British Drug Houses (Poole, Dorset, 
England).
M ethod fo r  isolation o f  intestinal epithelial cells '
Male Gordon Hartley guinea-pigs, 300—4 0 0  g were 
used. The animals were allowed free access to  food and 
water, and they , were killed by cervical dislocation  
between 8.30 and 9.15 a.m. each day.
Intestinal epithelial cells were isolated from  the up­
per 60 cm o f  small intestine. This section w as excised 
from the animal and flushed with ice-cold  saline 
(0.9% N aC l, w /v), pH 7.4. Three 20  cm lengths of in­
testine were then everted over a metal rod, removed 
from the rod and one end ligated. Each length was then 
filled to slight distension with a Krebs phosphate buffer, 
which was calcium and magnesium free and contained
0.5% (w /v) bovine serum albumin, 5 mM glucose and 
20 mM Hepes [Krebs CM F buffer (pH 7.4 )]. The other 
end was tied off and the lengths o f  intestine were then 
placed in a 250 ml conical flask containing 4 0  ml o f the 
Krebs CM F buffer, with the addition o f  protease 
(1 m g/m l) and ED TA  (1 mM). The flask w as incubated 
in a shaking water bath (55 cycles/m in) at 37°C  for 
20 min. The lengths o f  intestine were then transferred to 
another flask which contained 40  ml o f the K rebs CMF  
buffer, without enzyme or E D TA , and incubation con­
tinued for a further 10 min.
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The cells from both flasks were filtered through 
bolting cloth (1 5 0 /im pore size; Henry Simon Ltd., 
Cheadle Heath, Stockport), the filtrates were made up 
to 100 ml with ice-cold buffer and centrifuged (M.S.E. 
Minor) at approximately 200 g av for 5 min. The cells 
were washed twice with 50 ml o f  the ice-cold Krebs 
CM F buffer and finally resuspended at a concentration 
of approximately 6 x 106 cells/m l in Leibovitz L-15 
medium [ 17], containing 10% foetal calf serum (v/v). 
Cells were counted in an improved Neubauer Chamber 
(Gelman Hawksley, Lancing, Sussex) and viability 
assessed by the ability o f the cells to exclude trypan 
blue.
M etabolism  o f  1-ethoxycoumarin and 1-hydroxycou- 
marin by isolated intestinal epithelial cells from  guinea- 
Pigs
Intestinal epithelial cell suspensions (2 m l) were in- 
cubafed with substrate (100  p M ) in 25 ml open conical 
flasks in a shaking water bath (50  cycles/m in) at 37°C  
for the required length o f time. The reaction was termi­
nated by the addition of ice-cold ether (7 m l) containing
1.5% (v/v) isoamyl alcohol. Under these conditions the 
highly fluorescent, unconjugated 7-hydroxycoumarin 
was quantitatively extracted into the ether. The ether 
extracts (5 m l) were back extracted into 0 .2  M glycine/ 
sodium hydroxide buffer, pH 10.4 (3.5 m l). The fluo­
rescence o f the aqueous layer was determined at 2ex 
370 nm, 2fi 450  nm, using a Perkin-Elmer MPF-3
spectrofluorimeter and compared with appropriate 
standards and controls. The rest o f the method is the 
same as that used by Shirkey e t al. [7].
M etabolism o f  4- and 2-hydroxybiphenyls by isolated  
intestinal epithelial cells fro m  guinea-pigs
The cell suspension was divided into duplicate por­
tions (2 m l) in 25 ml open conical flasks on ice. The 
substrate was added in 2 p\ dimethylformamide (D M F) 
to give a final concentration o f  100 /zM. The flasks were 
incubated in a shaking water bath (50 cycles/m in) at 
37°C . The reaction was stopped at the appropriate 
time, by placing the flasks on ice. The unmetabolised 
substrate was removed by extraction into three 7 ml 
portions o f n-heptane, containing 1.5% isoamyl alco­
hol, and discarded. The aqueous phase was then sub­
jected to deconjugation by the addition o f 1ml 0 .2  M  
acetate buffer, pH 5.0 and 1 m l ketodase 03-glucuroni­
dase in the same buffer), followed by overnight incuba­
tion at 37°C . The hydroxybiphenyl released was ex­
tracted into 7 ml n-heptane and 2 ml o f the organic 
layer was back extracted into 5 ml o f 0 .2  M N aO H . The 
hydroxybiphenyls were measured fluorimetrically, by 
the technique o f Creaven et a i  [ 18]. T o  the aqueous 
phase remaining after deconjugation and extraction o f  
the aglycones, was added 1 m g/m l o f arylsulphatase 
and the deconjugation, extraction and measurement 
procedure was repeated. Appropriate standards and 
controls were also measured.
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Fig. 1. Percentage viability of isolated intestinal epithelial cells from guinea-pigs, during incubation at 37°C. 
A suspension of isolated intestinal cells in cell culture medium (Leibovitz L-15), containing 10 per cent foetal 
calf serum (v/v), was incubated at 37°C in a shaking water bath (55 cycles/min). Aliquots (0.25 ml) of the 
cell suspension were withdrawn at the times indicated, for assessment of the percentage viability.
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Fig. 2. Time course of the metabolism of 7-etho.~ycoumarin in suspension of intestinal epithelial cells from 
guinea-pigs. Viable intestinal epithelial cells (approx. 1.2 x 107 cells in a 2 ml vol.) were incubated with 
100 /tM 7-ethoxycoumarin at 37°C in a shaking water bath (50 cycles/min), for periods of up to 60 min. At 
the times indicated, the suspensions were deconjugated, extracted with ether, and the ether fraction extracted 
i with glycine/NaOH buffer, pH 10.4. The various fractions obtained by this procedure were analysed 
fluorimetrically for 7-hydroxycoumarin. Cells were pooled from 2 animals. Results represent the mean of 
three determinations. A total metabolites; O glucuronides; □  sulphates; A free metabolites.
r e su l t s  glucuronic acid (29.5 per cen t) conjugates o f  7-hy-
droxycoumarin (Fig. 2). The total amount o f  7-ethoxy- 
A  suspension o f isolated cells was incubated at 3 7°C coumarin found as metabolites, after a 1 hr incubation,
in a shaking water bath (55 cycles/m in) in order to  was less than 2 per cent o f  the substrate added (i.e.
assess the suitability o f the cells for studies o f drug < 4 n m oles/1.2 x  107 cells). W hen 7-hydroxycou-
metabolism. Portions (0.25 m l) o f the cell suspension marin was the added substrate (at the same concentra-
were withdrawn at the times indicated in Fig. 1, and the tion as that used when 7-ethoxycoumarin w as sub­
viability measured by the ability o f the cells to exclude strate), over 75 per cent o f  the substrate was
the dye trypan blue. The percentage o f cells which were metabolised in 1 hr (Fig. 3 ). T he metabolites in this
viable remained close to 90  per cent for up to 2 hr, instance were glucuronic acid (23  per cent) and sul-
before gradually falling to  60 per cent after 3.5 hr phate (77 per cent) conjugates, 
incubation. The cells were thus deemed suitable for Sulphation of 4-hydroxybiphenyl was linear over the
drug metabolism studies, where the incubation time time period studied (one hour), whilst glucuronidation
was always less than 1.5 hr. was non-linear (Fig. 4). A t the earlier tim e points
The O-de-ethylation of 7-ethoxycoumarin resulted in (<  30  min) there was a greater proportion o f  glucuron-
very little free 7-hydroxycoumarin (3 per cent), most o f ides produced than sulphates, but sulphate conjugation
the metabolites being sulphate (67.5 per cent) and dominated when the incubation time was greater than
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45 min. Approximately 25 per cent o f the substrate viability never fell below 83 per cent (results not 
added was found as conjugates after 1 hr incubation shown)].
(i.e. 50 n m oles/1.2 x  107 cells). 7-Ethoxycoumarin O-de-ethylation and subsequent
2-Hydroxybiphenyl produced a very different pat- conjugation (Fig. 2) was very much slower
tern o f conjugates (Fig. 5). The rate o f sulphate conju- (<  4 nm oles/1.2 x  107 cells/hr) than conjugation
gation was linear, as for 4-hydroxybiphenyl, but the alone, determined by using 7-hydroxycoumarin as sub­
amount o f  sulphates produced was very low (approx. 1 strate (<  150 n m oles/1.2 x  107 cells/hr) (Fig. 3).
per cent o f the substrate added). Glucuronic acid conju- Thus it appears that in guinea-pigs when 7-ethoxycou-
gation accounted for 94.5 per cent o f the metabolites marin is the substrate, the phase I reaction is. the rate-
produced (i.e. 18 nm oles/1.2 x  107 cells) in an hour limiting step, conjugation being forty times faster. With
(Fig. 5). intestinal cells isolated from rats [7], conjugation o f 7-
hydroxycoumarin was only seven times faster than O- 
d is c u s s io n  de-ethylation o f 7-ethoxycoumarin. The finding that the
oxidation rate of xenobiotics is rather low  in the intes- 
The percentage viability of the isolated intestinal tine compared with the liver is supported by findings
epithelial cells was always between 88 and 98 per cent using microsomes from both organs [ 19].
immediately after isolation. On incubation o f the cells Sulphate conjugation accounted for over two-thirds
at 37°C  in a shaking water bath (55 cycles/m in), in the o f the metabolites in guinea-pigs regardless o f whether
absence o f substrate, the viability remained close to 90 7-ethoxycoumarin or 7-hydroxycoumarin was the sub-
per cent for up to 2 hr (Fig. 1). A ll drug metabolism strate (Figs. 2 and 3). In contrast, in rat intestinal cell
studies were conducted on the cell suspension within suspensions [7], conjugation with glucuronic acid gave
1 |  hr o f  their isolation. Incubation for an hour with approximately 85 per cent o f  the total metabolites, for
100 pM  o f any o f the substrates used resulted in a drop both 7-ethoxycoumarin and 7-hydroxycoumarin. A
in percentage viability o f not more than 5 per cent [i.e. low level o f  sulphate conjugation in rat intestine has
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Fig. 3. Time course of the metabolism of 7-hydroxycoumarin in suspensions of intestinal epithelial cells from 
guinea-pigs. Viable intestinal epithelial cells (approx. 1.2 x 107 cells in a 2 ml vol.) were incubated with 
100 /«M 7-hydroxycoumarin at 37°C in a shaking water bath (50 cycles/min), for periods of up to 60 min. 
At the times indicated the suspensions were deconjugated, extracted with ether and the ether fraction 
extracted with glycine/NaOH buffer, pH 10.4. The various fractions obtained by this procedure were 
analysed fluorimetrically for 7-hydroxycoumarin. Cells were pooled from 2 animals. Results represent the 
mean of 3 determinations. A total metabolites; O glucuronides; □  sulphates.
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Fig. 4. Time course of the metabolism of 4-hydroxybiphenyl in suspensions of intestinal epithelial cells from 
guinea-pigs. Viable intestinal epithelial cells (approx. 1.2 x 107 cells in a 2 ml vol.) were incubated with 
100 pM 4-hydroxybiphenyl at 37°C in a shaking water bath (50 cycles/min), for periods of up to 60 min. At 
the times indicated the suspensions were deconjugated, extracted with n-heptane and the n-heptane fraction 
extracted with NaOH (0.2 M). The various fractions obtained by this procedure were analysed fluorimetri- 
cally for 4-hydroxybiphenyl. Cells were pooled from 2 animals. Results represent the mean of 3 determina­
tions. A total metabolites; O glucuronides; □ sulphates.
been demonstrated in a number o f studies using various The pattern o f  conjugation seen with 4-hydrOxybi-
intestinal preparations 13 -7 , 20]; however, no similar phenyl as substrate (Fig. 4 ) contrasts with that obtained 
studies have previously been reported using guinea-pig when 2-hydroxybiphenyl was the substrate (Fig. 5).
intestine. The results o f the present investigation have Although sulphate conjugation in both instances was
been confirmed using gut sacs and isolated in situ  loops linear, 2-hydroxybiphenyl resulted in very few (<  6 per
of guinea-pig small intestine (J. R. Dawson and J. W. cent o f  the total metabolites) sulphate conjugates,
Bridges, submitted for publication). whereas 4-hydroxybiphenyl resulted in alm ost equal
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proportions o f sulphate and glucuronic acid conjugates, phenols by the intestine is easily saturated [2 2  24], 
The amount of glucuronides formed was roughly the whilst glucuronic acid conjugation is not [ 3, 6, 2 2 ,2 3 ] .  
same for both hydroxybiphenyl substrates. The only The results o f the present investigation show that in
difference in the metabolism o f 2-hydroxybiphenyl and guinea-pig intestine glucuronic acid conjugation ap-
4-hydroxybiphenyl was in the amount o f  sulphate con- pears to be saturable (Figs. 3—5), whilst sulphate conju-
jugates formed. The same phenomenon was observed in gation is not. When 7-hydroxycoumarin was adminis-
vivo and in vitro in rat liver with harmol and harmalol, tered to a suspension o f isolated intestinal cells from 
which differ from each other only in the saturation o f a guinea-pigs, at concentrations o f up to 3 0 0  /iM
double bond. In vivo harmol was excreted mostly as (107 cells in a 2 ml v o l.)  no evidence o f  sulphate conju-
harmol-sulphate (70  per cent), with 30 per cent o f the gation saturation was observed, whilst conjugation with
excretion products being harmol-glucuronide [21]. glucuronic acid was maximal at 100 /iM  substrate, and 
Harmalol, however, was excreted mainly as the glucu- no further increase in  glucuronide formation was ob-
ronide (70 per cent), with only a trace (< 3  per cent), served on increasing the substrate concentration (un­
present as harmalol sulphate. Another similarity with published data). .
the hydroxybiphenyls is that harmol and harmalol were In principle the cell isolation technique described 
glucuronidated by U D P  glucuronyltransferase at com- above can be applied to  other mammalian species. It is 
parable rates. This indicates that steric features may certainly applicable to  the rat though the rat prepara- 
influence sulphation to a much greater extent than tion tends to have lower viability because o f the effects
glucuronidation. Whether this effect occurs with other o f mucus. This isolated cell system could be useful for
pairs o f phenols is currently under investigation. the preliminary examination for the possibility o f  me­
l t  has been suggested that sulphate conjugation o f tabolism prior to  studying absorption o f new drug
Incubation time (mini
Fig. 5. Time course of the metabolism of 2-hydroxybiphenyl in suspensions of intestinal epithelial cells from 
guinea-pigs. Viable intestinal epithelial cells (approx. 1.2 x I07 cells in a 2 ml vol.) were incubated with 
100 juM 2-hydroxybiphenyl at 37°C in a shaking water bath (50 cycles/min) for periods of up to 60 min. At 
the times indicated the suspensions were deconjugated, extracted with n-heptane and the n-heptane fraction, 
extracted with NaOH (0.2 M). The various fractions obtained by this procedure were analysed fluorimetri- 
cally for 2-hydroxybiphenyl. Cells were pooled from 2 animals. Results represent the mean of 3 determina­
tions. A total metabolites; O glucuronides; □  sulphates.
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candidates. It may be especially pertinent to use this 
model for those drugs given at low levels which contain 
molecular groups which can be directly conjugated or 
hydrolysed.
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CONJUGATION AND EXCRETION OF METABOLITES OF 7- 
HYDROXYCOUMARIN IN THE SMALL INTESTINE OF 
RATS AND GUINEA-PIGS
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Abstract—  7-Hydroxycoumarin is conjugated with glucuronic acid and sulphate in intestinal preparations of 
both rats and guinea-pigs. The highest activity was found at the oral end of the small intestine and the lowest 
activity at the aboral end. Some distributional differences between the glucuronyl.transferase(s) and 
sulphotransferase(s) were observed. In both gut sacs and in situ preparations a considerable secretion of
conjugate into the lumen was found; the significance 
discussed.
A  number o f  investigators have studied the metabolism  
o f steroids and xenobiotics by the intestinal wall [ 1— 
12]. The aim o f  these investigations 'was mainly to  
obtain information on the nature and extent o f  direct 
conjugation o f  these compounds. In the majority o f  
cases an everted gut sac preparation was used [ 1 -  
7, 9, 10, 12]. The incubation time was at least an hour 
in each study, and often as long as 3 hr. When everted 
gut sacs are used it is difficult to ascertain the viability 
o f the preparation and since the cells will start to die as 
soon as the animal is killed, it is likely that most o f  the 
cells will not be viable after a 2 hr incubation period. 
The lack o f  an intact blood supply in the sacs could 
create an artificial barrier to absorption and excretion. 
Therefore, data obtained using gut sacs requires rein- 
foi cement by results obtained in situ , e.g. from an 
isolated in situ  loop o f intestine.
The intestinal wall is known to be very active in 
conjugation o f  xenobiotics, but little is known o f  the 
fate o f  the conjugates. Different parts o f the small 
intestine may have different enzyme activities [ 17 ,18 ]. 
It has been shown, using gut sacs from rats, that the 
conjugates generally pass into the serosal fluid [ 3 , 4 , 8 -  
12], though in most instances small amounts o f conju­
gates were also found in the mucosal fluid.
The fate o f xenobiotic conjugates, formed in the 
intestinal wall, is not clear. W e have chosen an easily 
measured xenobiotic, 7-hydroxycoumarin, and investi­
gated the fate o f  its glucuronic acid and sulphate con­
jugates using short term incubations with everted gut 
sacs and in situ isolated loops from both guinea-pigs 
and rats. W e have chosen the guinea-pig for particular 
attention because individual cells isolated from the 
guinea-pig intestine have been shown to have a much 
better viability than those derived from rat intestine. (J. 
R. Dawson and J. W. Bridges, Unpublished data). We 
have also examined the distribution o f conjugating 
ability along the intestine using everted gut sacs pre­
pared from different parts o f the gut.
of this finding to chemical toxicity in the lower gut is
MATERIALS AND METHODS
Chemicals
7-Hydroxycoumarin was purchased from Sigma 
Chemicals Co. (Poole, D orset, England). Leibovitz L- 
15 medium was purchased from Gibco Biocult (Pais­
ley, Renfrewshire, Scotland). A ll other chemicals and 
solvents used were o f Analar grade from British Drug 
Houses, (Poole, Dorset, England).
Anim als
Male Gordon Hartley guinea-pigs, 3 0 0 -4 0 0  g, and 
male Wistar albino rats, 250  g  (bred in University o f  
Surrey Animal Unit), allowed free access to food and 
water were used. /
In situ isolated loop experiments
Animals were anaethetised, using pentobarbitone or 
urethane, and a longitudinal abdominal incision was 
made. The method used was essentially that o f D oluisio  
e t al. [13 ], except that a 10—15 cm long portion o f  the 
small intestine was used instead o f  the entire small and 
large intestine. The section o f  intestine used in the 
guinea-pig was between 90 and 110 cm away from the 
pylorus, this being the m ost accessible portion. In the 
rat the section used was between 3 and 20 cm below the 
entry o f  the bile duct. The intestinal loop was flushed 
out with approximately 20 m l o f  cell culture medium 
(Leibovitz L-15 medium [ 2 2 ]), to remove the intestinal 
contents. Substrate solution (between 4 and 5 ml o f  cell 
culture medium containing 100 pM  7-hydroxycou­
marin), at 37°C , was introduced into the loop, and the 
loop made into a closed system  by shutting the stop­
cocks at both ends. After the requisite incubation time, 
the entire contents o f the loop were flushed out with air, 
by means o f a syringe, into a collection syringe, and an 
aliquot o f  this solution was taken for determination o f  
the conjugates produced. Each incubation was followed  
by a 5 min post-incubation ‘w ash’, in order to obtain an
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indication o f the amount o f conjugates left in the cells 
after such incubation. Fresh cell culture medium, which 
was substrate-free, was introduced into the intestinal 
loop, removed after 5 min and an aliquot taken for 
determination o f 7-hydroxycoumarin conjugates.
M easurement o f  7-hydroxycoumarin conjugates
A  0.2 ml portion o f the incubation fluid was made up 
to 2 ml with fresh cell culture medium, and placed in a 
screw-cap tube. The unmetabolised 7-hydroxycou­
marin was extracted into three 7 ml portions o f  ether 
containing 1.5% isoamyl alcohol (efficiency o f extrac­
tion greater than 98 per cent), and discarded. The 7- 
hydroxycoumarin conjugates were hydrolysed and 
measured by the method o f  Shirkey et al. [ 14].
E verted  sacs o f  guinea-pig sm all intestine
A  length o f  small intestine was excised from an 
animal and flushed out with ice-cold saline. The intes­
tine was then cut into six 10 cm lengths. Each length 
was everted over a metal rod, one end tied off, the sac 
was then filled to slight distension with cell culture 
medium, and the other end ligated. The sac was placed 
in a 50 ml open conical flask containing 5 ml cell 
culture medium. 7-Hydroxycoumarin was added in 5 pi 
dimethylformamide, to  give a final concentration o f  
100 pM in the luminal fluid surrounding the sacs. In 
order to  minimise variations between preparations in 
enzyme activity with distance from the stomach, a 
portion o f intestine from the aboral end o f the section 
used was paired with a portion from the oral end. The 
flasks were incubated in a shaking water bath 
(5 5 cycles/m in) at 3 7°C for the required length o f time. 
The reaction was stopped by plunging the flasks into 
ice-water. A n aliquot (0.5 m l) o f the luminal fluid was 
taken, made up to 2 ml with cell culture medium and 
used for determination o f  amounts o f conjugates. The 
remainder o f  the luminal fluid was discarded and the 
flask and sac rinsed once with medium* which was also 
discarded. The sac was then cut open and a portion 
(0.5 ml) o f  the contents taken, made up to 2 ml with cell 
culture medium and used for the determination o f  
conjugates, as before.
Determination o f  variation in conjugation ability with 
distance from  the pylorus
A  length o f small intestine was removed from each 
guinea-pig and cut into eight 15 cm lengths. Each 
length was everted and filled with medium, as previ­
ously described. This was incubated in 5 ml cell culture 
medium, containing 100 pM  7-hydroxycoumarin, at 
37°C  for 20 min. The reaction was stopped by plung­
ing the flasks into ice-water, and a portion was taken 
from each flask for determination o f 7-hydroxycou- 
marin conjugates, as before.
RESULTS
1-Hydroxycoumarin conjugation by everted sacs o f  
guinea-pig sm all intestine
The initial concentration o f 7-hydroxycoumarin in 
the luminal fluid was 100 nmole/ml. After a 5 min incu­
bation o f the everted sacs, 10 per cent o f the substrate 
had reappeared in the lumen in the form o f glucuronic 
acid (4.5 per cent) and sulphate (5.5 per cent) conjug­
ates (Fig. 1A), whilst only 4 per cent had appeared in
the serosal fluid (Fig. IB ) as conjugates. After 30 min 
incubation, 28 per cent o f the 7-hydroxycoumarin had 
reappeared in the lumen as glucuronic acid (10 per 
cent) and sulphate (18  per cent) conjugates, whilst only 
5 per cent o f the substrate had appeared as conjugates in 
the serosal fluid.
M etabolism o f  1-hydroxycoumarin in situ
• The results o f the guinea-pig in situ  loop experiments 
(Fig. 2) confirmed those obtained using the everted 
sacs. The mesenteric blood was not sampled, owing to  
the difficulty o f assaying for 7-hydroxycoumarin and 
its conjugates in blood. Measurement o f  the levels o f  
conjugates in the lumen o f  the intestine agreed quite 
well with the results o f the everted sac experiments, the 
main difference being in the relative proportions o f  
sulphate and glucuronic acid conjugates. After a 5 min 
incubation in the isolated loop, 13 per cent o f  the total 
7-hydroxycoumarin added had emerged into the lumen, 
conjugated with sulphate (4 per cent) and glucuronic 
acid (9 per cent). After 30 min incubation 27 per cent 
o f the total substrate had emerged into the lumen, 
conjugated to sulphate (9.5 per cent) and glucuronic 
acid (16.5 per cent).
The Wistar albino rat was used to determine if  the 
appearance o f conjugates in the lumen in such high 
concentrations was peculiar to the guinea-pig. The in 
situ  isolated loop o f  rat small intestine gave a very 
similar picture to that seen with the guinea-pig, the main 
difference being that rat intestine had a linear rate o f  
sulphate conjugation, which was proportionally lower 
than that found in guinea-pig. After 5 min incubation in 
rat, 4 per cent o f  the total 7-hydroxycoumarin added 
had emerged into the lumen (Fig. 3 ), conjugated with 
sulphate (0.5 per cent) and glucuronic acid (3.5 per 
cent). After 30 min incubation, 14 per cent had ap­
peared in the lumen as sulphate (3.5 per cent) and 
glucuronic acid (10.5 per cent) conjugates.
Variation in,.conjugation o f  1-hydroxycoumarin along  
the intestine
Consecutive lengths o f  guinea-pig small intestine 
were incubated as everted sacs in 100 /iM  7-hydroxy- 
coumarin to investigate the variation in conjugating 
ability in the small intestine. Glucuronic acid conjuga­
tion increased.between 0  and 45 cm from the pylorus, 
before decreasing to half o f the initial level at over 
90  cm from the pylorus. Sulphate conjugation did not 
show any initial increase, but fell slightly between 0  and 
60 cm from the pylorus, then fell to  less than half the 
initial level at distances greater than 60  cm away. A l­
though there was some variation between individual 
animals, the same distributional pattern was seen in 
each animal.
DISCUSSION
It has previously been postulated that glucuronida­
tion in the small intestine might be an important mecha­
nism for the transfer o f  steroids and xenobiotics from 
the lumen into the blood stream [ 1 -6 ]. U sing everted 
gut sacs we have shown that substantial amounts o f  7- 
hydroxycoumarin conjugates are released back into the 
luminal fluid rather than being transferred to the serosal 
fluid. Previous workers using everted gut sac prepara­
tions have shown that exit o f conjugates from the rat
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Fig. 1. Time course of the metabolism of 7-hydroxycoumarin in guinea-pig everted gut sacs. A-Conjugates 
released into the luminal fluid. B-Conjugates released into the serosal fluid.
Everted gut sacs were incubated with 100 fiM 7-hydroxycoumarin at 3 7°C for periods of up to 30 min. At 
the times indicated, samples of the luminal and serosal fluid were taken. These samples were deconjugated, 
extracted with ether and the ether fraction extracted with glycine/NaOH buffer, pH 10.4. The various 
fractions obtained by this procedure were analysed fluorimetrically for 7-hydroxycoumarin. Results 
represent the mean of 3 determinations. A total metabolites; O glucuronides; □  sulphates.
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Fig. 2. Time course of the metabolism of 7-hydroxycoumarin by an isolated in situ loop of guinea-pig small 
intestine, showing A-conjugates released into luminal fluid during substrate incubation, and B-conjugates 
released into luminal fluid during a 5 min post-incubation ‘wash’. 7-Hydroxycoumarin (100 ;iM) was 
incubated in an isolated in situ loop of guinea-pig small intestine for periods of up to 30 min. At the times 
indicated, the luminal fluid was withdrawn and an aliquot taken for deconjugation, extraction and measure­
ment of the 7-hydroxycoumarin released. After each period of incubation the conjugates remaining in the 
epithelial cells were determined by a 5 min incubation with substrate-free medium and the conjugates released 
were measured as before— all other details as for Fig. 1.
Metabolites of 7-hydroxycoumarin 3295
.A__
I ncuba t ion  t ime (min)
Q_ IT)
155 10 20 30
Incubat ion t ime (min)
Fig. 3. Time course of the metabolism of 7-hydroxycoumarin by an isolated in situ loop of rat small intestine. 
A— Conjugates released into luminal fluid during incubation of substrate. B— Conjugates released into 
. luminal fluid during 5 minute post-incubation ‘wash’. Results represent the mean of four determinations-— all
other details as for Fig. 1.
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intestinal mucosa into the lumen may occur [ 2 -  
4, 6, 9, 10], though in most cases only trace amounts of 
conjugates were found in the lumen and little in vivo 
significance was ascribed to the results.
In the present investigation the gut sac results are 
supported by the finding that in in situ preparations o f  
both guinea-pigs and rats substantial amounts o f glucu­
ronic acid and sulphate conjugates o f 7-hydroxycou- . 
marin are also found in the luminal fluid. In the present 
investigation, sulphate conjugation accounted for 21 
per cent in rats, and 36 per cent in guinea-pigs, o f the 
total conjugates produced in situ. When gut sacs were
used relatively larger proportions o f  sulphate conju­
gates (~ 5 0  per cent) were formed along the entire 
length o f the small intestine. Whether this discrepancy 
is due to som e loss o f viability o f  the gut sac prepara­
tions or to pharmacokinetic reasons, is difficult to  
ascertain. Sulphate conjugation o f  phenol by the intes­
tine has been reported previously in one study [1 6 ] , but 
the amount was only one twentieth o f the extent o f  
glucuronidation, whereas other investigators have 
failed to detect significant levels o f sulphate conjugation 
[1- 12].
Some workers [ 1 ,3 ,4 ,9 ,  10] have shown an accu-
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Fig. 4. Metabolism of 7-hydroxycoumarin along the small intestine of guinea-pig. Glucuronides (A) and 
sulphates (B) produced at different distances from the pylorus. Everted gut sacs of guinea-pig small intestine 
were incubated for 20 min and the conjugates in the luminal fluid determined as for Fig. 1. The results 
represent the mean of three determinations— all other details as for Fig. 1.
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mulation o f radioactivity in the intestinal wall during 
absorption o f a radio labelled compound. This is partic­
ularly common with gut sac preparations [23]. The in 
situ experiments (Figs. 2B and 3B) show release o f  
conjugates into the lumen o f the intestine over a 5 min 
period, after removal of substrate from the lumen, 
accounting for 3 -9  per cent o f the 7-hydroxycoumarin 
added originally. This demonstrates that considerable 
amounts o f substrate can accumulate in the epithelial 
cells prior to release o f metabolites into the lumen.
The variation o f UDP-glucuronyl transferase with 
distance from the pylorus, in the rat, has been demon­
strated by Hanninen e ta l. [ 18], who found ah exponen­
tial decrease in the oral half and a much less marked 
decrease in the aboral half. Scharf and Ullrich [17] 
investigated the variation in 7-ethoxycoumarin 0-de- 
ethylase in mouse intestine, relative to distance from the 
pylorus. They found an initial increase in activity be­
tween 0  and 60 cm, followed by a decrease between 10 
and 26 cm.-In the present study, glucuronidation o f 7- 
hydroxycoumarin in guinea-pig small intestine in­
creased between 0  and 45 cm before gradually decreas­
ing to less than half o f  the maximum value. In contrast, 
sulphate conjugation gave no initial increase, but fell to  
less than half o f the highest value, after 60 cm. This 
decrease in conjugating enzymes as distance from the 
pylorus increases may be an adaptation to the level o f  
dietary substrates encountered. The highest levels o f  
orally ingested xenobiotics found will be nearest the 
stomach, progressively smaller amounts will be en­
countered in the lower part o f the intestine because 
increasingly the xenobiotic will be absorbed and/or 
metabolised.
The release o f conjugates formed in the intestinal 
epithelial cells into the intestinal lumen has important 
implications, especially in the case o f low molecular 
weight compounds, such as phenol, which would not be 
excreted into the bile after hepatic metabolism. Glucu- 
ronides which are excreted into the lumen o f  the small 
intestine will pass into the large intestine, where signifi­
cant amounts o f bacterial //-glucuronidase are found 
[19—21]. The glucuronides excreted into the small 
intestine could be lysed in the lower gut and since there 
are much lower levels o f conjugating enzymes in these 
regions the aglycqnes could cause damage to the cells o f  
the gut in this region, leading to possible chronic toxic 
sequalae such as colonic cancer. Volp and Lage (1978 )  
have shown that the major water-soluble metabolite o f  
digitoxin, a glucuronide, was excreted in the bile, but
only a few per cent of the amount excreted in the bile 
was recovered in the faeces and urine. This they found 
to be due to bacterial hydrolysis of the glucuronide in 
the caecum [ 24]. Significant levels of bacterial sulpha­
tases in the colon have not been reported but may also 
occur.
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